id	sid	tid	token	lemma	pos
dpc-2111	1	1	dermatology	dermatology	NOUN
dpc-2111	1	2	:	:	PUNCT
dpc-2111	1	3	practical	practical	ADJ
dpc-2111	1	4	and	and	CCONJ
dpc-2111	1	5	conceptual	conceptual	ADJ
dpc-2111	1	6	original	original	ADJ
dpc-2111	1	7	article	article	NOUN
dpc-2111	1	8	|	|	ADV
dpc-2111	1	9	dermatol	dermatol	ADJ
dpc-2111	1	10	pract	pract	NOUN
dpc-2111	1	11	concept	concept	NOUN
dpc-2111	1	12	.	.	PUNCT
dpc-2111	2	1	2022;12(3):e2022146	2022;12(3):e2022146	NUM
dpc-2111	2	2	1	1	NUM
dpc-2111	2	3	introduction	introduction	NOUN
dpc-2111	2	4	:	:	PUNCT
dpc-2111	2	5	it	it	PRON
dpc-2111	2	6	has	have	AUX
dpc-2111	2	7	been	be	AUX
dpc-2111	2	8	reported	report	VERB
dpc-2111	2	9	that	that	SCONJ
dpc-2111	2	10	the	the	DET
dpc-2111	2	11	use	use	NOUN
dpc-2111	2	12	of	of	ADP
dpc-2111	2	13	oral	oral	ADJ
dpc-2111	2	14	isotretinoin	isotretinoin	PROPN
dpc-2111	2	15	may	may	AUX
dpc-2111	2	16	have	have	VERB
dpc-2111	2	17	positive	positive	ADJ
dpc-2111	2	18	and	and	CCONJ
dpc-2111	2	19	negative	negative	ADJ
dpc-2111	2	20	effects	effect	NOUN
dpc-2111	2	21	on	on	ADP
dpc-2111	2	22	the	the	DET
dpc-2111	2	23	course	course	NOUN
dpc-2111	2	24	of	of	ADP
dpc-2111	2	25	covid-19	covid-19	PROPN
dpc-2111	2	26	and	and	CCONJ
dpc-2111	2	27	the	the	DET
dpc-2111	2	28	risk	risk	NOUN
dpc-2111	2	29	of	of	ADP
dpc-2111	2	30	transmission	transmission	NOUN
dpc-2111	2	31	.	.	PUNCT
dpc-2111	3	1	objectives	objective	NOUN
dpc-2111	3	2	:	:	PUNCT
dpc-2111	3	3	the	the	DET
dpc-2111	3	4	purpose	purpose	NOUN
dpc-2111	3	5	of	of	ADP
dpc-2111	3	6	our	our	PRON
dpc-2111	3	7	study	study	NOUN
dpc-2111	3	8	is	be	AUX
dpc-2111	3	9	to	to	PART
dpc-2111	3	10	evaluate	evaluate	VERB
dpc-2111	3	11	how	how	SCONJ
dpc-2111	3	12	our	our	PRON
dpc-2111	3	13	patients	patient	NOUN
dpc-2111	3	14	that	that	PRON
dpc-2111	3	15	took	take	VERB
dpc-2111	3	16	oral	oral	ADJ
dpc-2111	3	17	isotretinoin	isotretinoin	NOUN
dpc-2111	3	18	during	during	ADP
dpc-2111	3	19	the	the	DET
dpc-2111	3	20	pandemic	pandemic	NOUN
dpc-2111	3	21	were	be	AUX
dpc-2111	3	22	affected	affect	VERB
dpc-2111	3	23	by	by	ADP
dpc-2111	3	24	covid-19	covid-19	PROPN
dpc-2111	3	25	.	.	PUNCT
dpc-2111	4	1	methods	method	NOUN
dpc-2111	4	2	:	:	PUNCT
dpc-2111	4	3	the	the	DET
dpc-2111	4	4	clinical	clinical	ADJ
dpc-2111	4	5	processes	process	NOUN
dpc-2111	4	6	of	of	ADP
dpc-2111	4	7	moderate	moderate	ADJ
dpc-2111	4	8	-	-	PUNCT
dpc-2111	4	9	to	to	ADP
dpc-2111	4	10	-	-	PUNCT
dpc-2111	4	11	severe	severe	ADJ
dpc-2111	4	12	acne	acne	NOUN
dpc-2111	4	13	vulgaris	vulgaris	NOUN
dpc-2111	4	14	patients	patient	NOUN
dpc-2111	4	15	between	between	ADP
dpc-2111	4	16	march	march	PROPN
dpc-2111	4	17	2020	2020	NUM
dpc-2111	4	18	and	and	CCONJ
dpc-2111	4	19	february	february	PROPN
dpc-2111	4	20	2021	2021	NUM
dpc-2111	4	21	were	be	AUX
dpc-2111	4	22	evaluated	evaluate	VERB
dpc-2111	4	23	.	.	PUNCT
dpc-2111	5	1	results	result	NOUN
dpc-2111	5	2	:	:	PUNCT
dpc-2111	5	3	of	of	ADP
dpc-2111	5	4	102	102	NUM
dpc-2111	5	5	moderate	moderate	ADJ
dpc-2111	5	6	-	-	PUNCT
dpc-2111	5	7	to	to	ADP
dpc-2111	5	8	-	-	PUNCT
dpc-2111	5	9	severe	severe	ADJ
dpc-2111	5	10	acne	acne	NOUN
dpc-2111	5	11	patients	patient	NOUN
dpc-2111	5	12	,	,	PUNCT
dpc-2111	5	13	67	67	NUM
dpc-2111	5	14	were	be	AUX
dpc-2111	5	15	using	use	VERB
dpc-2111	5	16	oral	oral	ADJ
dpc-2111	5	17	isotretinoin	isotretinoin	NOUN
dpc-2111	5	18	and	and	CCONJ
dpc-2111	5	19	35	35	NUM
dpc-2111	5	20	were	be	AUX
dpc-2111	5	21	using	use	VERB
dpc-2111	5	22	a	a	DET
dpc-2111	5	23	topical	topical	ADJ
dpc-2111	5	24	treatment	treatment	NOUN
dpc-2111	5	25	.	.	PUNCT
dpc-2111	6	1	of	of	ADP
dpc-2111	6	2	27	27	NUM
dpc-2111	6	3	patients	patient	NOUN
dpc-2111	6	4	who	who	PRON
dpc-2111	6	5	tested	test	VERB
dpc-2111	6	6	positive	positive	ADJ
dpc-2111	6	7	for	for	ADP
dpc-2111	6	8	covid-19	covid-19	PROPN
dpc-2111	6	9	,	,	PUNCT
dpc-2111	6	10	16	16	NUM
dpc-2111	6	11	(	(	PUNCT
dpc-2111	6	12	59.3	59.3	NUM
dpc-2111	6	13	%	%	NOUN
dpc-2111	6	14	)	)	PUNCT
dpc-2111	6	15	were	be	AUX
dpc-2111	6	16	using	use	VERB
dpc-2111	6	17	oral	oral	ADJ
dpc-2111	6	18	isotretinoin	isotretinoin	NOUN
dpc-2111	6	19	and	and	CCONJ
dpc-2111	6	20	11	11	NUM
dpc-2111	6	21	(	(	PUNCT
dpc-2111	6	22	40.7	40.7	NUM
dpc-2111	6	23	%	%	NOUN
dpc-2111	6	24	)	)	PUNCT
dpc-2111	6	25	were	be	AUX
dpc-2111	6	26	using	use	VERB
dpc-2111	6	27	topical	topical	ADJ
dpc-2111	6	28	treatment	treatment	NOUN
dpc-2111	6	29	,	,	PUNCT
dpc-2111	6	30	there	there	PRON
dpc-2111	6	31	was	be	VERB
dpc-2111	6	32	no	no	DET
dpc-2111	6	33	statistical	statistical	ADJ
dpc-2111	6	34	difference	difference	NOUN
dpc-2111	6	35	in	in	ADP
dpc-2111	6	36	the	the	DET
dpc-2111	6	37	rates	rate	NOUN
dpc-2111	6	38	of	of	ADP
dpc-2111	6	39	covid-19	covid-19	PROPN
dpc-2111	6	40	positivity	positivity	NOUN
dpc-2111	6	41	between	between	ADP
dpc-2111	6	42	the	the	DET
dpc-2111	6	43	two	two	NUM
dpc-2111	6	44	groups	group	NOUN
dpc-2111	6	45	(	(	PUNCT
dpc-2111	6	46	p	p	X
dpc-2111	6	47	=	=	NOUN
dpc-2111	6	48	0.412	0.412	NUM
dpc-2111	6	49	)	)	PUNCT
dpc-2111	6	50	.	.	PUNCT
dpc-2111	7	1	the	the	DET
dpc-2111	7	2	rates	rate	NOUN
dpc-2111	7	3	of	of	ADP
dpc-2111	7	4	positive	positive	ADJ
dpc-2111	7	5	tests	test	NOUN
dpc-2111	7	6	for	for	ADP
dpc-2111	7	7	covid-19	covid-19	PROPN
dpc-2111	7	8	were	be	AUX
dpc-2111	7	9	similar	similar	ADJ
dpc-2111	7	10	between	between	ADP
dpc-2111	7	11	contacted	contact	VERB
dpc-2111	7	12	patients	patient	NOUN
dpc-2111	7	13	of	of	ADP
dpc-2111	7	14	two	two	NUM
dpc-2111	7	15	groups	group	NOUN
dpc-2111	7	16	(	(	PUNCT
dpc-2111	7	17	p	p	X
dpc-2111	7	18	=	=	NOUN
dpc-2111	7	19	0.391	0.391	NUM
dpc-2111	7	20	)	)	PUNCT
dpc-2111	7	21	.	.	PUNCT
dpc-2111	8	1	loss	loss	NOUN
dpc-2111	8	2	of	of	ADP
dpc-2111	8	3	smell	smell	NOUN
dpc-2111	8	4	/	/	SYM
dpc-2111	8	5	taste	taste	NOUN
dpc-2111	8	6	was	be	AUX
dpc-2111	8	7	lower	low	ADJ
dpc-2111	8	8	in	in	ADP
dpc-2111	8	9	patients	patient	NOUN
dpc-2111	8	10	using	use	VERB
dpc-2111	8	11	oral	oral	ADJ
dpc-2111	8	12	isotretinoin	isotretinoin	NOUN
dpc-2111	8	13	compared	compare	VERB
dpc-2111	8	14	to	to	ADP
dpc-2111	8	15	patients	patient	NOUN
dpc-2111	8	16	receiving	receive	VERB
dpc-2111	8	17	topical	topical	ADJ
dpc-2111	8	18	treatment	treatment	NOUN
dpc-2111	8	19	(	(	PUNCT
dpc-2111	8	20	46.7	46.7	NUM
dpc-2111	8	21	%	%	NOUN
dpc-2111	8	22	and	and	CCONJ
dpc-2111	8	23	72.7	72.7	NUM
dpc-2111	8	24	%	%	NOUN
dpc-2111	8	25	,	,	PUNCT
dpc-2111	8	26	respectively	respectively	ADV
dpc-2111	8	27	.	.	PUNCT
dpc-2111	8	28	)	)	PUNCT
dpc-2111	8	29	.	.	PUNCT
dpc-2111	9	1	headache	headache	NOUN
dpc-2111	9	2	symptoms	symptom	NOUN
dpc-2111	9	3	were	be	AUX
dpc-2111	9	4	less	less	ADV
dpc-2111	9	5	common	common	ADJ
dpc-2111	9	6	in	in	ADP
dpc-2111	9	7	patients	patient	NOUN
dpc-2111	9	8	using	use	VERB
dpc-2111	9	9	oral	oral	ADJ
dpc-2111	9	10	isotretinoin	isotretinoin	NOUN
dpc-2111	9	11	(	(	PUNCT
dpc-2111	9	12	p	p	X
dpc-2111	9	13	=	=	NOUN
dpc-2111	9	14	0.047	0.047	NUM
dpc-2111	9	15	)	)	PUNCT
dpc-2111	9	16	.	.	PUNCT
dpc-2111	10	1	conclusions	conclusion	NOUN
dpc-2111	10	2	:	:	PUNCT
dpc-2111	10	3	the	the	DET
dpc-2111	10	4	use	use	NOUN
dpc-2111	10	5	of	of	ADP
dpc-2111	10	6	oral	oral	ADJ
dpc-2111	10	7	isotretinoin	isotretinoin	PROPN
dpc-2111	10	8	did	do	AUX
dpc-2111	10	9	not	not	PART
dpc-2111	10	10	cause	cause	VERB
dpc-2111	10	11	an	an	DET
dpc-2111	10	12	increase	increase	NOUN
dpc-2111	10	13	or	or	CCONJ
dpc-2111	10	14	decrease	decrease	NOUN
dpc-2111	10	15	in	in	ADP
dpc-2111	10	16	the	the	DET
dpc-2111	10	17	risk	risk	NOUN
dpc-2111	10	18	of	of	ADP
dpc-2111	10	19	covid-19	covid-19	PROPN
dpc-2111	10	20	transmission	transmission	NOUN
dpc-2111	10	21	.	.	PUNCT
dpc-2111	11	1	the	the	DET
dpc-2111	11	2	patients	patient	NOUN
dpc-2111	11	3	using	use	VERB
dpc-2111	11	4	oral	oral	ADJ
dpc-2111	11	5	isotretinoin	isotretinoin	PROPN
dpc-2111	11	6	had	have	VERB
dpc-2111	11	7	a	a	DET
dpc-2111	11	8	lower	low	ADJ
dpc-2111	11	9	incidence	incidence	NOUN
dpc-2111	11	10	of	of	ADP
dpc-2111	11	11	taste	taste	NOUN
dpc-2111	11	12	/	/	SYM
dpc-2111	11	13	smell	smell	NOUN
dpc-2111	11	14	loss	loss	NOUN
dpc-2111	11	15	and	and	CCONJ
dpc-2111	11	16	headache	headache	NOUN
dpc-2111	11	17	.	.	PUNCT
dpc-2111	12	1	how	how	SCONJ
dpc-2111	12	2	are	be	AUX
dpc-2111	12	3	acne	acne	NOUN
dpc-2111	12	4	vulgaris	vulgaris	NOUN
dpc-2111	12	5	patients	patient	NOUN
dpc-2111	12	6	using	use	VERB
dpc-2111	12	7	oral	oral	ADJ
dpc-2111	12	8	isotretinoin	isotretinoin	PROPN
dpc-2111	12	9	affected	affect	VERB
dpc-2111	12	10	by	by	ADP
dpc-2111	12	11	covid-19	covid-19	PROPN
dpc-2111	12	12	?	?	PUNCT
dpc-2111	13	1	mine	mine	NOUN
dpc-2111	13	2	müjde	müjde	NOUN
dpc-2111	13	3	kuş1	kuş1	PROPN
dpc-2111	13	4	,	,	PUNCT
dpc-2111	13	5	perihan	perihan	PROPN
dpc-2111	13	6	öztürk1	öztürk1	NOUN
dpc-2111	13	7	,	,	PUNCT
dpc-2111	13	8	tutku	tutku	NOUN
dpc-2111	13	9	bulut1	bulut1	NOUN
dpc-2111	13	10	,	,	PUNCT
dpc-2111	13	11	celal	celal	PROPN
dpc-2111	13	12	kuş2	kuş2	PROPN
dpc-2111	13	13	,	,	PUNCT
dpc-2111	13	14	mehmet	mehmet	PROPN
dpc-2111	13	15	enes	enes	PROPN
dpc-2111	13	16	güner1	güner1	PROPN
dpc-2111	13	17	,	,	PUNCT
dpc-2111	13	18	hülya	hülya	ADJ
dpc-2111	13	19	nazik1	nazik1	PROPN
dpc-2111	13	20	,	,	PUNCT
dpc-2111	14	1	mehmet	mehmet	PROPN
dpc-2111	14	2	kamil	kamil	PROPN
dpc-2111	14	3	mülayim1	mülayim1	PROPN
dpc-2111	14	4	1	1	NUM
dpc-2111	14	5	kahramanmaraş	kahramanmaraş	NOUN
dpc-2111	14	6	sütçü	sütçü	NOUN
dpc-2111	14	7	i̇mam	i̇mam	PROPN
dpc-2111	14	8	university	university	NOUN
dpc-2111	14	9	,	,	PUNCT
dpc-2111	14	10	faculty	faculty	NOUN
dpc-2111	14	11	of	of	ADP
dpc-2111	14	12	medicine	medicine	NOUN
dpc-2111	14	13	,	,	PUNCT
dpc-2111	14	14	department	department	NOUN
dpc-2111	14	15	of	of	ADP
dpc-2111	14	16	dermatology	dermatology	NOUN
dpc-2111	14	17	,	,	PUNCT
dpc-2111	14	18	kahramanmaraş	kahramanmaraş	NOUN
dpc-2111	14	19	,	,	PUNCT
dpc-2111	14	20	turkey	turkey	PROPN
dpc-2111	14	21	2	2	NUM
dpc-2111	14	22	kahramanmaraş	kahramanmaraş	NOUN
dpc-2111	14	23	sütçü	sütçü	NOUN
dpc-2111	14	24	i̇mam	i̇mam	PROPN
dpc-2111	14	25	university	university	NOUN
dpc-2111	14	26	,	,	PUNCT
dpc-2111	14	27	faculty	faculty	NOUN
dpc-2111	14	28	of	of	ADP
dpc-2111	14	29	medicine	medicine	NOUN
dpc-2111	14	30	,	,	PUNCT
dpc-2111	14	31	department	department	NOUN
dpc-2111	14	32	of	of	ADP
dpc-2111	14	33	family	family	NOUN
dpc-2111	14	34	medicine	medicine	NOUN
dpc-2111	14	35	,	,	PUNCT
dpc-2111	14	36	kahramanmaraş	kahramanmaraş	NOUN
dpc-2111	14	37	,	,	PUNCT
dpc-2111	14	38	turkey	turkey	NOUN
dpc-2111	14	39	key	key	ADJ
dpc-2111	14	40	words	word	NOUN
dpc-2111	14	41	:	:	PUNCT
dpc-2111	14	42	covid-19	covid-19	PROPN
dpc-2111	14	43	,	,	PUNCT
dpc-2111	14	44	isotretinoin	isotretinoin	PROPN
dpc-2111	14	45	,	,	PUNCT
dpc-2111	14	46	smell	smell	NOUN
dpc-2111	14	47	,	,	PUNCT
dpc-2111	14	48	taste	taste	NOUN
dpc-2111	14	49	,	,	PUNCT
dpc-2111	14	50	headache	headache	NOUN
dpc-2111	14	51	citation	citation	NOUN
dpc-2111	14	52	:	:	PUNCT
dpc-2111	14	53	kuş	kuş	PROPN
dpc-2111	14	54	mm	mm	PROPN
dpc-2111	14	55	,	,	PUNCT
dpc-2111	14	56	öztürk	öztürk	NOUN
dpc-2111	14	57	p	p	NOUN
dpc-2111	14	58	,	,	PUNCT
dpc-2111	14	59	bulut	bulut	PROPN
dpc-2111	14	60	t	t	PROPN
dpc-2111	14	61	,	,	PUNCT
dpc-2111	14	62	et	et	PROPN
dpc-2111	14	63	al	al	PROPN
dpc-2111	14	64	.	.	PUNCT
dpc-2111	15	1	how	how	SCONJ
dpc-2111	15	2	are	be	AUX
dpc-2111	15	3	acne	acne	NOUN
dpc-2111	15	4	vulgaris	vulgaris	NOUN
dpc-2111	15	5	patients	patient	NOUN
dpc-2111	15	6	using	use	VERB
dpc-2111	15	7	oral	oral	ADJ
dpc-2111	15	8	isotretinoin	isotretinoin	PROPN
dpc-2111	15	9	affected	affect	VERB
dpc-2111	15	10	by	by	ADP
dpc-2111	15	11	covid-19	covid-19	PROPN
dpc-2111	15	12	?	?	PUNCT
dpc-2111	16	1	dermatol	dermatol	PROPN
dpc-2111	16	2	pract	pract	PROPN
dpc-2111	16	3	concept	concept	NOUN
dpc-2111	16	4	.	.	PUNCT
dpc-2111	17	1	2022;12(3):e2022146	2022;12(3):e2022146	X
dpc-2111	17	2	.	.	PUNCT
dpc-2111	17	3	doi	doi	PROPN
dpc-2111	17	4	:	:	PUNCT
dpc-2111	17	5	https://doi.org/10.5826/dpc.1203a146	https://doi.org/10.5826/dpc.1203a146	PROPN
dpc-2111	17	6	accepted	accept	VERB
dpc-2111	17	7	:	:	PUNCT
dpc-2111	17	8	december	december	PROPN
dpc-2111	17	9	26	26	NUM
dpc-2111	17	10	,	,	PUNCT
dpc-2111	17	11	2021	2021	NUM
dpc-2111	17	12	;	;	PUNCT
dpc-2111	17	13	published	publish	VERB
dpc-2111	17	14	:	:	PUNCT
dpc-2111	17	15	july	july	PROPN
dpc-2111	17	16	2022	2022	NUM
dpc-2111	18	1	copyright	copyright	NOUN
dpc-2111	18	2	:	:	PUNCT
dpc-2111	18	3	©	©	PROPN
dpc-2111	18	4	2022	2022	NUM
dpc-2111	18	5	kuş	kuş	PROPN
dpc-2111	18	6	et	et	PROPN
dpc-2111	18	7	al	al	PROPN
dpc-2111	18	8	.	.	PUNCT
dpc-2111	19	1	this	this	PRON
dpc-2111	19	2	is	be	AUX
dpc-2111	19	3	an	an	DET
dpc-2111	19	4	open	open	ADJ
dpc-2111	19	5	-	-	PUNCT
dpc-2111	19	6	access	access	NOUN
dpc-2111	19	7	article	article	NOUN
dpc-2111	19	8	distributed	distribute	VERB
dpc-2111	19	9	under	under	ADP
dpc-2111	19	10	the	the	DET
dpc-2111	19	11	terms	term	NOUN
dpc-2111	19	12	of	of	ADP
dpc-2111	19	13	the	the	DET
dpc-2111	19	14	creative	creative	ADJ
dpc-2111	19	15	commons	common	NOUN
dpc-2111	19	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2111	19	17	license	license	NOUN
dpc-2111	19	18	(	(	PUNCT
dpc-2111	19	19	by	by	ADP
dpc-2111	19	20	-	-	PUNCT
dpc-2111	19	21	nc-4.0	nc-4.0	NOUN
dpc-2111	19	22	)	)	PUNCT
dpc-2111	19	23	,	,	PUNCT
dpc-2111	19	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2111	19	25	,	,	PUNCT
dpc-2111	19	26	which	which	PRON
dpc-2111	19	27	permits	permit	VERB
dpc-2111	19	28	unrestricted	unrestricted	ADJ
dpc-2111	19	29	noncommercial	noncommercial	ADJ
dpc-2111	19	30	use	use	NOUN
dpc-2111	19	31	,	,	PUNCT
dpc-2111	19	32	distribution	distribution	NOUN
dpc-2111	19	33	,	,	PUNCT
dpc-2111	19	34	and	and	CCONJ
dpc-2111	19	35	reproduction	reproduction	NOUN
dpc-2111	19	36	in	in	ADP
dpc-2111	19	37	any	any	DET
dpc-2111	19	38	medium	medium	NOUN
dpc-2111	19	39	,	,	PUNCT
dpc-2111	19	40	provided	provide	VERB
dpc-2111	19	41	the	the	DET
dpc-2111	19	42	original	original	ADJ
dpc-2111	19	43	authors	author	NOUN
dpc-2111	19	44	and	and	CCONJ
dpc-2111	19	45	source	source	NOUN
dpc-2111	19	46	are	be	AUX
dpc-2111	19	47	credited	credit	VERB
dpc-2111	19	48	.	.	PUNCT
dpc-2111	20	1	funding	funding	NOUN
dpc-2111	20	2	:	:	PUNCT
dpc-2111	20	3	none	none	NOUN
dpc-2111	20	4	.	.	PUNCT
dpc-2111	21	1	competing	compete	VERB
dpc-2111	21	2	interests	interest	NOUN
dpc-2111	21	3	:	:	PUNCT
dpc-2111	21	4	none	none	NOUN
dpc-2111	21	5	.	.	PUNCT
dpc-2111	22	1	authorship	authorship	NOUN
dpc-2111	22	2	:	:	PUNCT
dpc-2111	22	3	concept	concept	NOUN
dpc-2111	22	4	:	:	PUNCT
dpc-2111	22	5	m.m.k	m.m.k	PROPN
dpc-2111	22	6	.	.	PUNCT
dpc-2111	22	7	,	,	PUNCT
dpc-2111	22	8	p.ö	p.ö	PROPN
dpc-2111	22	9	.	.	PROPN
dpc-2111	22	10	,	,	PUNCT
dpc-2111	22	11	design	design	NOUN
dpc-2111	22	12	:	:	PUNCT
dpc-2111	23	1	m.m.k	m.m.k	INTJ
dpc-2111	23	2	.	.	PUNCT
dpc-2111	23	3	,	,	PUNCT
dpc-2111	23	4	p.ö	p.ö	PROPN
dpc-2111	23	5	.	.	PROPN
dpc-2111	23	6	,	,	PUNCT
dpc-2111	23	7	c.k	c.k	PROPN
dpc-2111	23	8	.	.	PROPN
dpc-2111	23	9	,	,	PUNCT
dpc-2111	23	10	data	datum	NOUN
dpc-2111	23	11	collection	collection	NOUN
dpc-2111	23	12	or	or	CCONJ
dpc-2111	23	13	processing	processing	NOUN
dpc-2111	23	14	:	:	PUNCT
dpc-2111	23	15	t.b	t.b	PROPN
dpc-2111	23	16	.	.	PROPN
dpc-2111	23	17	,m.e.g	,m.e.g	PROPN
dpc-2111	23	18	.	.	PUNCT
dpc-2111	23	19	,	,	PUNCT
dpc-2111	24	1	h.n	h.n	PROPN
dpc-2111	24	2	.	.	PROPN
dpc-2111	24	3	,	,	PUNCT
dpc-2111	24	4	m.k.m	m.k.m	NOUN
dpc-2111	24	5	.	.	PUNCT
dpc-2111	24	6	,	,	PUNCT
dpc-2111	24	7	analysis	analysis	NOUN
dpc-2111	24	8	or	or	CCONJ
dpc-2111	24	9	interpretation	interpretation	NOUN
dpc-2111	24	10	:	:	PUNCT
dpc-2111	25	1	m.m.k	m.m.k	PROPN
dpc-2111	25	2	.	.	PROPN
dpc-2111	25	3	,	,	PUNCT
dpc-2111	25	4	t.b	t.b	PROPN
dpc-2111	25	5	.	.	PROPN
dpc-2111	25	6	,	,	PUNCT
dpc-2111	25	7	c.k	c.k	PROPN
dpc-2111	25	8	.	.	PROPN
dpc-2111	25	9	,	,	PUNCT
dpc-2111	25	10	literature	literature	NOUN
dpc-2111	25	11	search	search	NOUN
dpc-2111	25	12	:	:	PUNCT
dpc-2111	25	13	m.m.k	m.m.k	NOUN
dpc-2111	25	14	.	.	PUNCT
dpc-2111	25	15	,	,	PUNCT
dpc-2111	25	16	t.b	t.b	PROPN
dpc-2111	25	17	.	.	PROPN
dpc-2111	25	18	,	,	PUNCT
dpc-2111	25	19	m.e.g	m.e.g	PROPN
dpc-2111	25	20	.	.	PROPN
dpc-2111	25	21	,	,	PUNCT
dpc-2111	25	22	c.k	c.k	PROPN
dpc-2111	25	23	.	.	PROPN
dpc-2111	25	24	,	,	PUNCT
dpc-2111	25	25	h.n	h.n	PROPN
dpc-2111	25	26	.	.	PROPN
dpc-2111	25	27	,	,	PUNCT
dpc-2111	25	28	m.k.m	m.k.m	NOUN
dpc-2111	25	29	.	.	PROPN
dpc-2111	25	30	,	,	PUNCT
dpc-2111	25	31	writing	writing	NOUN
dpc-2111	25	32	:	:	PUNCT
dpc-2111	25	33	m.m.k	m.m.k	INTJ
dpc-2111	25	34	.	.	PUNCT
dpc-2111	25	35	,	,	PUNCT
dpc-2111	25	36	p.ö	p.ö	PROPN
dpc-2111	25	37	.	.	PROPN
dpc-2111	25	38	,m.e.g	,m.e.g	PROPN
dpc-2111	25	39	.	.	PUNCT
dpc-2111	25	40	,	,	PUNCT
dpc-2111	25	41	h.n	h.n	PROPN
dpc-2111	25	42	.	.	PROPN
dpc-2111	25	43	,	,	PUNCT
dpc-2111	25	44	m.k.m	m.k.m	NOUN
dpc-2111	25	45	.	.	PUNCT
dpc-2111	26	1	corresponding	correspond	VERB
dpc-2111	26	2	author	author	NOUN
dpc-2111	26	3	:	:	PUNCT
dpc-2111	26	4	mine	mine	NOUN
dpc-2111	26	5	müjde	müjde	PROPN
dpc-2111	26	6	kuş	kuş	PROPN
dpc-2111	26	7	md	md	PROPN
dpc-2111	26	8	,	,	PUNCT
dpc-2111	26	9	kahramanmaraş	kahramanmaraş	PROPN
dpc-2111	26	10	sütçü	sütçü	NOUN
dpc-2111	26	11	i̇mam	i̇mam	PROPN
dpc-2111	26	12	university	university	NOUN
dpc-2111	26	13	,	,	PUNCT
dpc-2111	26	14	department	department	NOUN
dpc-2111	26	15	of	of	ADP
dpc-2111	26	16	dermatology	dermatology	NOUN
dpc-2111	26	17	,	,	PUNCT
dpc-2111	26	18	kahramanmaraş	kahramanmaraş	NOUN
dpc-2111	26	19	,	,	PUNCT
dpc-2111	26	20	turkey	turkey	PROPN
dpc-2111	26	21	–	–	PUNCT
dpc-2111	26	22	0	0	NUM
dpc-2111	26	23	(	(	PUNCT
dpc-2111	26	24	507	507	NUM
dpc-2111	26	25	)	)	PUNCT
dpc-2111	26	26	204	204	NUM
dpc-2111	26	27	55	55	NUM
dpc-2111	26	28	36	36	NUM
dpc-2111	26	29	e	e	NOUN
dpc-2111	26	30	-	-	NOUN
dpc-2111	26	31	mail	mail	NOUN
dpc-2111	26	32	:	:	PUNCT
dpc-2111	26	33	mmujde_ozdemir@hotmail.com	mmujde_ozdemir@hotmail.com	X
dpc-2111	26	34	abstract	abstract	ADJ
dpc-2111	26	35	2	2	NUM
dpc-2111	26	36	original	original	ADJ
dpc-2111	26	37	article	article	NOUN
dpc-2111	26	38	|	|	ADV
dpc-2111	26	39	dermatol	dermatol	ADJ
dpc-2111	26	40	pract	pract	NOUN
dpc-2111	26	41	concept	concept	NOUN
dpc-2111	26	42	.	.	PUNCT
dpc-2111	27	1	2022;12(3):e2022146	2022;12(3):e2022146	NUM
dpc-2111	27	2	introduction	introduction	NOUN
dpc-2111	27	3	the	the	DET
dpc-2111	27	4	coronavirus	coronavirus	NOUN
dpc-2111	27	5	disease	disease	NOUN
dpc-2111	27	6	19	19	NUM
dpc-2111	27	7	(	(	PUNCT
dpc-2111	27	8	covid-19	covid-19	PROPN
dpc-2111	27	9	)	)	PUNCT
dpc-2111	27	10	pandemic	pandemic	NOUN
dpc-2111	27	11	was	be	AUX
dpc-2111	27	12	declared	declare	VERB
dpc-2111	27	13	by	by	ADP
dpc-2111	27	14	the	the	DET
dpc-2111	27	15	world	world	PROPN
dpc-2111	27	16	health	health	PROPN
dpc-2111	27	17	organization	organization	NOUN
dpc-2111	27	18	in	in	ADP
dpc-2111	27	19	march	march	PROPN
dpc-2111	27	20	2020	2020	NUM
dpc-2111	27	21	,	,	PUNCT
dpc-2111	27	22	and	and	CCONJ
dpc-2111	27	23	covid-19	covid-19	PROPN
dpc-2111	27	24	was	be	AUX
dpc-2111	27	25	the	the	DET
dpc-2111	27	26	leading	lead	VERB
dpc-2111	27	27	cause	cause	NOUN
dpc-2111	27	28	of	of	ADP
dpc-2111	27	29	death	death	NOUN
dpc-2111	27	30	in	in	ADP
dpc-2111	27	31	many	many	ADJ
dpc-2111	27	32	countries	country	NOUN
dpc-2111	27	33	in	in	ADP
dpc-2111	27	34	2020	2020	NUM
dpc-2111	28	1	[	[	X
dpc-2111	28	2	1	1	NUM
dpc-2111	28	3	]	]	PUNCT
dpc-2111	28	4	.	.	PUNCT
dpc-2111	29	1	no	no	DET
dpc-2111	29	2	specific	specific	ADJ
dpc-2111	29	3	treatment	treatment	NOUN
dpc-2111	29	4	has	have	AUX
dpc-2111	29	5	yet	yet	ADV
dpc-2111	29	6	been	be	AUX
dpc-2111	29	7	found	find	VERB
dpc-2111	29	8	for	for	ADP
dpc-2111	29	9	covid-19	covid-19	PROPN
dpc-2111	29	10	.	.	PUNCT
dpc-2111	30	1	in	in	ADP
dpc-2111	30	2	addition	addition	NOUN
dpc-2111	30	3	,	,	PUNCT
dpc-2111	30	4	as	as	ADP
dpc-2111	30	5	in	in	ADP
dpc-2111	30	6	other	other	ADJ
dpc-2111	30	7	branches	branch	NOUN
dpc-2111	30	8	of	of	ADP
dpc-2111	30	9	medicine	medicine	NOUN
dpc-2111	30	10	,	,	PUNCT
dpc-2111	30	11	the	the	DET
dpc-2111	30	12	positive	positive	ADJ
dpc-2111	30	13	and/or	and/or	CCONJ
dpc-2111	30	14	negative	negative	ADJ
dpc-2111	30	15	effects	effect	NOUN
dpc-2111	30	16	of	of	ADP
dpc-2111	30	17	the	the	DET
dpc-2111	30	18	drugs	drug	NOUN
dpc-2111	30	19	we	we	PRON
dpc-2111	30	20	frequently	frequently	ADV
dpc-2111	30	21	use	use	VERB
dpc-2111	30	22	in	in	ADP
dpc-2111	30	23	dermatology	dermatology	NOUN
dpc-2111	30	24	on	on	ADP
dpc-2111	30	25	the	the	DET
dpc-2111	30	26	course	course	NOUN
dpc-2111	30	27	of	of	ADP
dpc-2111	30	28	covid-19	covid-19	PROPN
dpc-2111	30	29	remain	remain	VERB
dpc-2111	30	30	unclear	unclear	ADJ
dpc-2111	30	31	.	.	PUNCT
dpc-2111	31	1	oral	oral	ADJ
dpc-2111	31	2	isotretinoin	isotretinoin	PROPN
dpc-2111	31	3	(	(	PUNCT
dpc-2111	31	4	13	13	NUM
dpc-2111	31	5	-	-	PUNCT
dpc-2111	31	6	cis	cis	NOUN
dpc-2111	31	7	-	-	PUNCT
dpc-2111	31	8	retinoic	retinoic	NOUN
dpc-2111	31	9	acid	acid	NOUN
dpc-2111	31	10	)	)	PUNCT
dpc-2111	31	11	,	,	PUNCT
dpc-2111	31	12	a	a	DET
dpc-2111	31	13	synthetic	synthetic	ADJ
dpc-2111	31	14	analog	analog	NOUN
dpc-2111	31	15	of	of	ADP
dpc-2111	31	16	vitamin	vitamin	NOUN
dpc-2111	31	17	a	a	PRON
dpc-2111	31	18	,	,	PUNCT
dpc-2111	31	19	is	be	AUX
dpc-2111	31	20	a	a	DET
dpc-2111	31	21	first	first	ADJ
dpc-2111	31	22	-	-	PUNCT
dpc-2111	31	23	generation	generation	NOUN
dpc-2111	31	24	retinoid	retinoid	NOUN
dpc-2111	31	25	used	use	VERB
dpc-2111	31	26	for	for	ADP
dpc-2111	31	27	the	the	DET
dpc-2111	31	28	treatment	treatment	NOUN
dpc-2111	31	29	of	of	ADP
dpc-2111	31	30	acne	acne	NOUN
dpc-2111	31	31	vulgaris	vulgaris	NOUN
dpc-2111	31	32	[	[	X
dpc-2111	31	33	2	2	NUM
dpc-2111	31	34	]	]	PUNCT
dpc-2111	31	35	.	.	PUNCT
dpc-2111	32	1	nasal	nasal	ADJ
dpc-2111	32	2	mucosal	mucosal	NOUN
dpc-2111	32	3	dryness	dryness	NOUN
dpc-2111	32	4	is	be	AUX
dpc-2111	32	5	observed	observe	VERB
dpc-2111	32	6	in	in	ADP
dpc-2111	32	7	two	two	NUM
dpc-2111	32	8	-	-	PUNCT
dpc-2111	32	9	thirds	third	NOUN
dpc-2111	32	10	of	of	ADP
dpc-2111	32	11	patients	patient	NOUN
dpc-2111	32	12	during	during	ADP
dpc-2111	32	13	oral	oral	ADJ
dpc-2111	32	14	isotretinoin	isotretinoin	PROPN
dpc-2111	32	15	treatment	treatment	NOUN
dpc-2111	32	16	[	[	X
dpc-2111	32	17	3	3	NUM
dpc-2111	32	18	]	]	PUNCT
dpc-2111	32	19	.	.	PUNCT
dpc-2111	33	1	the	the	DET
dpc-2111	33	2	covid-19	covid-19	PROPN
dpc-2111	33	3	agent	agent	NOUN
dpc-2111	33	4	sars	sar	NOUN
dpc-2111	33	5	-	-	PUNCT
dpc-2111	33	6	cov-2	cov-2	PART
dpc-2111	33	7	enters	enter	VERB
dpc-2111	33	8	the	the	DET
dpc-2111	33	9	human	human	ADJ
dpc-2111	33	10	body	body	NOUN
dpc-2111	33	11	through	through	ADP
dpc-2111	33	12	angiotensin	angiotensin	NOUN
dpc-2111	33	13	-	-	PUNCT
dpc-2111	33	14	converting	convert	VERB
dpc-2111	33	15	enzyme-2	enzyme-2	NUM
dpc-2111	33	16	(	(	PUNCT
dpc-2111	33	17	ace2	ace2	NOUN
dpc-2111	33	18	)	)	PUNCT
dpc-2111	33	19	receptors	receptor	NOUN
dpc-2111	33	20	.	.	PUNCT
dpc-2111	34	1	ace-2	ace-2	X
dpc-2111	34	2	receptor	receptor	NOUN
dpc-2111	34	3	expression	expression	NOUN
dpc-2111	34	4	was	be	AUX
dpc-2111	34	5	found	find	VERB
dpc-2111	34	6	in	in	ADP
dpc-2111	34	7	the	the	DET
dpc-2111	34	8	basal	basal	ADJ
dpc-2111	34	9	layer	layer	NOUN
dpc-2111	34	10	of	of	ADP
dpc-2111	34	11	nonkeratinized	nonkeratinized	ADJ
dpc-2111	34	12	squamous	squamous	ADJ
dpc-2111	34	13	epithelium	epithelium	NOUN
dpc-2111	34	14	in	in	ADP
dpc-2111	34	15	the	the	DET
dpc-2111	34	16	nasal	nasal	PROPN
dpc-2111	34	17	mucosa	mucosa	PROPN
dpc-2111	34	18	.	.	PUNCT
dpc-2111	35	1	isotretinoin	isotretinoin	PROPN
dpc-2111	35	2	has	have	VERB
dpc-2111	35	3	the	the	DET
dpc-2111	35	4	effect	effect	NOUN
dpc-2111	35	5	of	of	ADP
dpc-2111	35	6	revealing	reveal	VERB
dpc-2111	35	7	ace-2	ace-2	X
dpc-2111	35	8	receptors	receptor	NOUN
dpc-2111	35	9	by	by	ADP
dpc-2111	35	10	causing	cause	VERB
dpc-2111	35	11	nasal	nasal	ADJ
dpc-2111	35	12	mucosa	mucosa	NOUN
dpc-2111	35	13	dryness	dryness	NOUN
dpc-2111	35	14	and	and	CCONJ
dpc-2111	35	15	down	down	ADV
dpc-2111	35	16	-	-	PUNCT
dpc-2111	35	17	regulating	regulate	VERB
dpc-2111	35	18	ace-2	ace-2	PUNCT
dpc-2111	35	19	receptors	receptor	NOUN
dpc-2111	35	20	at	at	ADP
dpc-2111	35	21	the	the	DET
dpc-2111	35	22	same	same	ADJ
dpc-2111	35	23	time	time	NOUN
dpc-2111	35	24	[	[	X
dpc-2111	35	25	4	4	NUM
dpc-2111	35	26	-	-	SYM
dpc-2111	35	27	6	6	NUM
dpc-2111	35	28	]	]	PUNCT
dpc-2111	35	29	.	.	PUNCT
dpc-2111	36	1	biological	biological	ADJ
dpc-2111	36	2	processes	process	NOUN
dpc-2111	36	3	showing	show	VERB
dpc-2111	36	4	the	the	DET
dpc-2111	36	5	pharmacological	pharmacological	ADJ
dpc-2111	36	6	functions	function	NOUN
dpc-2111	36	7	of	of	ADP
dpc-2111	36	8	vitamin	vitamin	NOUN
dpc-2111	36	9	a	a	PRON
dpc-2111	36	10	for	for	ADP
dpc-2111	36	11	the	the	DET
dpc-2111	36	12	treatment	treatment	NOUN
dpc-2111	36	13	of	of	ADP
dpc-2111	36	14	covid-19	covid-19	PROPN
dpc-2111	36	15	have	have	AUX
dpc-2111	36	16	been	be	AUX
dpc-2111	36	17	defined	define	VERB
dpc-2111	36	18	and	and	CCONJ
dpc-2111	36	19	its	its	PRON
dpc-2111	36	20	therapeutic	therapeutic	ADJ
dpc-2111	36	21	mechanisms	mechanism	NOUN
dpc-2111	36	22	have	have	AUX
dpc-2111	36	23	been	be	AUX
dpc-2111	36	24	proven	prove	VERB
dpc-2111	36	25	by	by	ADP
dpc-2111	36	26	signaling	signal	VERB
dpc-2111	36	27	pathways	pathway	NOUN
dpc-2111	36	28	and	and	CCONJ
dpc-2111	36	29	it	it	PRON
dpc-2111	36	30	is	be	AUX
dpc-2111	36	31	thought	think	VERB
dpc-2111	36	32	that	that	SCONJ
dpc-2111	36	33	it	it	PRON
dpc-2111	36	34	can	can	AUX
dpc-2111	36	35	be	be	AUX
dpc-2111	36	36	used	use	VERB
dpc-2111	36	37	in	in	ADP
dpc-2111	36	38	the	the	DET
dpc-2111	36	39	treatment	treatment	NOUN
dpc-2111	36	40	of	of	ADP
dpc-2111	36	41	covid-19	covid-19	PROPN
dpc-2111	36	42	  	  	SPACE
dpc-2111	37	1	[	[	X
dpc-2111	37	2	7	7	NUM
dpc-2111	37	3	]	]	PUNCT
dpc-2111	37	4	.	.	PUNCT
dpc-2111	38	1	however	however	ADV
dpc-2111	38	2	,	,	PUNCT
dpc-2111	38	3	some	some	DET
dpc-2111	38	4	authors	author	NOUN
dpc-2111	38	5	suggested	suggest	VERB
dpc-2111	38	6	that	that	SCONJ
dpc-2111	38	7	covid-19	covid-19	PROPN
dpc-2111	38	8	is	be	AUX
dpc-2111	38	9	a	a	DET
dpc-2111	38	10	hypervitaminosis	hypervitaminosis	NOUN
dpc-2111	38	11	of	of	ADP
dpc-2111	38	12	vitamin	vitamin	NOUN
dpc-2111	38	13	a	a	PRON
dpc-2111	38	14	and	and	CCONJ
dpc-2111	38	15	that	that	SCONJ
dpc-2111	38	16	all	all	DET
dpc-2111	38	17	drugs	drug	NOUN
dpc-2111	38	18	metabolized	metabolize	VERB
dpc-2111	38	19	in	in	ADP
dpc-2111	38	20	the	the	DET
dpc-2111	38	21	liver	liver	NOUN
dpc-2111	38	22	should	should	AUX
dpc-2111	38	23	be	be	AUX
dpc-2111	38	24	discontinued	discontinue	VERB
dpc-2111	38	25	[	[	PUNCT
dpc-2111	38	26	8	8	NUM
dpc-2111	38	27	]	]	PUNCT
dpc-2111	38	28	.	.	PUNCT
dpc-2111	39	1	objectives	objective	NOUN
dpc-2111	39	2	according	accord	VERB
dpc-2111	39	3	to	to	ADP
dpc-2111	39	4	these	these	DET
dpc-2111	39	5	data	datum	NOUN
dpc-2111	39	6	in	in	ADP
dpc-2111	39	7	the	the	DET
dpc-2111	39	8	literature	literature	NOUN
dpc-2111	39	9	,	,	PUNCT
dpc-2111	39	10	the	the	DET
dpc-2111	39	11	effects	effect	NOUN
dpc-2111	39	12	of	of	ADP
dpc-2111	39	13	oral	oral	ADJ
dpc-2111	39	14	isotretinoin	isotretinoin	PROPN
dpc-2111	39	15	,	,	PUNCT
dpc-2111	39	16	a	a	DET
dpc-2111	39	17	vitamin	vitamin	NOUN
dpc-2111	39	18	a	a	DET
dpc-2111	39	19	derivative	derivative	NOUN
dpc-2111	39	20	,	,	PUNCT
dpc-2111	39	21	on	on	ADP
dpc-2111	39	22	the	the	DET
dpc-2111	39	23	transmission	transmission	NOUN
dpc-2111	39	24	and	and	CCONJ
dpc-2111	39	25	course	course	NOUN
dpc-2111	39	26	of	of	ADP
dpc-2111	39	27	covid-19	covid-19	PROPN
dpc-2111	39	28	are	be	AUX
dpc-2111	39	29	not	not	PART
dpc-2111	39	30	clear	clear	ADJ
dpc-2111	39	31	.	.	PUNCT
dpc-2111	40	1	the	the	DET
dpc-2111	40	2	aim	aim	NOUN
dpc-2111	40	3	of	of	ADP
dpc-2111	40	4	our	our	PRON
dpc-2111	40	5	study	study	NOUN
dpc-2111	40	6	is	be	AUX
dpc-2111	40	7	to	to	PART
dpc-2111	40	8	evaluate	evaluate	VERB
dpc-2111	40	9	whether	whether	SCONJ
dpc-2111	40	10	the	the	DET
dpc-2111	40	11	use	use	NOUN
dpc-2111	40	12	of	of	ADP
dpc-2111	40	13	oral	oral	ADJ
dpc-2111	40	14	isotretinoin	isotretinoin	PROPN
dpc-2111	40	15	affects	affect	VERB
dpc-2111	40	16	the	the	DET
dpc-2111	40	17	findings	finding	NOUN
dpc-2111	40	18	and	and	CCONJ
dpc-2111	40	19	symptoms	symptom	NOUN
dpc-2111	40	20	of	of	ADP
dpc-2111	40	21	covid-19	covid-19	PROPN
dpc-2111	40	22	and	and	CCONJ
dpc-2111	40	23	the	the	DET
dpc-2111	40	24	risk	risk	NOUN
dpc-2111	40	25	of	of	ADP
dpc-2111	40	26	transmission	transmission	NOUN
dpc-2111	40	27	.	.	PUNCT
dpc-2111	41	1	methods	method	NOUN
dpc-2111	41	2	our	our	PRON
dpc-2111	41	3	study	study	NOUN
dpc-2111	41	4	was	be	AUX
dpc-2111	41	5	a	a	DET
dpc-2111	41	6	retrospective	retrospective	ADJ
dpc-2111	41	7	,	,	PUNCT
dpc-2111	41	8	descriptive	descriptive	ADJ
dpc-2111	41	9	and	and	CCONJ
dpc-2111	41	10	cross	cross	ADJ
dpc-2111	41	11	-	-	ADJ
dpc-2111	41	12	sectional	sectional	ADJ
dpc-2111	41	13	study	study	NOUN
dpc-2111	41	14	.	.	PUNCT
dpc-2111	42	1	the	the	DET
dpc-2111	42	2	clinical	clinical	ADJ
dpc-2111	42	3	processes	process	NOUN
dpc-2111	42	4	of	of	ADP
dpc-2111	42	5	moderate	moderate	ADJ
dpc-2111	42	6	-	-	PUNCT
dpc-2111	42	7	to	to	ADP
dpc-2111	42	8	-	-	PUNCT
dpc-2111	42	9	severe	severe	ADJ
dpc-2111	42	10	acne	acne	NOUN
dpc-2111	42	11	vulgaris	vulgaris	NOUN
dpc-2111	42	12	patients	patient	NOUN
dpc-2111	42	13	aged	age	VERB
dpc-2111	42	14	16	16	NUM
dpc-2111	42	15	years	year	NOUN
dpc-2111	42	16	and	and	CCONJ
dpc-2111	42	17	older	old	ADJ
dpc-2111	42	18	who	who	PRON
dpc-2111	42	19	were	be	AUX
dpc-2111	42	20	followed	follow	VERB
dpc-2111	42	21	up	up	ADP
dpc-2111	42	22	in	in	ADP
dpc-2111	42	23	our	our	PRON
dpc-2111	42	24	clinic	clinic	NOUN
dpc-2111	42	25	between	between	ADP
dpc-2111	42	26	march	march	PROPN
dpc-2111	42	27	2020	2020	NUM
dpc-2111	42	28	and	and	CCONJ
dpc-2111	42	29	february	february	PROPN
dpc-2111	42	30	2021	2021	NUM
dpc-2111	42	31	and	and	CCONJ
dpc-2111	42	32	using	use	VERB
dpc-2111	42	33	oral	oral	ADJ
dpc-2111	42	34	isotretinoin	isotretinoin	NOUN
dpc-2111	42	35	at	at	ADP
dpc-2111	42	36	a	a	DET
dpc-2111	42	37	dose	dose	NOUN
dpc-2111	42	38	of	of	ADP
dpc-2111	42	39	0.5	0.5	NUM
dpc-2111	42	40	-	-	PUNCT
dpc-2111	42	41	1mg	1mg	NUM
dpc-2111	42	42	/	/	SYM
dpc-2111	42	43	kg	kg	NOUN
dpc-2111	42	44	or	or	CCONJ
dpc-2111	42	45	topical	topical	ADJ
dpc-2111	42	46	treatment	treatment	NOUN
dpc-2111	42	47	(	(	PUNCT
dpc-2111	42	48	patients	patient	NOUN
dpc-2111	42	49	who	who	PRON
dpc-2111	42	50	do	do	AUX
dpc-2111	42	51	not	not	PART
dpc-2111	42	52	accept	accept	VERB
dpc-2111	42	53	systemic	systemic	ADJ
dpc-2111	42	54	treatment	treatment	NOUN
dpc-2111	42	55	)	)	PUNCT
dpc-2111	42	56	,	,	PUNCT
dpc-2111	42	57	were	be	AUX
dpc-2111	42	58	evaluated	evaluate	VERB
dpc-2111	42	59	.	.	PUNCT
dpc-2111	43	1	the	the	DET
dpc-2111	43	2	data	data	NOUN
dpc-2111	43	3	form	form	NOUN
dpc-2111	43	4	was	be	AUX
dpc-2111	43	5	filled	fill	VERB
dpc-2111	43	6	via	via	ADP
dpc-2111	43	7	file	file	NOUN
dpc-2111	43	8	scanning	scanning	NOUN
dpc-2111	43	9	,	,	PUNCT
dpc-2111	43	10	during	during	ADP
dpc-2111	43	11	control	control	NOUN
dpc-2111	43	12	examination	examination	NOUN
dpc-2111	43	13	,	,	PUNCT
dpc-2111	43	14	or	or	CCONJ
dpc-2111	43	15	by	by	ADP
dpc-2111	43	16	teleconference	teleconference	NOUN
dpc-2111	43	17	interview	interview	NOUN
dpc-2111	43	18	method	method	NOUN
dpc-2111	43	19	.	.	PUNCT
dpc-2111	44	1	in	in	ADP
dpc-2111	44	2	the	the	DET
dpc-2111	44	3	data	datum	NOUN
dpc-2111	44	4	,	,	PUNCT
dpc-2111	44	5	form	form	NOUN
dpc-2111	44	6	followings	following	NOUN
dpc-2111	44	7	were	be	AUX
dpc-2111	44	8	questioned	question	VERB
dpc-2111	44	9	:	:	PUNCT
dpc-2111	44	10	patients	patient	NOUN
dpc-2111	44	11	age	age	NOUN
dpc-2111	44	12	,	,	PUNCT
dpc-2111	44	13	gender	gender	NOUN
dpc-2111	44	14	,	,	PUNCT
dpc-2111	44	15	body	body	NOUN
dpc-2111	44	16	mass	mass	PROPN
dpc-2111	44	17	index	index	NOUN
dpc-2111	44	18	,	,	PUNCT
dpc-2111	44	19	treatment	treatment	NOUN
dpc-2111	44	20	received	receive	VERB
dpc-2111	44	21	,	,	PUNCT
dpc-2111	44	22	disease	disease	NOUN
dpc-2111	44	23	severity	severity	NOUN
dpc-2111	44	24	,	,	PUNCT
dpc-2111	44	25	smoking	smoking	NOUN
dpc-2111	44	26	,	,	PUNCT
dpc-2111	44	27	additional	additional	ADJ
dpc-2111	44	28	disease	disease	NOUN
dpc-2111	44	29	,	,	PUNCT
dpc-2111	44	30	additional	additional	ADJ
dpc-2111	44	31	treatments	treatment	NOUN
dpc-2111	44	32	,	,	PUNCT
dpc-2111	44	33	pneumococcal	pneumococcal	ADJ
dpc-2111	44	34	and	and	CCONJ
dpc-2111	44	35	influenza	influenza	ADJ
dpc-2111	44	36	vaccines	vaccine	NOUN
dpc-2111	44	37	,	,	PUNCT
dpc-2111	44	38	history	history	NOUN
dpc-2111	44	39	of	of	ADP
dpc-2111	44	40	contact	contact	NOUN
dpc-2111	44	41	with	with	ADP
dpc-2111	44	42	someone	someone	PRON
dpc-2111	44	43	with	with	ADP
dpc-2111	44	44	covid-19	covid-19	PROPN
dpc-2111	44	45	,	,	PUNCT
dpc-2111	44	46	whether	whether	SCONJ
dpc-2111	44	47	patients	patient	NOUN
dpc-2111	44	48	had	have	VERB
dpc-2111	44	49	covid-19	covid-19	PROPN
dpc-2111	44	50	,	,	PUNCT
dpc-2111	44	51	if	if	SCONJ
dpc-2111	44	52	they	they	PRON
dpc-2111	44	53	had	have	VERB
dpc-2111	44	54	,	,	PUNCT
dpc-2111	44	55	symptoms	symptom	NOUN
dpc-2111	44	56	,	,	PUNCT
dpc-2111	44	57	treatment	treatment	NOUN
dpc-2111	44	58	of	of	ADP
dpc-2111	44	59	choice	choice	NOUN
dpc-2111	44	60	(	(	PUNCT
dpc-2111	44	61	without	without	ADP
dpc-2111	44	62	treatment	treatment	NOUN
dpc-2111	44	63	,	,	PUNCT
dpc-2111	44	64	with	with	ADP
dpc-2111	44	65	medication	medication	NOUN
dpc-2111	44	66	at	at	ADP
dpc-2111	44	67	home	home	NOUN
dpc-2111	44	68	,	,	PUNCT
dpc-2111	44	69	inpatient	inpatient	PROPN
dpc-2111	44	70	,	,	PUNCT
dpc-2111	44	71	in	in	ADP
dpc-2111	44	72	intensive	intensive	ADJ
dpc-2111	44	73	care	care	NOUN
dpc-2111	44	74	)	)	PUNCT
dpc-2111	44	75	,	,	PUNCT
dpc-2111	44	76	whether	whether	SCONJ
dpc-2111	44	77	there	there	PRON
dpc-2111	44	78	were	be	VERB
dpc-2111	44	79	any	any	DET
dpc-2111	44	80	sequelae	sequelae	NOUN
dpc-2111	44	81	.	.	PUNCT
dpc-2111	45	1	the	the	DET
dpc-2111	45	2	obtained	obtain	VERB
dpc-2111	45	3	data	datum	NOUN
dpc-2111	45	4	were	be	AUX
dpc-2111	45	5	transferred	transfer	VERB
dpc-2111	45	6	to	to	ADP
dpc-2111	45	7	the	the	DET
dpc-2111	45	8	computer	computer	NOUN
dpc-2111	45	9	.	.	PUNCT
dpc-2111	46	1	spss	spss	PROPN
dpc-2111	46	2	version	version	NOUN
dpc-2111	46	3	20.0	20.0	NUM
dpc-2111	46	4	statistical	statistical	ADJ
dpc-2111	46	5	package	package	NOUN
dpc-2111	46	6	program	program	NOUN
dpc-2111	46	7	was	be	AUX
dpc-2111	46	8	used	use	VERB
dpc-2111	46	9	in	in	ADP
dpc-2111	46	10	the	the	DET
dpc-2111	46	11	analysis	analysis	NOUN
dpc-2111	46	12	of	of	ADP
dpc-2111	46	13	the	the	DET
dpc-2111	46	14	data	datum	NOUN
dpc-2111	46	15	.	.	PUNCT
dpc-2111	47	1	in	in	ADP
dpc-2111	47	2	the	the	DET
dpc-2111	47	3	representation	representation	NOUN
dpc-2111	47	4	of	of	ADP
dpc-2111	47	5	the	the	DET
dpc-2111	47	6	descriptive	descriptive	ADJ
dpc-2111	47	7	statistics	statistic	NOUN
dpc-2111	47	8	of	of	ADP
dpc-2111	47	9	the	the	DET
dpc-2111	47	10	study	study	NOUN
dpc-2111	47	11	,	,	PUNCT
dpc-2111	47	12	mean	mean	VERB
dpc-2111	47	13	±	±	NUM
dpc-2111	47	14	standard	standard	ADJ
dpc-2111	47	15	deviation	deviation	NOUN
dpc-2111	47	16	(	(	PUNCT
dpc-2111	47	17	sd	sd	NOUN
dpc-2111	47	18	)	)	PUNCT
dpc-2111	47	19	,	,	PUNCT
dpc-2111	47	20	minimum	minimum	ADJ
dpc-2111	47	21	-	-	PUNCT
dpc-2111	47	22	maximum	maximum	ADJ
dpc-2111	47	23	values	value	NOUN
dpc-2111	47	24	for	for	ADP
dpc-2111	47	25	continuous	continuous	ADJ
dpc-2111	47	26	numerical	numerical	ADJ
dpc-2111	47	27	variables	variable	NOUN
dpc-2111	47	28	,	,	PUNCT
dpc-2111	47	29	number	number	NOUN
dpc-2111	47	30	(	(	PUNCT
dpc-2111	47	31	n	n	CCONJ
dpc-2111	47	32	)	)	PUNCT
dpc-2111	47	33	,	,	PUNCT
dpc-2111	47	34	and	and	CCONJ
dpc-2111	47	35	percentage	percentage	NOUN
dpc-2111	47	36	(	(	PUNCT
dpc-2111	47	37	%	%	INTJ
dpc-2111	47	38	)	)	PUNCT
dpc-2111	47	39	were	be	AUX
dpc-2111	47	40	used	use	VERB
dpc-2111	47	41	for	for	ADP
dpc-2111	47	42	categorical	categorical	ADJ
dpc-2111	47	43	variables	variable	NOUN
dpc-2111	47	44	.	.	PUNCT
dpc-2111	48	1	pearson	pearson	PROPN
dpc-2111	48	2	chi	chi	PROPN
dpc-2111	48	3	-	-	PUNCT
dpc-2111	48	4	square	square	PROPN
dpc-2111	48	5	and	and	CCONJ
dpc-2111	48	6	fisher	fisher	PROPN
dpc-2111	48	7	tests	test	NOUN
dpc-2111	48	8	were	be	AUX
dpc-2111	48	9	used	use	VERB
dpc-2111	48	10	to	to	PART
dpc-2111	48	11	compare	compare	VERB
dpc-2111	48	12	categorical	categorical	ADJ
dpc-2111	48	13	variables	variable	NOUN
dpc-2111	48	14	.	.	PUNCT
dpc-2111	49	1	according	accord	VERB
dpc-2111	49	2	to	to	ADP
dpc-2111	49	3	the	the	DET
dpc-2111	49	4	normality	normality	NOUN
dpc-2111	49	5	evaluation	evaluation	NOUN
dpc-2111	49	6	made	make	VERB
dpc-2111	49	7	by	by	ADP
dpc-2111	49	8	kolmogorov	kolmogorov	NOUN
dpc-2111	49	9	-	-	PUNCT
dpc-2111	49	10	smirnov	smirnov	PROPN
dpc-2111	49	11	and	and	CCONJ
dpc-2111	49	12	shapiro	shapiro	NOUN
dpc-2111	49	13	-	-	PUNCT
dpc-2111	49	14	wilk	wilk	NOUN
dpc-2111	49	15	tests	test	NOUN
dpc-2111	49	16	;	;	PUNCT
dpc-2111	49	17	parametric	parametric	ADJ
dpc-2111	49	18	tests	test	NOUN
dpc-2111	49	19	(	(	PUNCT
dpc-2111	49	20	paired	pair	VERB
dpc-2111	49	21	sample	sample	NOUN
dpc-2111	49	22	t	t	PROPN
dpc-2111	49	23	-	-	PUNCT
dpc-2111	49	24	test	test	NOUN
dpc-2111	49	25	and	and	CCONJ
dpc-2111	49	26	t	t	NOUN
dpc-2111	49	27	-	-	PUNCT
dpc-2111	49	28	test	test	NOUN
dpc-2111	49	29	in	in	ADP
dpc-2111	49	30	independent	independent	ADJ
dpc-2111	49	31	groups	group	NOUN
dpc-2111	49	32	)	)	PUNCT
dpc-2111	49	33	were	be	AUX
dpc-2111	49	34	used	use	VERB
dpc-2111	49	35	where	where	SCONJ
dpc-2111	49	36	continuous	continuous	ADJ
dpc-2111	49	37	variables	variable	NOUN
dpc-2111	49	38	fit	fit	VERB
dpc-2111	49	39	the	the	DET
dpc-2111	49	40	normal	normal	ADJ
dpc-2111	49	41	distribution	distribution	NOUN
dpc-2111	49	42	,	,	PUNCT
dpc-2111	49	43	and	and	CCONJ
dpc-2111	49	44	nonparametric	nonparametric	NOUN
dpc-2111	49	45	tests	test	NOUN
dpc-2111	49	46	(	(	PUNCT
dpc-2111	49	47	mann	mann	PROPN
dpc-2111	49	48	-	-	PUNCT
dpc-2111	49	49	whitney	whitney	PROPN
dpc-2111	49	50	u	u	PROPN
dpc-2111	49	51	test	test	NOUN
dpc-2111	49	52	,	,	PUNCT
dpc-2111	49	53	kruskal	kruskal	PROPN
dpc-2111	49	54	wallis	wallis	PROPN
dpc-2111	49	55	test	test	PROPN
dpc-2111	49	56	)	)	PUNCT
dpc-2111	49	57	were	be	AUX
dpc-2111	49	58	used	use	VERB
dpc-2111	49	59	where	where	SCONJ
dpc-2111	49	60	they	they	PRON
dpc-2111	49	61	did	do	AUX
dpc-2111	49	62	not	not	PART
dpc-2111	49	63	fit	fit	VERB
dpc-2111	49	64	the	the	DET
dpc-2111	49	65	normal	normal	ADJ
dpc-2111	49	66	distribution	distribution	NOUN
dpc-2111	49	67	.	.	PUNCT
dpc-2111	50	1	statistical	statistical	ADJ
dpc-2111	50	2	significance	significance	NOUN
dpc-2111	50	3	level	level	NOUN
dpc-2111	50	4	was	be	AUX
dpc-2111	50	5	accepted	accept	VERB
dpc-2111	50	6	as	as	ADP
dpc-2111	50	7	p	p	NOUN
dpc-2111	50	8	<	<	X
dpc-2111	50	9	0.05	0.05	NUM
dpc-2111	50	10	.	.	PUNCT
dpc-2111	51	1	results	result	VERB
dpc-2111	51	2	the	the	DET
dpc-2111	51	3	study	study	NOUN
dpc-2111	51	4	included	include	VERB
dpc-2111	51	5	102	102	NUM
dpc-2111	51	6	moderate	moderate	ADJ
dpc-2111	51	7	-	-	PUNCT
dpc-2111	51	8	to	to	ADP
dpc-2111	51	9	-	-	PUNCT
dpc-2111	51	10	severe	severe	ADJ
dpc-2111	51	11	acne	acne	NOUN
dpc-2111	51	12	patients	patient	NOUN
dpc-2111	51	13	aged	age	VERB
dpc-2111	51	14	16	16	NUM
dpc-2111	51	15	years	year	NOUN
dpc-2111	51	16	and	and	CCONJ
dpc-2111	51	17	older	old	ADJ
dpc-2111	51	18	who	who	PRON
dpc-2111	51	19	were	be	AUX
dpc-2111	51	20	followed	follow	VERB
dpc-2111	51	21	up	up	ADP
dpc-2111	51	22	and	and	CCONJ
dpc-2111	51	23	treated	treat	VERB
dpc-2111	51	24	in	in	ADP
dpc-2111	51	25	our	our	PRON
dpc-2111	51	26	clinic	clinic	NOUN
dpc-2111	51	27	,	,	PUNCT
dpc-2111	51	28	using	use	VERB
dpc-2111	51	29	oral	oral	ADJ
dpc-2111	51	30	isotretinoin	isotretinoin	NOUN
dpc-2111	51	31	at	at	ADP
dpc-2111	51	32	a	a	DET
dpc-2111	51	33	dose	dose	NOUN
dpc-2111	51	34	of	of	ADP
dpc-2111	51	35	0.5	0.5	NUM
dpc-2111	51	36	-	-	PUNCT
dpc-2111	51	37	1mg	1mg	NUM
dpc-2111	51	38	/	/	SYM
dpc-2111	51	39	kg	kg	NOUN
dpc-2111	51	40	or	or	CCONJ
dpc-2111	51	41	topical	topical	ADJ
dpc-2111	51	42	treatment	treatment	NOUN
dpc-2111	51	43	(	(	PUNCT
dpc-2111	51	44	topical	topical	ADJ
dpc-2111	51	45	retinoid	retinoid	NOUN
dpc-2111	51	46	or	or	CCONJ
dpc-2111	51	47	topical	topical	ADJ
dpc-2111	51	48	benzoylperoxide	benzoylperoxide	NOUN
dpc-2111	51	49	plus	plus	CCONJ
dpc-2111	51	50	clindamycin	clindamycin	NOUN
dpc-2111	51	51	)	)	PUNCT
dpc-2111	51	52	for	for	ADP
dpc-2111	51	53	at	at	ADV
dpc-2111	51	54	least	least	ADV
dpc-2111	51	55	two	two	NUM
dpc-2111	51	56	months	month	NOUN
dpc-2111	51	57	.	.	PUNCT
dpc-2111	52	1	the	the	DET
dpc-2111	52	2	clinical	clinical	ADJ
dpc-2111	52	3	processes	process	NOUN
dpc-2111	52	4	between	between	ADP
dpc-2111	52	5	march	march	PROPN
dpc-2111	52	6	2020	2020	NUM
dpc-2111	52	7	and	and	CCONJ
dpc-2111	52	8	february	february	PROPN
dpc-2111	52	9	2021	2021	NUM
dpc-2111	52	10	were	be	AUX
dpc-2111	52	11	evaluated	evaluate	VERB
dpc-2111	52	12	.	.	PUNCT
dpc-2111	53	1	of	of	ADP
dpc-2111	53	2	the	the	DET
dpc-2111	53	3	67	67	NUM
dpc-2111	53	4	patients	patient	NOUN
dpc-2111	53	5	who	who	PRON
dpc-2111	53	6	took	take	VERB
dpc-2111	53	7	oral	oral	ADJ
dpc-2111	53	8	isotretinoin	isotretinoin	NOUN
dpc-2111	53	9	during	during	ADP
dpc-2111	53	10	the	the	DET
dpc-2111	53	11	pandemic	pandemic	ADJ
dpc-2111	53	12	,	,	PUNCT
dpc-2111	53	13	52	52	NUM
dpc-2111	53	14	(	(	PUNCT
dpc-2111	53	15	77.6	77.6	NUM
dpc-2111	53	16	%	%	NOUN
dpc-2111	53	17	)	)	PUNCT
dpc-2111	53	18	were	be	AUX
dpc-2111	53	19	female	female	ADJ
dpc-2111	53	20	and	and	CCONJ
dpc-2111	53	21	15	15	NUM
dpc-2111	53	22	(	(	PUNCT
dpc-2111	53	23	61	61	NUM
dpc-2111	53	24	%	%	NOUN
dpc-2111	53	25	)	)	PUNCT
dpc-2111	53	26	were	be	AUX
dpc-2111	53	27	male	male	ADJ
dpc-2111	53	28	,	,	PUNCT
dpc-2111	53	29	mean	mean	ADJ
dpc-2111	53	30	age	age	NOUN
dpc-2111	53	31	was	be	AUX
dpc-2111	53	32	22.64	22.64	NUM
dpc-2111	53	33	±	±	NUM
dpc-2111	53	34	6.62	6.62	NUM
dpc-2111	53	35	.	.	PUNCT
dpc-2111	54	1	of	of	ADP
dpc-2111	54	2	35	35	NUM
dpc-2111	54	3	patients	patient	NOUN
dpc-2111	54	4	who	who	PRON
dpc-2111	54	5	used	use	VERB
dpc-2111	54	6	topical	topical	ADJ
dpc-2111	54	7	treatment	treatment	NOUN
dpc-2111	54	8	,	,	PUNCT
dpc-2111	54	9	19	19	NUM
dpc-2111	54	10	(	(	PUNCT
dpc-2111	54	11	54.3	54.3	NUM
dpc-2111	54	12	%	%	NOUN
dpc-2111	54	13	)	)	PUNCT
dpc-2111	54	14	were	be	AUX
dpc-2111	54	15	female	female	ADJ
dpc-2111	54	16	and	and	CCONJ
dpc-2111	54	17	16	16	NUM
dpc-2111	54	18	(	(	PUNCT
dpc-2111	54	19	61	61	NUM
dpc-2111	54	20	%	%	NOUN
dpc-2111	54	21	)	)	PUNCT
dpc-2111	54	22	were	be	AUX
dpc-2111	54	23	male	male	ADJ
dpc-2111	54	24	,	,	PUNCT
dpc-2111	54	25	the	the	DET
dpc-2111	54	26	mean	mean	ADJ
dpc-2111	54	27	age	age	NOUN
dpc-2111	54	28	was	be	AUX
dpc-2111	54	29	25.74	25.74	NUM
dpc-2111	54	30	±	±	NUM
dpc-2111	54	31	8.16	8.16	NUM
dpc-2111	54	32	.	.	PROPN
dpc-2111	55	1	twenty	twenty	NUM
dpc-2111	55	2	(	(	PUNCT
dpc-2111	55	3	74.1	74.1	NUM
dpc-2111	55	4	%	%	NOUN
dpc-2111	55	5	)	)	PUNCT
dpc-2111	55	6	of	of	ADP
dpc-2111	55	7	the	the	DET
dpc-2111	55	8	women	woman	NOUN
dpc-2111	55	9	and	and	CCONJ
dpc-2111	55	10	7	7	NUM
dpc-2111	55	11	(	(	PUNCT
dpc-2111	55	12	25.9	25.9	NUM
dpc-2111	55	13	%	%	NOUN
dpc-2111	55	14	)	)	PUNCT
dpc-2111	55	15	of	of	ADP
dpc-2111	55	16	the	the	DET
dpc-2111	55	17	men	man	NOUN
dpc-2111	55	18	had	have	VERB
dpc-2111	55	19	a	a	DET
dpc-2111	55	20	history	history	NOUN
dpc-2111	55	21	of	of	ADP
dpc-2111	55	22	27	27	NUM
dpc-2111	55	23	covid-19	covid-19	PROPN
dpc-2111	55	24	positivity	positivity	NOUN
dpc-2111	55	25	confirmed	confirm	VERB
dpc-2111	55	26	by	by	ADP
dpc-2111	55	27	polymerase	polymerase	NOUN
dpc-2111	55	28	chain	chain	NOUN
dpc-2111	55	29	reaction	reaction	NOUN
dpc-2111	55	30	(	(	PUNCT
dpc-2111	55	31	pcr	pcr	NOUN
dpc-2111	55	32	)	)	PUNCT
dpc-2111	55	33	in	in	ADP
dpc-2111	55	34	the	the	DET
dpc-2111	55	35	nasal	nasal	PROPN
dpc-2111	55	36	swab	swab	PROPN
dpc-2111	55	37	sample	sample	NOUN
dpc-2111	55	38	.	.	PUNCT
dpc-2111	56	1	the	the	DET
dpc-2111	56	2	mean	mean	ADJ
dpc-2111	56	3	age	age	NOUN
dpc-2111	56	4	of	of	ADP
dpc-2111	56	5	those	those	PRON
dpc-2111	56	6	who	who	PRON
dpc-2111	56	7	were	be	AUX
dpc-2111	56	8	positive	positive	ADJ
dpc-2111	56	9	for	for	ADP
dpc-2111	56	10	covid-19	covid-19	PROPN
dpc-2111	56	11	was	be	AUX
dpc-2111	56	12	24.88	24.88	NUM
dpc-2111	56	13	±	±	NUM
dpc-2111	56	14	8.65	8.65	NUM
dpc-2111	56	15	,	,	PUNCT
dpc-2111	56	16	and	and	CCONJ
dpc-2111	56	17	there	there	PRON
dpc-2111	56	18	was	be	VERB
dpc-2111	56	19	no	no	DET
dpc-2111	56	20	statistical	statistical	ADJ
dpc-2111	56	21	difference	difference	NOUN
dpc-2111	56	22	in	in	ADP
dpc-2111	56	23	age	age	NOUN
dpc-2111	56	24	and	and	CCONJ
dpc-2111	56	25	gender	gender	NOUN
dpc-2111	56	26	between	between	ADP
dpc-2111	56	27	those	those	PRON
dpc-2111	56	28	who	who	PRON
dpc-2111	56	29	were	be	AUX
dpc-2111	56	30	positive	positive	ADJ
dpc-2111	56	31	for	for	ADP
dpc-2111	56	32	covid-19	covid-19	PROPN
dpc-2111	56	33	and	and	CCONJ
dpc-2111	56	34	those	those	PRON
dpc-2111	56	35	who	who	PRON
dpc-2111	56	36	were	be	AUX
dpc-2111	56	37	negative	negative	ADJ
dpc-2111	56	38	for	for	ADP
dpc-2111	56	39	covid-19	covid-19	PROPN
dpc-2111	56	40	(	(	PUNCT
dpc-2111	56	41	p	p	NOUN
dpc-2111	56	42	=	=	PROPN
dpc-2111	56	43	0.773	0.773	NUM
dpc-2111	56	44	and	and	CCONJ
dpc-2111	56	45	p	p	NOUN
dpc-2111	56	46	=	=	NOUN
dpc-2111	56	47	0.556	0.556	NUM
dpc-2111	56	48	,	,	PUNCT
dpc-2111	56	49	respectively	respectively	ADV
dpc-2111	56	50	)	)	PUNCT
dpc-2111	56	51	.	.	PUNCT
dpc-2111	57	1	there	there	PRON
dpc-2111	57	2	was	be	VERB
dpc-2111	57	3	no	no	DET
dpc-2111	57	4	statistical	statistical	ADJ
dpc-2111	57	5	difference	difference	NOUN
dpc-2111	57	6	between	between	ADP
dpc-2111	57	7	covid-19	covid-19	PROPN
dpc-2111	57	8	positive	positive	ADJ
dpc-2111	57	9	and	and	CCONJ
dpc-2111	57	10	covid-19	covid-19	PROPN
dpc-2111	57	11	negatives	negative	NOUN
dpc-2111	57	12	in	in	ADP
dpc-2111	57	13	terms	term	NOUN
dpc-2111	57	14	of	of	ADP
dpc-2111	57	15	body	body	NOUN
dpc-2111	57	16	mass	mass	NOUN
dpc-2111	57	17	index	index	NOUN
dpc-2111	57	18	(	(	PUNCT
dpc-2111	57	19	bmi	bmi	PROPN
dpc-2111	57	20	)	)	PUNCT
dpc-2111	57	21	average	average	ADJ
dpc-2111	57	22	,	,	PUNCT
dpc-2111	57	23	smoking	smoking	NOUN
dpc-2111	57	24	,	,	PUNCT
dpc-2111	57	25	additional	additional	ADJ
dpc-2111	57	26	disease	disease	NOUN
dpc-2111	57	27	status	status	NOUN
dpc-2111	57	28	,	,	PUNCT
dpc-2111	57	29	acne	acne	NOUN
dpc-2111	57	30	severity	severity	NOUN
dpc-2111	57	31	,	,	PUNCT
dpc-2111	57	32	pneumococcal	pneumococcal	ADJ
dpc-2111	57	33	and	and	CCONJ
dpc-2111	57	34	influenza	influenza	NOUN
dpc-2111	57	35	vaccination	vaccination	NOUN
dpc-2111	57	36	status	status	NOUN
dpc-2111	57	37	(	(	PUNCT
dpc-2111	57	38	table	table	NOUN
dpc-2111	57	39	1	1	NUM
dpc-2111	57	40	)	)	PUNCT
dpc-2111	57	41	.	.	PUNCT
dpc-2111	58	1	of	of	ADP
dpc-2111	58	2	the	the	DET
dpc-2111	58	3	27	27	NUM
dpc-2111	58	4	patients	patient	NOUN
dpc-2111	58	5	who	who	PRON
dpc-2111	58	6	were	be	AUX
dpc-2111	58	7	positive	positive	ADJ
dpc-2111	58	8	for	for	ADP
dpc-2111	58	9	covid-19	covid-19	PROPN
dpc-2111	58	10	,	,	PUNCT
dpc-2111	58	11	16	16	NUM
dpc-2111	58	12	(	(	PUNCT
dpc-2111	58	13	59.3	59.3	NUM
dpc-2111	58	14	)	)	PUNCT
dpc-2111	58	15	were	be	AUX
dpc-2111	58	16	using	use	VERB
dpc-2111	58	17	oral	oral	ADJ
dpc-2111	58	18	isotretinoin	isotretinoin	NOUN
dpc-2111	58	19	and	and	CCONJ
dpc-2111	58	20	11	11	NUM
dpc-2111	58	21	(	(	PUNCT
dpc-2111	58	22	40.7	40.7	NUM
dpc-2111	58	23	%	%	NOUN
dpc-2111	58	24	)	)	PUNCT
dpc-2111	58	25	were	be	AUX
dpc-2111	58	26	using	use	VERB
dpc-2111	58	27	a	a	DET
dpc-2111	58	28	topical	topical	ADJ
dpc-2111	58	29	treatment	treatment	NOUN
dpc-2111	58	30	.	.	PUNCT
dpc-2111	59	1	there	there	PRON
dpc-2111	59	2	was	be	VERB
dpc-2111	59	3	no	no	DET
dpc-2111	59	4	statistical	statistical	ADJ
dpc-2111	59	5	difference	difference	NOUN
dpc-2111	59	6	in	in	ADP
dpc-2111	59	7	covid-19	covid-19	PROPN
dpc-2111	59	8	positivity	positivity	NOUN
dpc-2111	59	9	rates	rate	NOUN
dpc-2111	59	10	between	between	ADP
dpc-2111	59	11	patients	patient	NOUN
dpc-2111	59	12	using	use	VERB
dpc-2111	59	13	oral	oral	ADJ
dpc-2111	59	14	isotretinoin	isotretinoin	NOUN
dpc-2111	59	15	and	and	CCONJ
dpc-2111	59	16	patients	patient	NOUN
dpc-2111	59	17	using	use	VERB
dpc-2111	59	18	topical	topical	ADJ
dpc-2111	59	19	treatment	treatment	NOUN
dpc-2111	59	20	(	(	PUNCT
dpc-2111	59	21	p	p	NOUN
dpc-2111	59	22	=	=	NOUN
dpc-2111	59	23	0.412	0.412	NUM
dpc-2111	59	24	)	)	PUNCT
dpc-2111	59	25	.	.	PUNCT
dpc-2111	60	1	original	original	ADJ
dpc-2111	60	2	article	article	NOUN
dpc-2111	60	3	|	|	ADV
dpc-2111	60	4	dermatol	dermatol	ADJ
dpc-2111	60	5	pract	pract	NOUN
dpc-2111	60	6	concept	concept	NOUN
dpc-2111	60	7	.	.	PUNCT
dpc-2111	61	1	2022;12(3):e2022146	2022;12(3):e2022146	NUM
dpc-2111	61	2	3	3	NUM
dpc-2111	61	3	considering	consider	VERB
dpc-2111	61	4	the	the	DET
dpc-2111	61	5	rates	rate	NOUN
dpc-2111	61	6	of	of	ADP
dpc-2111	61	7	covid-19	covid-19	PROPN
dpc-2111	61	8	transmission	transmission	NOUN
dpc-2111	61	9	after	after	ADP
dpc-2111	61	10	contact	contact	NOUN
dpc-2111	61	11	with	with	ADP
dpc-2111	61	12	a	a	DET
dpc-2111	61	13	covid-19	covid-19	PROPN
dpc-2111	61	14	positive	positive	ADJ
dpc-2111	61	15	person	person	NOUN
dpc-2111	61	16	,	,	PUNCT
dpc-2111	61	17	covid-19	covid-19	PROPN
dpc-2111	61	18	positivity	positivity	NOUN
dpc-2111	61	19	in	in	ADP
dpc-2111	61	20	14	14	NUM
dpc-2111	61	21	of	of	ADP
dpc-2111	61	22	29	29	NUM
dpc-2111	61	23	patients	patient	NOUN
dpc-2111	61	24	,	,	PUNCT
dpc-2111	61	25	who	who	PRON
dpc-2111	61	26	were	be	AUX
dpc-2111	61	27	using	use	VERB
dpc-2111	61	28	oral	oral	ADJ
dpc-2111	61	29	isotretinoin	isotretinoin	NOUN
dpc-2111	61	30	and	and	CCONJ
dpc-2111	61	31	came	come	VERB
dpc-2111	61	32	into	into	ADP
dpc-2111	61	33	contact	contact	NOUN
dpc-2111	61	34	with	with	ADP
dpc-2111	61	35	someone	someone	PRON
dpc-2111	61	36	that	that	PRON
dpc-2111	61	37	tested	test	VERB
dpc-2111	61	38	positive	positive	ADJ
dpc-2111	61	39	for	for	ADP
dpc-2111	61	40	covid-19	covid-19	PROPN
dpc-2111	61	41	was	be	AUX
dpc-2111	61	42	confirmed	confirm	VERB
dpc-2111	61	43	by	by	ADP
dpc-2111	61	44	pcr	pcr	ADJ
dpc-2111	61	45	test	test	NOUN
dpc-2111	61	46	;	;	PUNCT
dpc-2111	61	47	covid-19	covid-19	PROPN
dpc-2111	61	48	positivity	positivity	NOUN
dpc-2111	61	49	in	in	ADP
dpc-2111	61	50	11	11	NUM
dpc-2111	61	51	of	of	ADP
dpc-2111	61	52	18	18	NUM
dpc-2111	61	53	patients	patient	NOUN
dpc-2111	61	54	who	who	PRON
dpc-2111	61	55	were	be	AUX
dpc-2111	61	56	using	use	VERB
dpc-2111	61	57	the	the	DET
dpc-2111	61	58	topical	topical	ADJ
dpc-2111	61	59	treatment	treatment	NOUN
dpc-2111	61	60	and	and	CCONJ
dpc-2111	61	61	came	come	VERB
dpc-2111	61	62	into	into	ADP
dpc-2111	61	63	contact	contact	NOUN
dpc-2111	61	64	with	with	ADP
dpc-2111	61	65	someone	someone	PRON
dpc-2111	61	66	that	that	PRON
dpc-2111	61	67	tested	test	VERB
dpc-2111	61	68	positive	positive	ADJ
dpc-2111	61	69	for	for	ADP
dpc-2111	61	70	covid-19	covid-19	PROPN
dpc-2111	61	71	was	be	AUX
dpc-2111	61	72	confirmed	confirm	VERB
dpc-2111	61	73	by	by	ADP
dpc-2111	61	74	pcr	pcr	ADJ
dpc-2111	61	75	test	test	NOUN
dpc-2111	61	76	.	.	PUNCT
dpc-2111	62	1	there	there	PRON
dpc-2111	62	2	was	be	VERB
dpc-2111	62	3	no	no	DET
dpc-2111	62	4	statistical	statistical	ADJ
dpc-2111	62	5	difference	difference	NOUN
dpc-2111	62	6	in	in	ADP
dpc-2111	62	7	the	the	DET
dpc-2111	62	8	rates	rate	NOUN
dpc-2111	62	9	of	of	ADP
dpc-2111	62	10	being	be	AUX
dpc-2111	62	11	positive	positive	ADJ
dpc-2111	62	12	for	for	ADP
dpc-2111	62	13	covid-19	covid-19	PROPN
dpc-2111	62	14	between	between	ADP
dpc-2111	62	15	contacted	contact	VERB
dpc-2111	62	16	patients	patient	NOUN
dpc-2111	62	17	using	use	VERB
dpc-2111	62	18	oral	oral	ADJ
dpc-2111	62	19	isotretinoin	isotretinoin	NOUN
dpc-2111	62	20	and	and	CCONJ
dpc-2111	62	21	contacted	contact	VERB
dpc-2111	62	22	patients	patient	NOUN
dpc-2111	62	23	using	use	VERB
dpc-2111	62	24	topical	topical	ADJ
dpc-2111	62	25	treatment	treatment	NOUN
dpc-2111	62	26	(	(	PUNCT
dpc-2111	62	27	p	p	NOUN
dpc-2111	62	28	=	=	NOUN
dpc-2111	62	29	0.391	0.391	NUM
dpc-2111	62	30	)	)	PUNCT
dpc-2111	62	31	.	.	PUNCT
dpc-2111	63	1	of	of	ADP
dpc-2111	63	2	the	the	DET
dpc-2111	63	3	27	27	NUM
dpc-2111	63	4	patients	patient	NOUN
dpc-2111	63	5	who	who	PRON
dpc-2111	63	6	were	be	AUX
dpc-2111	63	7	positive	positive	ADJ
dpc-2111	63	8	for	for	ADP
dpc-2111	63	9	covid-19	covid-19	PROPN
dpc-2111	63	10	,	,	PUNCT
dpc-2111	63	11	26	26	NUM
dpc-2111	63	12	had	have	VERB
dpc-2111	63	13	symptoms	symptom	NOUN
dpc-2111	63	14	,	,	PUNCT
dpc-2111	63	15	only	only	ADV
dpc-2111	63	16	one	one	NUM
dpc-2111	63	17	patient	patient	NOUN
dpc-2111	63	18	using	use	VERB
dpc-2111	63	19	oral	oral	ADJ
dpc-2111	63	20	isotretinoin	isotretinoin	PROPN
dpc-2111	63	21	was	be	AUX
dpc-2111	63	22	asymptomatic	asymptomatic	ADJ
dpc-2111	63	23	,	,	PUNCT
dpc-2111	63	24	and	and	CCONJ
dpc-2111	63	25	there	there	PRON
dpc-2111	63	26	was	be	VERB
dpc-2111	63	27	no	no	DET
dpc-2111	63	28	statistical	statistical	ADJ
dpc-2111	63	29	difference	difference	NOUN
dpc-2111	63	30	in	in	ADP
dpc-2111	63	31	the	the	DET
dpc-2111	63	32	rates	rate	NOUN
dpc-2111	63	33	of	of	ADP
dpc-2111	63	34	asymptomatic	asymptomatic	ADJ
dpc-2111	63	35	covid-19	covid-19	PROPN
dpc-2111	63	36	positivity	positivity	NOUN
dpc-2111	63	37	between	between	ADP
dpc-2111	63	38	patients	patient	NOUN
dpc-2111	63	39	using	use	VERB
dpc-2111	63	40	oral	oral	ADJ
dpc-2111	63	41	isotretinoin	isotretinoin	NOUN
dpc-2111	63	42	and	and	CCONJ
dpc-2111	63	43	patients	patient	NOUN
dpc-2111	63	44	using	use	VERB
dpc-2111	63	45	topical	topical	ADJ
dpc-2111	63	46	treatment	treatment	NOUN
dpc-2111	63	47	(	(	PUNCT
dpc-2111	63	48	p	p	NOUN
dpc-2111	63	49	=	=	NOUN
dpc-2111	63	50	0.593	0.593	NUM
dpc-2111	63	51	)	)	PUNCT
dpc-2111	63	52	.	.	PUNCT
dpc-2111	64	1	in	in	ADP
dpc-2111	64	2	order	order	NOUN
dpc-2111	64	3	of	of	ADP
dpc-2111	64	4	frequency	frequency	NOUN
dpc-2111	64	5	,	,	PUNCT
dpc-2111	64	6	the	the	DET
dpc-2111	64	7	symptoms	symptom	NOUN
dpc-2111	64	8	associated	associate	VERB
dpc-2111	64	9	with	with	ADP
dpc-2111	64	10	covid-19	covid-19	PROPN
dpc-2111	64	11	were	be	AUX
dpc-2111	64	12	:	:	PUNCT
dpc-2111	64	13	taste\smell	taste\smell	NUM
dpc-2111	64	14	loss	loss	NOUN
dpc-2111	64	15	(	(	PUNCT
dpc-2111	64	16	15	15	NUM
dpc-2111	64	17	)	)	PUNCT
dpc-2111	64	18	,	,	PUNCT
dpc-2111	64	19	headache	headache	NOUN
dpc-2111	64	20	(	(	PUNCT
dpc-2111	64	21	13	13	NUM
dpc-2111	64	22	)	)	PUNCT
dpc-2111	64	23	,	,	PUNCT
dpc-2111	64	24	fever	fever	NOUN
dpc-2111	64	25	(	(	PUNCT
dpc-2111	64	26	12	12	NUM
dpc-2111	64	27	)	)	PUNCT
dpc-2111	64	28	,	,	PUNCT
dpc-2111	64	29	malaise	malaise	NOUN
dpc-2111	64	30	(	(	PUNCT
dpc-2111	64	31	12	12	NUM
dpc-2111	64	32	)	)	PUNCT
dpc-2111	64	33	,	,	PUNCT
dpc-2111	64	34	arthralgia\myalgia	arthralgia\myalgia	NUM
dpc-2111	64	35	(	(	PUNCT
dpc-2111	64	36	11	11	NUM
dpc-2111	64	37	)	)	PUNCT
dpc-2111	64	38	,	,	PUNCT
dpc-2111	64	39	cough	cough	NOUN
dpc-2111	64	40	(	(	PUNCT
dpc-2111	64	41	8)	8)	NUM
dpc-2111	64	42	,	,	PUNCT
dpc-2111	64	43	sore	sore	ADJ
dpc-2111	64	44	throat	throat	NOUN
dpc-2111	64	45	(	(	PUNCT
dpc-2111	64	46	6	6	NUM
dpc-2111	64	47	)	)	PUNCT
dpc-2111	64	48	,	,	PUNCT
dpc-2111	64	49	shortness	shortness	NOUN
dpc-2111	64	50	of	of	ADP
dpc-2111	64	51	breath	breath	NOUN
dpc-2111	64	52	(	(	PUNCT
dpc-2111	64	53	4	4	NUM
dpc-2111	64	54	)	)	PUNCT
dpc-2111	64	55	.	.	PUNCT
dpc-2111	65	1	there	there	PRON
dpc-2111	65	2	was	be	VERB
dpc-2111	65	3	no	no	DET
dpc-2111	65	4	statistical	statistical	ADJ
dpc-2111	65	5	difference	difference	NOUN
dpc-2111	65	6	between	between	ADP
dpc-2111	65	7	patients	patient	NOUN
dpc-2111	65	8	using	use	VERB
dpc-2111	65	9	oral	oral	ADJ
dpc-2111	65	10	isotretinoin	isotretinoin	NOUN
dpc-2111	65	11	and	and	CCONJ
dpc-2111	65	12	patients	patient	NOUN
dpc-2111	65	13	using	use	VERB
dpc-2111	65	14	topical	topical	ADJ
dpc-2111	65	15	treatment	treatment	NOUN
dpc-2111	65	16	in	in	ADP
dpc-2111	65	17	terms	term	NOUN
dpc-2111	65	18	of	of	ADP
dpc-2111	65	19	the	the	DET
dpc-2111	65	20	incidence	incidence	NOUN
dpc-2111	65	21	of	of	ADP
dpc-2111	65	22	symptoms	symptom	NOUN
dpc-2111	65	23	other	other	ADJ
dpc-2111	65	24	than	than	ADP
dpc-2111	65	25	headache	headache	NOUN
dpc-2111	65	26	.	.	PUNCT
dpc-2111	66	1	headache	headache	NOUN
dpc-2111	66	2	was	be	AUX
dpc-2111	66	3	seen	see	VERB
dpc-2111	66	4	at	at	ADP
dpc-2111	66	5	a	a	DET
dpc-2111	66	6	lower	low	ADJ
dpc-2111	66	7	rate	rate	NOUN
dpc-2111	66	8	in	in	ADP
dpc-2111	66	9	patients	patient	NOUN
dpc-2111	66	10	using	use	VERB
dpc-2111	66	11	oral	oral	ADJ
dpc-2111	66	12	isotretinoin	isotretinoin	NOUN
dpc-2111	66	13	compared	compare	VERB
dpc-2111	66	14	to	to	ADP
dpc-2111	66	15	those	those	PRON
dpc-2111	66	16	using	use	VERB
dpc-2111	66	17	topical	topical	ADJ
dpc-2111	66	18	treatment	treatment	NOUN
dpc-2111	66	19	(	(	PUNCT
dpc-2111	66	20	33.3	33.3	NUM
dpc-2111	66	21	%	%	NOUN
dpc-2111	66	22	,	,	PUNCT
dpc-2111	66	23	72.7	72.7	NUM
dpc-2111	66	24	%	%	NOUN
dpc-2111	66	25	,	,	PUNCT
dpc-2111	66	26	respectively	respectively	ADV
dpc-2111	66	27	)	)	PUNCT
dpc-2111	66	28	,	,	PUNCT
dpc-2111	66	29	and	and	CCONJ
dpc-2111	66	30	there	there	PRON
dpc-2111	66	31	was	be	VERB
dpc-2111	66	32	a	a	DET
dpc-2111	66	33	statistically	statistically	ADV
dpc-2111	66	34	significant	significant	ADJ
dpc-2111	66	35	difference	difference	NOUN
dpc-2111	66	36	(	(	PUNCT
dpc-2111	66	37	p	p	X
dpc-2111	66	38	=	=	NOUN
dpc-2111	66	39	0.047	0.047	NUM
dpc-2111	66	40	)	)	PUNCT
dpc-2111	66	41	.	.	PUNCT
dpc-2111	67	1	taste\smell	taste\smell	NUM
dpc-2111	67	2	loss	loss	NOUN
dpc-2111	67	3	developed	develop	VERB
dpc-2111	67	4	in	in	ADP
dpc-2111	67	5	7	7	NUM
dpc-2111	67	6	(	(	PUNCT
dpc-2111	67	7	46.7	46.7	NUM
dpc-2111	67	8	%	%	NOUN
dpc-2111	67	9	)	)	PUNCT
dpc-2111	67	10	of	of	ADP
dpc-2111	67	11	16	16	NUM
dpc-2111	67	12	covid-19	covid-19	PROPN
dpc-2111	67	13	-	-	PUNCT
dpc-2111	67	14	positive	positive	ADJ
dpc-2111	67	15	patients	patient	NOUN
dpc-2111	67	16	using	use	VERB
dpc-2111	67	17	oral	oral	ADJ
dpc-2111	67	18	isotretinoin	isotretinoin	NOUN
dpc-2111	67	19	and	and	CCONJ
dpc-2111	67	20	8	8	NUM
dpc-2111	67	21	(	(	PUNCT
dpc-2111	67	22	72.7	72.7	NUM
dpc-2111	67	23	%	%	NOUN
dpc-2111	67	24	)	)	PUNCT
dpc-2111	67	25	of	of	ADP
dpc-2111	67	26	11	11	NUM
dpc-2111	67	27	covid-19	covid-19	PROPN
dpc-2111	67	28	-	-	PUNCT
dpc-2111	67	29	positive	positive	ADJ
dpc-2111	67	30	patients	patient	NOUN
dpc-2111	67	31	using	use	VERB
dpc-2111	67	32	topical	topical	ADJ
dpc-2111	67	33	treatment	treatment	NOUN
dpc-2111	67	34	,	,	PUNCT
dpc-2111	67	35	but	but	CCONJ
dpc-2111	67	36	there	there	PRON
dpc-2111	67	37	was	be	VERB
dpc-2111	67	38	no	no	DET
dpc-2111	67	39	statistical	statistical	ADJ
dpc-2111	67	40	difference	difference	NOUN
dpc-2111	67	41	(	(	PUNCT
dpc-2111	67	42	p	p	NOUN
dpc-2111	67	43	=	=	NOUN
dpc-2111	67	44	0.246	0.246	NUM
dpc-2111	67	45	)	)	PUNCT
dpc-2111	67	46	(	(	PUNCT
dpc-2111	67	47	table	table	NOUN
dpc-2111	67	48	2	2	NUM
dpc-2111	67	49	)	)	PUNCT
dpc-2111	67	50	.	.	PUNCT
dpc-2111	68	1	among	among	ADP
dpc-2111	68	2	the	the	DET
dpc-2111	68	3	gastrointestinal	gastrointestinal	NOUN
dpc-2111	68	4	(	(	PUNCT
dpc-2111	68	5	nausea	nausea	NOUN
dpc-2111	68	6	,	,	PUNCT
dpc-2111	68	7	vomiting	vomiting	NOUN
dpc-2111	68	8	,	,	PUNCT
dpc-2111	68	9	abdominal	abdominal	ADJ
dpc-2111	68	10	pain	pain	NOUN
dpc-2111	68	11	)	)	PUNCT
dpc-2111	68	12	and	and	CCONJ
dpc-2111	68	13	respiratory	respiratory	ADJ
dpc-2111	68	14	symptoms	symptom	NOUN
dpc-2111	68	15	(	(	PUNCT
dpc-2111	68	16	dyspnea	dyspnea	NOUN
dpc-2111	68	17	,	,	PUNCT
dpc-2111	68	18	chest	chest	NOUN
dpc-2111	68	19	pain	pain	NOUN
dpc-2111	68	20	)	)	PUNCT
dpc-2111	68	21	associated	associate	VERB
dpc-2111	68	22	with	with	ADP
dpc-2111	68	23	severe	severe	ADJ
dpc-2111	68	24	covid-19	covid-19	PROPN
dpc-2111	68	25	,	,	PUNCT
dpc-2111	68	26	only	only	ADV
dpc-2111	68	27	shortness	shortness	NOUN
dpc-2111	68	28	of	of	ADP
dpc-2111	68	29	breath	breath	NOUN
dpc-2111	68	30	was	be	AUX
dpc-2111	68	31	seen	see	VERB
dpc-2111	68	32	in	in	ADP
dpc-2111	68	33	4	4	NUM
dpc-2111	68	34	of	of	ADP
dpc-2111	68	35	our	our	PRON
dpc-2111	68	36	patients	patient	NOUN
dpc-2111	68	37	,	,	PUNCT
dpc-2111	68	38	other	other	ADJ
dpc-2111	68	39	severe	severe	ADJ
dpc-2111	68	40	symptoms	symptom	NOUN
dpc-2111	68	41	were	be	AUX
dpc-2111	68	42	not	not	PART
dpc-2111	68	43	encountered	encounter	VERB
dpc-2111	68	44	.	.	PUNCT
dpc-2111	69	1	dyspnea	dyspnea	PROPN
dpc-2111	69	2	was	be	AUX
dpc-2111	69	3	observed	observe	VERB
dpc-2111	69	4	in	in	ADP
dpc-2111	69	5	one	one	NUM
dpc-2111	69	6	patient	patient	NOUN
dpc-2111	69	7	(	(	PUNCT
dpc-2111	69	8	6.7	6.7	NUM
dpc-2111	69	9	%	%	NOUN
dpc-2111	69	10	)	)	PUNCT
dpc-2111	69	11	using	use	VERB
dpc-2111	69	12	oral	oral	ADJ
dpc-2111	69	13	isotretinoin	isotretinoin	NOUN
dpc-2111	69	14	and	and	CCONJ
dpc-2111	69	15	3	3	NUM
dpc-2111	69	16	(	(	PUNCT
dpc-2111	69	17	27.3	27.3	NUM
dpc-2111	69	18	%	%	NOUN
dpc-2111	69	19	)	)	PUNCT
dpc-2111	69	20	patients	patient	NOUN
dpc-2111	69	21	receiving	receive	VERB
dpc-2111	69	22	topical	topical	ADJ
dpc-2111	69	23	treatment	treatment	NOUN
dpc-2111	69	24	.	.	PUNCT
dpc-2111	70	1	there	there	PRON
dpc-2111	70	2	was	be	VERB
dpc-2111	70	3	no	no	DET
dpc-2111	70	4	statistically	statistically	ADV
dpc-2111	70	5	significant	significant	ADJ
dpc-2111	70	6	difference	difference	NOUN
dpc-2111	70	7	between	between	ADP
dpc-2111	70	8	the	the	DET
dpc-2111	70	9	two	two	NUM
dpc-2111	70	10	groups	group	NOUN
dpc-2111	70	11	(	(	PUNCT
dpc-2111	70	12	p	p	NOUN
dpc-2111	70	13	=	=	NOUN
dpc-2111	70	14	0.279	0.279	NUM
dpc-2111	70	15	)	)	PUNCT
dpc-2111	70	16	.	.	PUNCT
dpc-2111	71	1	no	no	DET
dpc-2111	71	2	patient	patient	NOUN
dpc-2111	71	3	with	with	ADP
dpc-2111	71	4	covid-19	covid-19	PROPN
dpc-2111	71	5	needed	need	VERB
dpc-2111	71	6	hospitalization	hospitalization	NOUN
dpc-2111	71	7	or	or	CCONJ
dpc-2111	71	8	intensive	intensive	ADJ
dpc-2111	71	9	care	care	NOUN
dpc-2111	71	10	.	.	PUNCT
dpc-2111	72	1	of	of	ADP
dpc-2111	72	2	the	the	DET
dpc-2111	72	3	16	16	NUM
dpc-2111	72	4	covid-19	covid-19	PROPN
dpc-2111	72	5	-	-	PUNCT
dpc-2111	72	6	positive	positive	ADJ
dpc-2111	72	7	patients	patient	NOUN
dpc-2111	72	8	who	who	PRON
dpc-2111	72	9	took	take	VERB
dpc-2111	72	10	oral	oral	ADJ
dpc-2111	72	11	isotretinoin	isotretinoin	NOUN
dpc-2111	72	12	,	,	PUNCT
dpc-2111	72	13	10	10	NUM
dpc-2111	72	14	recovered	recover	VERB
dpc-2111	72	15	with	with	ADP
dpc-2111	72	16	medical	medical	ADJ
dpc-2111	72	17	treatment	treatment	NOUN
dpc-2111	72	18	at	at	ADP
dpc-2111	72	19	home	home	NOUN
dpc-2111	72	20	and	and	CCONJ
dpc-2111	72	21	6	6	NUM
dpc-2111	72	22	without	without	ADP
dpc-2111	72	23	treatment	treatment	NOUN
dpc-2111	72	24	.	.	PUNCT
dpc-2111	73	1	all	all	DET
dpc-2111	73	2	11	11	NUM
dpc-2111	73	3	covid-19	covid-19	PROPN
dpc-2111	73	4	-	-	PUNCT
dpc-2111	73	5	positive	positive	ADJ
dpc-2111	73	6	patients	patient	NOUN
dpc-2111	73	7	who	who	PRON
dpc-2111	73	8	received	receive	VERB
dpc-2111	73	9	topical	topical	ADJ
dpc-2111	73	10	treatment	treatment	NOUN
dpc-2111	73	11	recovered	recover	VERB
dpc-2111	73	12	with	with	ADP
dpc-2111	73	13	medical	medical	ADJ
dpc-2111	73	14	treatment	treatment	NOUN
dpc-2111	73	15	at	at	ADP
dpc-2111	73	16	home	home	NOUN
dpc-2111	73	17	.	.	PUNCT
dpc-2111	74	1	there	there	PRON
dpc-2111	74	2	was	be	VERB
dpc-2111	74	3	no	no	DET
dpc-2111	74	4	statistical	statistical	ADJ
dpc-2111	74	5	difference	difference	NOUN
dpc-2111	74	6	between	between	ADP
dpc-2111	74	7	the	the	DET
dpc-2111	74	8	two	two	NUM
dpc-2111	74	9	groups	group	NOUN
dpc-2111	74	10	in	in	ADP
dpc-2111	74	11	terms	term	NOUN
dpc-2111	74	12	of	of	ADP
dpc-2111	74	13	the	the	DET
dpc-2111	74	14	need	need	NOUN
dpc-2111	74	15	for	for	ADP
dpc-2111	74	16	medical	medical	ADJ
dpc-2111	74	17	treatment	treatment	NOUN
dpc-2111	74	18	(	(	PUNCT
dpc-2111	74	19	p	p	NOUN
dpc-2111	74	20	=	=	NOUN
dpc-2111	74	21	0.054	0.054	NUM
dpc-2111	74	22	)	)	PUNCT
dpc-2111	74	23	.	.	PUNCT
dpc-2111	75	1	six	six	NUM
dpc-2111	75	2	of	of	ADP
dpc-2111	75	3	the	the	DET
dpc-2111	75	4	patients	patient	NOUN
dpc-2111	75	5	with	with	ADP
dpc-2111	75	6	covid-19	covid-19	PROPN
dpc-2111	75	7	had	have	VERB
dpc-2111	75	8	partial	partial	ADJ
dpc-2111	75	9	taste\	taste\	NOUN
dpc-2111	75	10	smell	smell	NOUN
dpc-2111	75	11	loss	loss	NOUN
dpc-2111	75	12	that	that	PRON
dpc-2111	75	13	continued	continue	VERB
dpc-2111	75	14	1	1	NUM
dpc-2111	75	15	month	month	NOUN
dpc-2111	75	16	after	after	SCONJ
dpc-2111	75	17	they	they	PRON
dpc-2111	75	18	had	have	VERB
dpc-2111	75	19	the	the	DET
dpc-2111	75	20	disease	disease	NOUN
dpc-2111	75	21	,	,	PUNCT
dpc-2111	75	22	table	table	NOUN
dpc-2111	75	23	1	1	NUM
dpc-2111	75	24	.	.	PUNCT
dpc-2111	75	25	sociodemographic	sociodemographic	ADJ
dpc-2111	75	26	and	and	CCONJ
dpc-2111	75	27	clinical	clinical	ADJ
dpc-2111	75	28	characteristics	characteristic	NOUN
dpc-2111	75	29	of	of	ADP
dpc-2111	75	30	the	the	DET
dpc-2111	75	31	acne	acne	NOUN
dpc-2111	75	32	vulgaris	vulgaris	NOUN
dpc-2111	75	33	patients	patient	NOUN
dpc-2111	75	34	(	(	PUNCT
dpc-2111	75	35	comparison	comparison	NOUN
dpc-2111	75	36	between	between	ADP
dpc-2111	75	37	covid-19	covid-19	PROPN
dpc-2111	75	38	-	-	PUNCT
dpc-2111	75	39	positive	positive	ADJ
dpc-2111	75	40	and	and	CCONJ
dpc-2111	75	41	negativepatients	negativepatient	NOUN
dpc-2111	75	42	)	)	PUNCT
dpc-2111	75	43	covid	covid	NOUN
dpc-2111	75	44	(	(	PUNCT
dpc-2111	75	45	+	+	ADJ
dpc-2111	75	46	)	)	PUNCT
dpc-2111	75	47	mean	mean	NOUN
dpc-2111	75	48	é	é	PROPN
dpc-2111	75	49	sd	sd	PROPN
dpc-2111	75	50	/	/	SYM
dpc-2111	75	51	n	n	PROPN
dpc-2111	75	52	(	(	PUNCT
dpc-2111	75	53	%	%	INTJ
dpc-2111	75	54	)	)	PUNCT
dpc-2111	75	55	covid	covid	PROPN
dpc-2111	75	56	(	(	PUNCT
dpc-2111	75	57	-	-	PUNCT
dpc-2111	75	58	)	)	PUNCT
dpc-2111	75	59	mean	mean	NOUN
dpc-2111	75	60	é	é	PROPN
dpc-2111	75	61	sd	sd	PROPN
dpc-2111	75	62	/	/	SYM
dpc-2111	75	63	n	n	PROPN
dpc-2111	75	64	(	(	PUNCT
dpc-2111	75	65	%	%	NOUN
dpc-2111	75	66	)	)	PUNCT
dpc-2111	75	67	p	p	NOUN
dpc-2111	75	68	age	age	NOUN
dpc-2111	75	69	24.88	24.88	NUM
dpc-2111	75	70	±	±	NUM
dpc-2111	75	71	8.65	8.65	NUM
dpc-2111	75	72	23.28	23.28	NUM
dpc-2111	75	73	±	±	NUM
dpc-2111	75	74	6.76	6.76	NUM
dpc-2111	75	75	0.773a	0.773a	ADJ
dpc-2111	75	76	bmi	bmi	X
dpc-2111	75	77	23.25	23.25	NUM
dpc-2111	75	78	±	±	NUM
dpc-2111	75	79	2.88	2.88	NUM
dpc-2111	75	80	22,64	22,64	NUM
dpc-2111	75	81	±	±	NUM
dpc-2111	75	82	3.01	3.01	NUM
dpc-2111	75	83	0.201a	0.201a	NOUN
dpc-2111	75	84	gender	gender	NOUN
dpc-2111	75	85	male	male	NOUN
dpc-2111	75	86	7	7	NUM
dpc-2111	75	87	(	(	PUNCT
dpc-2111	75	88	25.9	25.9	NUM
dpc-2111	75	89	)	)	PUNCT
dpc-2111	75	90	24	24	NUM
dpc-2111	75	91	(	(	PUNCT
dpc-2111	75	92	32.0	32.0	NUM
dpc-2111	75	93	)	)	PUNCT
dpc-2111	75	94	0.556b	0.556b	NOUN
dpc-2111	75	95	female	female	ADJ
dpc-2111	75	96	20	20	NUM
dpc-2111	75	97	(	(	PUNCT
dpc-2111	75	98	74.1	74.1	NUM
dpc-2111	75	99	)	)	PUNCT
dpc-2111	75	100	51	51	NUM
dpc-2111	75	101	(	(	PUNCT
dpc-2111	75	102	68.0	68.0	NUM
dpc-2111	75	103	)	)	PUNCT
dpc-2111	75	104	smoking	smoke	VERB
dpc-2111	75	105	yes	yes	INTJ
dpc-2111	75	106	4	4	NUM
dpc-2111	75	107	(	(	PUNCT
dpc-2111	75	108	14.8	14.8	NUM
dpc-2111	75	109	)	)	PUNCT
dpc-2111	75	110	15	15	NUM
dpc-2111	75	111	(	(	PUNCT
dpc-2111	75	112	20.0	20.0	NUM
dpc-2111	75	113	)	)	PUNCT
dpc-2111	75	114	0.553b	0.553b	NOUN
dpc-2111	75	115	no	no	DET
dpc-2111	75	116	23	23	NUM
dpc-2111	75	117	(	(	PUNCT
dpc-2111	75	118	85.2	85.2	NUM
dpc-2111	75	119	)	)	SYM
dpc-2111	75	120	60	60	NUM
dpc-2111	75	121	(	(	PUNCT
dpc-2111	75	122	80.0	80.0	NUM
dpc-2111	75	123	)	)	PUNCT
dpc-2111	75	124	additional	additional	ADJ
dpc-2111	75	125	disease	disease	NOUN
dpc-2111	75	126	yes	yes	INTJ
dpc-2111	75	127	1	1	NUM
dpc-2111	75	128	(	(	PUNCT
dpc-2111	75	129	3.7	3.7	NUM
dpc-2111	75	130	)	)	PUNCT
dpc-2111	75	131	7	7	NUM
dpc-2111	75	132	(	(	PUNCT
dpc-2111	75	133	9.3	9.3	NUM
dpc-2111	75	134	)	)	PUNCT
dpc-2111	75	135	0.678b	0.678b	NOUN
dpc-2111	75	136	no	no	DET
dpc-2111	75	137	26	26	NUM
dpc-2111	75	138	(	(	PUNCT
dpc-2111	75	139	96.3	96.3	NUM
dpc-2111	75	140	)	)	PUNCT
dpc-2111	75	141	68	68	NUM
dpc-2111	75	142	(	(	PUNCT
dpc-2111	75	143	90.7	90.7	NUM
dpc-2111	75	144	)	)	PUNCT
dpc-2111	75	145	pneumococcal	pneumococcal	ADJ
dpc-2111	75	146	vaccine	vaccine	NOUN
dpc-2111	76	1	yes	yes	INTJ
dpc-2111	76	2	0	0	PUNCT
dpc-2111	76	3	(	(	PUNCT
dpc-2111	76	4	0.0	0.0	NUM
dpc-2111	76	5	)	)	PUNCT
dpc-2111	76	6	4	4	NUM
dpc-2111	76	7	(	(	PUNCT
dpc-2111	76	8	5.3	5.3	NUM
dpc-2111	76	9	)	)	PUNCT
dpc-2111	76	10	0.571b	0.571b	NOUN
dpc-2111	76	11	no	no	DET
dpc-2111	76	12	27	27	NUM
dpc-2111	76	13	(	(	PUNCT
dpc-2111	76	14	100	100	NUM
dpc-2111	76	15	)	)	PUNCT
dpc-2111	76	16	71	71	NUM
dpc-2111	76	17	(	(	PUNCT
dpc-2111	76	18	94.7	94.7	NUM
dpc-2111	76	19	)	)	PUNCT
dpc-2111	76	20	influenza	influenza	NOUN
dpc-2111	76	21	vaccine	vaccine	NOUN
dpc-2111	76	22	yes	yes	INTJ
dpc-2111	76	23	1	1	NUM
dpc-2111	76	24	(	(	PUNCT
dpc-2111	76	25	3.7	3.7	NUM
dpc-2111	76	26	)	)	PUNCT
dpc-2111	76	27	2	2	NUM
dpc-2111	76	28	(	(	PUNCT
dpc-2111	76	29	2.7	2.7	NUM
dpc-2111	76	30	)	)	PUNCT
dpc-2111	76	31	0.607b	0.607b	NOUN
dpc-2111	76	32	no	no	DET
dpc-2111	76	33	26	26	NUM
dpc-2111	76	34	(	(	PUNCT
dpc-2111	76	35	96.3	96.3	NUM
dpc-2111	76	36	)	)	PUNCT
dpc-2111	76	37	73	73	NUM
dpc-2111	76	38	(	(	PUNCT
dpc-2111	76	39	97.3	97.3	NUM
dpc-2111	76	40	)	)	PUNCT
dpc-2111	76	41	bmi	bmi	NOUN
dpc-2111	76	42	=	=	SYM
dpc-2111	76	43	body	body	PROPN
dpc-2111	76	44	mass	mass	PROPN
dpc-2111	76	45	index	index	NOUN
dpc-2111	76	46	;	;	PUNCT
dpc-2111	76	47	sd	sd	NOUN
dpc-2111	76	48	=	=	SYM
dpc-2111	76	49	standard	standard	ADJ
dpc-2111	76	50	deviation	deviation	NOUN
dpc-2111	76	51	.	.	PUNCT
dpc-2111	77	1	amann	amann	PROPN
dpc-2111	77	2	-	-	PUNCT
dpc-2111	77	3	whitney	whitney	PROPN
dpc-2111	77	4	u	u	PROPN
dpc-2111	77	5	test	test	NOUN
dpc-2111	77	6	;	;	PUNCT
dpc-2111	77	7	bchi	bchi	ADV
dpc-2111	77	8	-	-	PUNCT
dpc-2111	77	9	squared	square	VERB
dpc-2111	77	10	or	or	CCONJ
dpc-2111	77	11	fisher	fisher	PROPN
dpc-2111	77	12	test	test	NOUN
dpc-2111	77	13	for	for	ADP
dpc-2111	77	14	the	the	DET
dpc-2111	77	15	comparison	comparison	NOUN
dpc-2111	77	16	between	between	ADP
dpc-2111	77	17	the	the	DET
dpc-2111	77	18	groups	group	NOUN
dpc-2111	77	19	.	.	PUNCT
dpc-2111	78	1	4	4	NUM
dpc-2111	78	2	original	original	ADJ
dpc-2111	78	3	article	article	NOUN
dpc-2111	78	4	|	|	ADV
dpc-2111	78	5	dermatol	dermatol	ADJ
dpc-2111	78	6	pract	pract	NOUN
dpc-2111	78	7	concept	concept	NOUN
dpc-2111	78	8	.	.	PUNCT
dpc-2111	79	1	2022;12(3):e2022146	2022;12(3):e2022146	NUM
dpc-2111	79	2	thanks	thank	NOUN
dpc-2111	79	3	to	to	ADP
dpc-2111	79	4	their	their	PRON
dpc-2111	79	5	antioxidant	antioxidant	ADJ
dpc-2111	79	6	and	and	CCONJ
dpc-2111	79	7	surfactant	surfactant	NOUN
dpc-2111	79	8	-	-	PUNCT
dpc-2111	79	9	mediated	mediate	VERB
dpc-2111	79	10	properties	property	NOUN
dpc-2111	79	11	[	[	X
dpc-2111	79	12	9	9	NUM
dpc-2111	79	13	]	]	PUNCT
dpc-2111	79	14	.	.	PUNCT
dpc-2111	80	1	we	we	PRON
dpc-2111	80	2	did	do	AUX
dpc-2111	80	3	not	not	PART
dpc-2111	80	4	see	see	VERB
dpc-2111	80	5	ards	ard	NOUN
dpc-2111	80	6	symptoms	symptom	NOUN
dpc-2111	80	7	in	in	ADP
dpc-2111	80	8	any	any	PRON
dpc-2111	80	9	of	of	ADP
dpc-2111	80	10	our	our	PRON
dpc-2111	80	11	patients	patient	NOUN
dpc-2111	80	12	.	.	PUNCT
dpc-2111	81	1	we	we	PRON
dpc-2111	81	2	could	could	AUX
dpc-2111	81	3	not	not	PART
dpc-2111	81	4	associate	associate	VERB
dpc-2111	81	5	this	this	PRON
dpc-2111	81	6	with	with	ADP
dpc-2111	81	7	the	the	DET
dpc-2111	81	8	protective	protective	ADJ
dpc-2111	81	9	use	use	NOUN
dpc-2111	81	10	of	of	ADP
dpc-2111	81	11	oral	oral	ADJ
dpc-2111	81	12	isotretinoin	isotretinoin	NOUN
dpc-2111	81	13	,	,	PUNCT
dpc-2111	81	14	because	because	SCONJ
dpc-2111	81	15	our	our	PRON
dpc-2111	81	16	patients	patient	NOUN
dpc-2111	81	17	had	have	VERB
dpc-2111	81	18	a	a	DET
dpc-2111	81	19	low	low	ADJ
dpc-2111	81	20	mean	mean	NOUN
dpc-2111	81	21	age	age	NOUN
dpc-2111	81	22	and	and	CCONJ
dpc-2111	81	23	a	a	DET
dpc-2111	81	24	very	very	ADV
dpc-2111	81	25	low	low	ADJ
dpc-2111	81	26	rate	rate	NOUN
dpc-2111	81	27	of	of	ADP
dpc-2111	81	28	possible	possible	ADJ
dpc-2111	81	29	risk	risk	NOUN
dpc-2111	81	30	factors	factor	NOUN
dpc-2111	81	31	for	for	ADP
dpc-2111	81	32	ards	ard	NOUN
dpc-2111	81	33	.	.	PUNCT
dpc-2111	82	1	gastrointestinal	gastrointestinal	ADJ
dpc-2111	82	2	(	(	PUNCT
dpc-2111	82	3	nausea	nausea	NOUN
dpc-2111	82	4	,	,	PUNCT
dpc-2111	82	5	vomiting	vomiting	NOUN
dpc-2111	82	6	,	,	PUNCT
dpc-2111	82	7	abdominal	abdominal	ADJ
dpc-2111	82	8	pain	pain	NOUN
dpc-2111	82	9	)	)	PUNCT
dpc-2111	82	10	and	and	CCONJ
dpc-2111	82	11	respiratory	respiratory	ADJ
dpc-2111	82	12	symptoms	symptom	NOUN
dpc-2111	82	13	(	(	PUNCT
dpc-2111	82	14	shortness	shortness	NOUN
dpc-2111	82	15	of	of	ADP
dpc-2111	82	16	breath	breath	NOUN
dpc-2111	82	17	,	,	PUNCT
dpc-2111	82	18	chest	chest	NOUN
dpc-2111	82	19	pain	pain	NOUN
dpc-2111	82	20	)	)	PUNCT
dpc-2111	82	21	have	have	AUX
dpc-2111	82	22	been	be	AUX
dpc-2111	82	23	associated	associate	VERB
dpc-2111	82	24	with	with	ADP
dpc-2111	82	25	severe	severe	ADJ
dpc-2111	82	26	covid-19	covid-19	PROPN
dpc-2111	83	1	[	[	X
dpc-2111	83	2	10	10	NUM
dpc-2111	83	3	]	]	PUNCT
dpc-2111	83	4	.	.	PUNCT
dpc-2111	84	1	severe	severe	ADJ
dpc-2111	84	2	covid-19	covid-19	PROPN
dpc-2111	84	3	-	-	PUNCT
dpc-2111	84	4	associated	associate	VERB
dpc-2111	84	5	dyspnea	dyspnea	NOUN
dpc-2111	84	6	was	be	AUX
dpc-2111	84	7	seen	see	VERB
dpc-2111	84	8	at	at	ADP
dpc-2111	84	9	a	a	DET
dpc-2111	84	10	lower	low	ADJ
dpc-2111	84	11	rate	rate	NOUN
dpc-2111	84	12	in	in	ADP
dpc-2111	84	13	patients	patient	NOUN
dpc-2111	84	14	using	use	VERB
dpc-2111	84	15	oral	oral	ADJ
dpc-2111	84	16	isotretinoin	isotretinoin	NOUN
dpc-2111	84	17	compared	compare	VERB
dpc-2111	84	18	to	to	ADP
dpc-2111	84	19	patients	patient	NOUN
dpc-2111	84	20	receiving	receive	VERB
dpc-2111	84	21	topical	topical	ADJ
dpc-2111	84	22	treatment	treatment	NOUN
dpc-2111	84	23	6.7	6.7	NUM
dpc-2111	84	24	%	%	NOUN
dpc-2111	84	25	,	,	PUNCT
dpc-2111	84	26	and27.3	and27.3	NOUN
dpc-2111	84	27	%	%	NOUN
dpc-2111	84	28	,	,	PUNCT
dpc-2111	84	29	respectively	respectively	ADV
dpc-2111	84	30	)	)	PUNCT
dpc-2111	84	31	,	,	PUNCT
dpc-2111	84	32	we	we	PRON
dpc-2111	84	33	thought	think	VERB
dpc-2111	84	34	that	that	SCONJ
dpc-2111	84	35	this	this	PRON
dpc-2111	84	36	might	might	AUX
dpc-2111	84	37	be	be	AUX
dpc-2111	84	38	related	relate	VERB
dpc-2111	84	39	to	to	ADP
dpc-2111	84	40	the	the	DET
dpc-2111	84	41	protection	protection	NOUN
dpc-2111	84	42	of	of	ADP
dpc-2111	84	43	oral	oral	ADJ
dpc-2111	84	44	isotretinoin	isotretinoin	NOUN
dpc-2111	84	45	against	against	ADP
dpc-2111	84	46	severe	severe	ADJ
dpc-2111	84	47	covid-19	covid-19	PROPN
dpc-2111	84	48	,	,	PUNCT
dpc-2111	84	49	but	but	CCONJ
dpc-2111	84	50	we	we	PRON
dpc-2111	84	51	did	do	AUX
dpc-2111	84	52	not	not	PART
dpc-2111	84	53	detect	detect	VERB
dpc-2111	84	54	a	a	DET
dpc-2111	84	55	statistically	statistically	ADV
dpc-2111	84	56	significant	significant	ADJ
dpc-2111	84	57	difference	difference	NOUN
dpc-2111	84	58	(	(	PUNCT
dpc-2111	84	59	p	p	NOUN
dpc-2111	84	60	=	=	NOUN
dpc-2111	84	61	0.279	0.279	NUM
dpc-2111	84	62	)	)	PUNCT
dpc-2111	84	63	.	.	PUNCT
dpc-2111	85	1	ace2	ace2	PROPN
dpc-2111	85	2	has	have	AUX
dpc-2111	85	3	been	be	AUX
dpc-2111	85	4	shown	show	VERB
dpc-2111	85	5	to	to	PART
dpc-2111	85	6	be	be	AUX
dpc-2111	85	7	a	a	DET
dpc-2111	85	8	functional	functional	ADJ
dpc-2111	85	9	receptor	receptor	NOUN
dpc-2111	85	10	for	for	ADP
dpc-2111	85	11	sars	sar	NOUN
dpc-2111	85	12	-	-	PUNCT
dpc-2111	85	13	cov	cov	NOUN
dpc-2111	85	14	to	to	PART
dpc-2111	85	15	enter	enter	VERB
dpc-2111	85	16	host	host	NOUN
dpc-2111	85	17	target	target	NOUN
dpc-2111	85	18	cells	cell	NOUN
dpc-2111	85	19	[	[	X
dpc-2111	85	20	11	11	NUM
dpc-2111	85	21	]	]	PUNCT
dpc-2111	85	22	.	.	PUNCT
dpc-2111	86	1	ace2	ace2	PROPN
dpc-2111	86	2	receptor	receptor	NOUN
dpc-2111	86	3	expression	expression	NOUN
dpc-2111	86	4	has	have	AUX
dpc-2111	86	5	been	be	AUX
dpc-2111	86	6	found	find	VERB
dpc-2111	86	7	in	in	ADP
dpc-2111	86	8	the	the	DET
dpc-2111	86	9	basal	basal	ADJ
dpc-2111	86	10	layer	layer	NOUN
dpc-2111	86	11	of	of	ADP
dpc-2111	86	12	the	the	DET
dpc-2111	86	13	squamous	squamous	ADJ
dpc-2111	86	14	epithelium	epithelium	NOUN
dpc-2111	86	15	in	in	ADP
dpc-2111	86	16	the	the	DET
dpc-2111	86	17	nasal	nasal	PROPN
dpc-2111	86	18	mucosa	mucosa	PROPN
dpc-2111	86	19	.	.	PUNCT
dpc-2111	87	1	the	the	DET
dpc-2111	87	2	use	use	NOUN
dpc-2111	87	3	of	of	ADP
dpc-2111	87	4	oral	oral	ADJ
dpc-2111	87	5	isotretinoin	isotretinoin	NOUN
dpc-2111	87	6	,	,	PUNCT
dpc-2111	87	7	which	which	PRON
dpc-2111	87	8	causes	cause	VERB
dpc-2111	87	9	dryness	dryness	NOUN
dpc-2111	87	10	in	in	ADP
dpc-2111	87	11	the	the	DET
dpc-2111	87	12	nasal	nasal	PROPN
dpc-2111	87	13	mucosa	mucosa	NOUN
dpc-2111	87	14	,	,	PUNCT
dpc-2111	87	15	causes	cause	VERB
dpc-2111	87	16	mucosal	mucosal	ADJ
dpc-2111	87	17	fragmentation	fragmentation	NOUN
dpc-2111	87	18	,	,	PUNCT
dpc-2111	87	19	and	and	CCONJ
dpc-2111	87	20	may	may	AUX
dpc-2111	87	21	facilitate	facilitate	VERB
dpc-2111	87	22	the	the	DET
dpc-2111	87	23	adhesion	adhesion	NOUN
dpc-2111	87	24	of	of	ADP
dpc-2111	87	25	the	the	DET
dpc-2111	87	26	coronavirus	coronavirus	NOUN
dpc-2111	87	27	to	to	ADP
dpc-2111	87	28	the	the	DET
dpc-2111	87	29	nasal	nasal	ADJ
dpc-2111	87	30	mucosa	mucosa	NOUN
dpc-2111	87	31	by	by	ADP
dpc-2111	87	32	exposing	expose	VERB
dpc-2111	87	33	the	the	DET
dpc-2111	87	34	basal	basal	ADJ
dpc-2111	87	35	layer	layer	NOUN
dpc-2111	88	1	[	[	X
dpc-2111	88	2	4,5	4,5	NUM
dpc-2111	88	3	]	]	PUNCT
dpc-2111	88	4	.	.	PUNCT
dpc-2111	89	1	on	on	ADP
dpc-2111	89	2	the	the	DET
dpc-2111	89	3	other	other	ADJ
dpc-2111	89	4	hand	hand	NOUN
dpc-2111	89	5	,	,	PUNCT
dpc-2111	89	6	since	since	SCONJ
dpc-2111	89	7	isotretinoin	isotretinoin	PROPN
dpc-2111	89	8	is	be	AUX
dpc-2111	89	9	one	one	NUM
dpc-2111	89	10	of	of	ADP
dpc-2111	89	11	the	the	DET
dpc-2111	89	12	strongest	strong	ADJ
dpc-2111	89	13	down	down	ADJ
dpc-2111	89	14	-	-	PUNCT
dpc-2111	89	15	regulators	regulator	NOUN
dpc-2111	89	16	of	of	ADP
dpc-2111	89	17	ace-2	ace-2	ADJ
dpc-2111	89	18	receptors	receptor	NOUN
dpc-2111	89	19	,	,	PUNCT
dpc-2111	89	20	it	it	PRON
dpc-2111	89	21	was	be	AUX
dpc-2111	89	22	thought	think	VERB
dpc-2111	89	23	that	that	SCONJ
dpc-2111	89	24	the	the	DET
dpc-2111	89	25	use	use	NOUN
dpc-2111	89	26	of	of	ADP
dpc-2111	89	27	isotretinoin	isotretinoin	PROPN
dpc-2111	89	28	may	may	AUX
dpc-2111	89	29	be	be	AUX
dpc-2111	89	30	protective	protective	ADJ
dpc-2111	89	31	against	against	ADP
dpc-2111	89	32	the	the	DET
dpc-2111	89	33	transmission	transmission	NOUN
dpc-2111	89	34	of	of	ADP
dpc-2111	89	35	covid-19	covid-19	PROPN
dpc-2111	89	36	in	in	SCONJ
dpc-2111	89	37	that	that	SCONJ
dpc-2111	89	38	it	it	PRON
dpc-2111	89	39	reduces	reduce	VERB
dpc-2111	89	40	the	the	DET
dpc-2111	89	41	possibility	possibility	NOUN
dpc-2111	89	42	of	of	ADP
dpc-2111	89	43	cellular	cellular	ADJ
dpc-2111	89	44	entry	entry	NOUN
dpc-2111	89	45	of	of	ADP
dpc-2111	89	46	the	the	DET
dpc-2111	89	47	virus	virus	NOUN
dpc-2111	90	1	[	[	X
dpc-2111	90	2	6	6	NUM
dpc-2111	90	3	]	]	PUNCT
dpc-2111	90	4	.	.	PUNCT
dpc-2111	91	1	to	to	PART
dpc-2111	91	2	evaluate	evaluate	VERB
dpc-2111	91	3	these	these	DET
dpc-2111	91	4	hypotheses	hypothesis	NOUN
dpc-2111	91	5	,	,	PUNCT
dpc-2111	91	6	we	we	PRON
dpc-2111	91	7	looked	look	VERB
dpc-2111	91	8	at	at	ADP
dpc-2111	91	9	the	the	DET
dpc-2111	91	10	rates	rate	NOUN
dpc-2111	91	11	of	of	ADP
dpc-2111	91	12	being	be	AUX
dpc-2111	91	13	positive	positive	ADJ
dpc-2111	91	14	for	for	ADP
dpc-2111	91	15	covid-19	covid-19	PROPN
dpc-2111	91	16	after	after	ADP
dpc-2111	91	17	contact	contact	NOUN
dpc-2111	91	18	with	with	ADP
dpc-2111	91	19	a	a	DET
dpc-2111	91	20	covid-19(+	covid-19(+	PROPN
dpc-2111	91	21	)	)	PUNCT
dpc-2111	91	22	person	person	NOUN
dpc-2111	91	23	,	,	PUNCT
dpc-2111	91	24	and	and	CCONJ
dpc-2111	91	25	we	we	PRON
dpc-2111	91	26	did	do	AUX
dpc-2111	91	27	not	not	PART
dpc-2111	91	28	find	find	VERB
dpc-2111	91	29	any	any	DET
dpc-2111	91	30	difference	difference	NOUN
dpc-2111	91	31	in	in	ADP
dpc-2111	91	32	the	the	DET
dpc-2111	91	33	rates	rate	NOUN
dpc-2111	91	34	of	of	ADP
dpc-2111	91	35	being	be	AUX
dpc-2111	91	36	covid-19	covid-19	PROPN
dpc-2111	91	37	-	-	PUNCT
dpc-2111	91	38	positive	positive	ADJ
dpc-2111	91	39	between	between	ADP
dpc-2111	91	40	contact	contact	NOUN
dpc-2111	91	41	patients	patient	NOUN
dpc-2111	91	42	using	use	VERB
dpc-2111	91	43	oral	oral	ADJ
dpc-2111	91	44	isotretinoin	isotretinoin	NOUN
dpc-2111	91	45	and	and	CCONJ
dpc-2111	91	46	contact	contact	NOUN
dpc-2111	91	47	patients	patient	NOUN
dpc-2111	91	48	using	use	VERB
dpc-2111	91	49	topical	topical	ADJ
dpc-2111	91	50	treatment	treatment	NOUN
dpc-2111	91	51	(	(	PUNCT
dpc-2111	91	52	p	p	NOUN
dpc-2111	91	53	=	=	NOUN
dpc-2111	91	54	0.391	0.391	NUM
dpc-2111	91	55	)	)	PUNCT
dpc-2111	91	56	.	.	PUNCT
dpc-2111	92	1	öğüt	öğüt	VERB
dpc-2111	92	2	et	et	PROPN
dpc-2111	92	3	al	al	PROPN
dpc-2111	92	4	also	also	ADV
dpc-2111	92	5	found	find	VERB
dpc-2111	92	6	that	that	SCONJ
dpc-2111	92	7	oral	oral	ADJ
dpc-2111	92	8	isotretinoin	isotretinoin	PROPN
dpc-2111	92	9	treatment	treatment	NOUN
dpc-2111	92	10	was	be	AUX
dpc-2111	92	11	not	not	PART
dpc-2111	92	12	associated	associate	VERB
dpc-2111	92	13	with	with	ADP
dpc-2111	92	14	an	an	DET
dpc-2111	92	15	increased	increase	VERB
dpc-2111	92	16	risk	risk	NOUN
dpc-2111	92	17	of	of	ADP
dpc-2111	92	18	contracting	contract	VERB
dpc-2111	92	19	covid-19	covid-19	PROPN
dpc-2111	93	1	[	[	X
dpc-2111	93	2	12	12	NUM
dpc-2111	93	3	]	]	PUNCT
dpc-2111	93	4	.	.	PUNCT
dpc-2111	94	1	these	these	DET
dpc-2111	94	2	results	result	NOUN
dpc-2111	94	3	suggest	suggest	VERB
dpc-2111	94	4	that	that	SCONJ
dpc-2111	94	5	oral	oral	ADJ
dpc-2111	94	6	isotretinoin	isotretinoin	PROPN
dpc-2111	94	7	use	use	NOUN
dpc-2111	94	8	increases	increase	VERB
dpc-2111	94	9	the	the	DET
dpc-2111	94	10	risk	risk	NOUN
dpc-2111	94	11	of	of	ADP
dpc-2111	94	12	transmission	transmission	NOUN
dpc-2111	94	13	by	by	ADP
dpc-2111	94	14	exposing	expose	VERB
dpc-2111	94	15	ace2	ace2	NOUN
dpc-2111	94	16	receptors	receptor	NOUN
dpc-2111	94	17	,	,	PUNCT
dpc-2111	94	18	while	while	SCONJ
dpc-2111	94	19	reducing	reduce	VERB
dpc-2111	94	20	the	the	DET
dpc-2111	94	21	risk	risk	NOUN
dpc-2111	94	22	of	of	ADP
dpc-2111	94	23	transmission	transmission	NOUN
dpc-2111	94	24	by	by	ADP
dpc-2111	94	25	down	down	ADV
dpc-2111	94	26	-	-	PUNCT
dpc-2111	94	27	regulating	regulate	VERB
dpc-2111	94	28	ace2	ace2	NOUN
dpc-2111	94	29	receptors	receptor	NOUN
dpc-2111	94	30	,	,	PUNCT
dpc-2111	94	31	leading	lead	VERB
dpc-2111	94	32	to	to	ADP
dpc-2111	94	33	a	a	DET
dpc-2111	94	34	similar	similar	ADJ
dpc-2111	94	35	risk	risk	NOUN
dpc-2111	94	36	of	of	ADP
dpc-2111	94	37	transmission	transmission	NOUN
dpc-2111	94	38	with	with	ADP
dpc-2111	94	39	people	people	NOUN
dpc-2111	94	40	who	who	PRON
dpc-2111	94	41	do	do	AUX
dpc-2111	94	42	not	not	PART
dpc-2111	94	43	use	use	VERB
dpc-2111	94	44	isotretinoin	isotretinoin	PROPN
dpc-2111	94	45	.	.	PROPN
dpc-2111	94	46	2	2	NUM
dpc-2111	94	47	(	(	PUNCT
dpc-2111	94	48	12.5	12.5	NUM
dpc-2111	94	49	%	%	NOUN
dpc-2111	94	50	)	)	PUNCT
dpc-2111	94	51	were	be	AUX
dpc-2111	94	52	receiving	receive	VERB
dpc-2111	94	53	oral	oral	ADJ
dpc-2111	94	54	isotretinoin	isotretinoin	NOUN
dpc-2111	94	55	and	and	CCONJ
dpc-2111	94	56	4	4	NUM
dpc-2111	94	57	(	(	PUNCT
dpc-2111	94	58	36	36	NUM
dpc-2111	94	59	%	%	NOUN
dpc-2111	94	60	)	)	PUNCT
dpc-2111	94	61	were	be	AUX
dpc-2111	94	62	receiving	receive	VERB
dpc-2111	94	63	topical	topical	ADJ
dpc-2111	94	64	treatment	treatment	NOUN
dpc-2111	94	65	.	.	PUNCT
dpc-2111	95	1	there	there	PRON
dpc-2111	95	2	was	be	VERB
dpc-2111	95	3	no	no	DET
dpc-2111	95	4	statistical	statistical	ADJ
dpc-2111	95	5	difference	difference	NOUN
dpc-2111	95	6	between	between	ADP
dpc-2111	95	7	the	the	DET
dpc-2111	95	8	patients	patient	NOUN
dpc-2111	95	9	using	use	VERB
dpc-2111	95	10	oral	oral	ADJ
dpc-2111	95	11	isotretinoin	isotretinoin	NOUN
dpc-2111	95	12	and	and	CCONJ
dpc-2111	95	13	the	the	DET
dpc-2111	95	14	patients	patient	NOUN
dpc-2111	95	15	using	use	VERB
dpc-2111	95	16	topical	topical	ADJ
dpc-2111	95	17	treatment	treatment	NOUN
dpc-2111	95	18	in	in	ADP
dpc-2111	95	19	terms	term	NOUN
dpc-2111	95	20	of	of	ADP
dpc-2111	95	21	taste	taste	NOUN
dpc-2111	95	22	/	/	SYM
dpc-2111	95	23	smell	smell	NOUN
dpc-2111	95	24	loss	loss	NOUN
dpc-2111	95	25	sequela	sequela	NOUN
dpc-2111	95	26	(	(	PUNCT
dpc-2111	95	27	p	p	NOUN
dpc-2111	95	28	=	=	NOUN
dpc-2111	95	29	0.350	0.350	NUM
dpc-2111	95	30	)	)	PUNCT
dpc-2111	95	31	.	.	PUNCT
dpc-2111	96	1	discussion	discussion	NOUN
dpc-2111	96	2	it	it	PRON
dpc-2111	96	3	has	have	AUX
dpc-2111	96	4	been	be	AUX
dpc-2111	96	5	reported	report	VERB
dpc-2111	96	6	that	that	SCONJ
dpc-2111	96	7	the	the	DET
dpc-2111	96	8	use	use	NOUN
dpc-2111	96	9	of	of	ADP
dpc-2111	96	10	oral	oral	ADJ
dpc-2111	96	11	isotretinoin	isotretinoin	PROPN
dpc-2111	96	12	may	may	AUX
dpc-2111	96	13	have	have	VERB
dpc-2111	96	14	positive	positive	ADJ
dpc-2111	96	15	and	and	CCONJ
dpc-2111	96	16	negative	negative	ADJ
dpc-2111	96	17	effects	effect	NOUN
dpc-2111	96	18	on	on	ADP
dpc-2111	96	19	the	the	DET
dpc-2111	96	20	course	course	NOUN
dpc-2111	96	21	of	of	ADP
dpc-2111	96	22	covid-19	covid-19	PROPN
dpc-2111	96	23	and	and	CCONJ
dpc-2111	96	24	the	the	DET
dpc-2111	96	25	risk	risk	NOUN
dpc-2111	96	26	of	of	ADP
dpc-2111	96	27	transmission	transmission	NOUN
dpc-2111	96	28	(	(	PUNCT
dpc-2111	96	29	table	table	NOUN
dpc-2111	96	30	3	3	NUM
dpc-2111	96	31	)	)	PUNCT
dpc-2111	96	32	.	.	PUNCT
dpc-2111	97	1	mawson	mawson	PROPN
dpc-2111	97	2	et	et	PROPN
dpc-2111	97	3	al	al	PROPN
dpc-2111	97	4	.	.	PROPN
dpc-2111	97	5	found	find	VERB
dpc-2111	97	6	that	that	SCONJ
dpc-2111	97	7	covid-19	covid-19	PROPN
dpc-2111	97	8	disease	disease	NOUN
dpc-2111	97	9	is	be	AUX
dpc-2111	97	10	very	very	ADV
dpc-2111	97	11	similar	similar	ADJ
dpc-2111	97	12	to	to	ADP
dpc-2111	97	13	an	an	DET
dpc-2111	97	14	endogenous	endogenous	ADJ
dpc-2111	97	15	form	form	NOUN
dpc-2111	97	16	of	of	ADP
dpc-2111	97	17	a	a	DET
dpc-2111	97	18	hypervitaminosis	hypervitaminosis	NOUN
dpc-2111	97	19	of	of	ADP
dpc-2111	97	20	vitamin	vitamin	NOUN
dpc-2111	97	21	a	a	PRON
dpc-2111	97	22	,	,	PUNCT
dpc-2111	97	23	that	that	SCONJ
dpc-2111	97	24	liver	liver	NOUN
dpc-2111	97	25	damage	damage	NOUN
dpc-2111	97	26	caused	cause	VERB
dpc-2111	97	27	by	by	ADP
dpc-2111	97	28	the	the	DET
dpc-2111	97	29	sars	sar	NOUN
dpc-2111	97	30	-	-	PUNCT
dpc-2111	97	31	cov-2	cov-2	PART
dpc-2111	97	32	virus	virus	NOUN
dpc-2111	97	33	causes	cause	VERB
dpc-2111	97	34	toxic	toxic	ADJ
dpc-2111	97	35	concentrations	concentration	NOUN
dpc-2111	97	36	of	of	ADP
dpc-2111	97	37	retinoic	retinoic	ADJ
dpc-2111	97	38	acid	acid	PROPN
dpc-2111	97	39	and	and	CCONJ
dpc-2111	97	40	stored	store	VERB
dpc-2111	97	41	retinyl	retinyl	NOUN
dpc-2111	97	42	esters	ester	NOUN
dpc-2111	97	43	to	to	PART
dpc-2111	97	44	be	be	AUX
dpc-2111	97	45	released	release	VERB
dpc-2111	97	46	into	into	ADP
dpc-2111	97	47	the	the	DET
dpc-2111	97	48	circulation	circulation	NOUN
dpc-2111	97	49	,	,	PUNCT
dpc-2111	97	50	including	include	VERB
dpc-2111	97	51	the	the	DET
dpc-2111	97	52	lungs	lung	NOUN
dpc-2111	97	53	,	,	PUNCT
dpc-2111	97	54	heart	heart	NOUN
dpc-2111	97	55	,	,	PUNCT
dpc-2111	97	56	blood	blood	NOUN
dpc-2111	97	57	vessels	vessel	NOUN
dpc-2111	97	58	,	,	PUNCT
dpc-2111	97	59	and	and	CCONJ
dpc-2111	97	60	skin	skin	NOUN
dpc-2111	97	61	,	,	PUNCT
dpc-2111	97	62	without	without	ADP
dpc-2111	97	63	binding	bind	VERB
dpc-2111	97	64	to	to	ADP
dpc-2111	97	65	protein	protein	NOUN
dpc-2111	97	66	.	.	PUNCT
dpc-2111	98	1	they	they	PRON
dpc-2111	98	2	claimed	claim	VERB
dpc-2111	98	3	it	it	PRON
dpc-2111	98	4	caused	cause	VERB
dpc-2111	98	5	damage	damage	NOUN
dpc-2111	98	6	to	to	ADP
dpc-2111	98	7	organs	organ	NOUN
dpc-2111	98	8	.	.	PUNCT
dpc-2111	99	1	they	they	PRON
dpc-2111	99	2	recommended	recommend	VERB
dpc-2111	99	3	that	that	SCONJ
dpc-2111	99	4	treatment	treatment	NOUN
dpc-2111	99	5	strategies	strategy	NOUN
dpc-2111	99	6	focus	focus	VERB
dpc-2111	99	7	on	on	ADP
dpc-2111	99	8	reducing	reduce	VERB
dpc-2111	99	9	circulating	circulate	VERB
dpc-2111	99	10	retinoid	retinoid	NOUN
dpc-2111	99	11	concentrations	concentration	NOUN
dpc-2111	99	12	.	.	PUNCT
dpc-2111	100	1	they	they	PRON
dpc-2111	100	2	argued	argue	VERB
dpc-2111	100	3	that	that	SCONJ
dpc-2111	100	4	all	all	DET
dpc-2111	100	5	nonessential	nonessential	ADJ
dpc-2111	100	6	drugs	drug	NOUN
dpc-2111	100	7	that	that	PRON
dpc-2111	100	8	are	be	AUX
dpc-2111	100	9	metabolized	metabolize	VERB
dpc-2111	100	10	in	in	ADP
dpc-2111	100	11	the	the	DET
dpc-2111	100	12	liver	liver	NOUN
dpc-2111	100	13	should	should	AUX
dpc-2111	100	14	be	be	AUX
dpc-2111	100	15	discontinued	discontinue	VERB
dpc-2111	100	16	,	,	PUNCT
dpc-2111	100	17	and	and	CCONJ
dpc-2111	100	18	also	also	ADV
dpc-2111	100	19	that	that	SCONJ
dpc-2111	100	20	all	all	DET
dpc-2111	100	21	drugs	drug	NOUN
dpc-2111	100	22	that	that	PRON
dpc-2111	100	23	damage	damage	VERB
dpc-2111	100	24	the	the	DET
dpc-2111	100	25	liver	liver	NOUN
dpc-2111	100	26	should	should	AUX
dpc-2111	100	27	be	be	AUX
dpc-2111	100	28	avoided	avoid	VERB
dpc-2111	100	29	during	during	ADP
dpc-2111	100	30	the	the	DET
dpc-2111	100	31	acute	acute	ADJ
dpc-2111	100	32	phase	phase	NOUN
dpc-2111	100	33	of	of	ADP
dpc-2111	100	34	treatment	treatment	NOUN
dpc-2111	100	35	[	[	X
dpc-2111	100	36	8	8	NUM
dpc-2111	100	37	]	]	PUNCT
dpc-2111	100	38	.	.	PUNCT
dpc-2111	101	1	however	however	ADV
dpc-2111	101	2	,	,	PUNCT
dpc-2111	101	3	the	the	DET
dpc-2111	101	4	patients	patient	NOUN
dpc-2111	101	5	using	use	VERB
dpc-2111	101	6	oral	oral	ADJ
dpc-2111	101	7	isotretinoin	isotretinoin	PROPN
dpc-2111	101	8	included	include	VERB
dpc-2111	101	9	in	in	ADP
dpc-2111	101	10	our	our	PRON
dpc-2111	101	11	study	study	NOUN
dpc-2111	101	12	did	do	AUX
dpc-2111	101	13	not	not	PART
dpc-2111	101	14	need	need	VERB
dpc-2111	101	15	hospitalization	hospitalization	NOUN
dpc-2111	101	16	or	or	CCONJ
dpc-2111	101	17	intensive	intensive	ADJ
dpc-2111	101	18	care	care	NOUN
dpc-2111	101	19	even	even	ADV
dpc-2111	101	20	though	though	SCONJ
dpc-2111	101	21	they	they	PRON
dpc-2111	101	22	continued	continue	VERB
dpc-2111	101	23	their	their	PRON
dpc-2111	101	24	medication	medication	NOUN
dpc-2111	101	25	when	when	SCONJ
dpc-2111	101	26	they	they	PRON
dpc-2111	101	27	became	become	VERB
dpc-2111	101	28	covid-19	covid-19	PROPN
dpc-2111	101	29	-	-	PUNCT
dpc-2111	101	30	positive	positive	ADJ
dpc-2111	101	31	.	.	PUNCT
dpc-2111	102	1	retinoic	retinoic	ADJ
dpc-2111	102	2	acid	acid	PROPN
dpc-2111	102	3	and	and	CCONJ
dpc-2111	102	4	carotenoids	carotenoid	NOUN
dpc-2111	102	5	exert	exert	VERB
dpc-2111	102	6	many	many	ADJ
dpc-2111	102	7	physiological	physiological	ADJ
dpc-2111	102	8	effects	effect	NOUN
dpc-2111	102	9	,	,	PUNCT
dpc-2111	102	10	along	along	ADP
dpc-2111	102	11	with	with	ADP
dpc-2111	102	12	the	the	DET
dpc-2111	102	13	enhancement	enhancement	NOUN
dpc-2111	102	14	of	of	ADP
dpc-2111	102	15	t	t	NOUN
dpc-2111	102	16	-	-	PUNCT
dpc-2111	102	17	cell	cell	NOUN
dpc-2111	102	18	function	function	NOUN
dpc-2111	102	19	,	,	PUNCT
dpc-2111	102	20	which	which	PRON
dpc-2111	102	21	develops	develop	VERB
dpc-2111	102	22	an	an	DET
dpc-2111	102	23	inducible	inducible	ADJ
dpc-2111	102	24	immune	immune	ADJ
dpc-2111	102	25	response	response	NOUN
dpc-2111	102	26	against	against	ADP
dpc-2111	102	27	pathogens	pathogen	NOUN
dpc-2111	102	28	such	such	ADJ
dpc-2111	102	29	as	as	ADP
dpc-2111	102	30	viruses	virus	NOUN
dpc-2111	102	31	[	[	X
dpc-2111	102	32	9	9	NUM
dpc-2111	102	33	]	]	PUNCT
dpc-2111	102	34	.	.	PUNCT
dpc-2111	103	1	bioinformatics	bioinformatics	NOUN
dpc-2111	103	2	computational	computational	ADJ
dpc-2111	103	3	findings	finding	NOUN
dpc-2111	103	4	showed	show	VERB
dpc-2111	103	5	that	that	SCONJ
dpc-2111	103	6	vitamin	vitamin	NOUN
dpc-2111	103	7	a	a	PRON
dpc-2111	103	8	has	have	VERB
dpc-2111	103	9	anti	anti	ADJ
dpc-2111	103	10	-	-	ADJ
dpc-2111	103	11	viral	viral	ADJ
dpc-2111	103	12	,	,	PUNCT
dpc-2111	103	13	anti	anti	ADJ
dpc-2111	103	14	-	-	ADJ
dpc-2111	103	15	inflammatory	inflammatory	ADJ
dpc-2111	103	16	,	,	PUNCT
dpc-2111	103	17	and	and	CCONJ
dpc-2111	103	18	immunomodulatory	immunomodulatory	ADJ
dpc-2111	103	19	effects	effect	NOUN
dpc-2111	103	20	through	through	ADP
dpc-2111	103	21	different	different	ADJ
dpc-2111	103	22	biological	biological	ADJ
dpc-2111	103	23	processes	process	NOUN
dpc-2111	103	24	and	and	CCONJ
dpc-2111	103	25	cell	cell	NOUN
dpc-2111	103	26	signaling	signal	VERB
dpc-2111	103	27	pathways	pathway	NOUN
dpc-2111	103	28	.	.	PUNCT
dpc-2111	104	1	as	as	ADP
dpc-2111	104	2	a	a	DET
dpc-2111	104	3	result	result	NOUN
dpc-2111	104	4	of	of	ADP
dpc-2111	104	5	these	these	DET
dpc-2111	104	6	findings	finding	NOUN
dpc-2111	104	7	,	,	PUNCT
dpc-2111	104	8	the	the	DET
dpc-2111	104	9	therapeutic	therapeutic	ADJ
dpc-2111	104	10	mechanisms	mechanism	NOUN
dpc-2111	104	11	of	of	ADP
dpc-2111	104	12	vitamin	vitamin	NOUN
dpc-2111	104	13	a	a	PRON
dpc-2111	104	14	for	for	ADP
dpc-2111	104	15	the	the	DET
dpc-2111	104	16	clinical	clinical	ADJ
dpc-2111	104	17	treatment	treatment	NOUN
dpc-2111	104	18	of	of	ADP
dpc-2111	104	19	covid-19	covid-19	PROPN
dpc-2111	104	20	have	have	AUX
dpc-2111	104	21	been	be	AUX
dpc-2111	104	22	defined	define	VERB
dpc-2111	104	23	[	[	PUNCT
dpc-2111	104	24	7	7	NUM
dpc-2111	104	25	]	]	PUNCT
dpc-2111	104	26	.	.	PUNCT
dpc-2111	105	1	therefore	therefore	ADV
dpc-2111	105	2	,	,	PUNCT
dpc-2111	105	3	contrary	contrary	ADV
dpc-2111	105	4	to	to	ADP
dpc-2111	105	5	mawson	mawson	PROPN
dpc-2111	105	6	et	et	PROPN
dpc-2111	105	7	al	al	PROPN
dpc-2111	105	8	,	,	PUNCT
dpc-2111	105	9	it	it	PRON
dpc-2111	105	10	is	be	AUX
dpc-2111	105	11	thought	think	VERB
dpc-2111	105	12	that	that	SCONJ
dpc-2111	105	13	vitamin	vitamin	NOUN
dpc-2111	105	14	a	a	DET
dpc-2111	105	15	derivatives	derivative	NOUN
dpc-2111	105	16	may	may	AUX
dpc-2111	105	17	have	have	VERB
dpc-2111	105	18	a	a	DET
dpc-2111	105	19	protective	protective	ADJ
dpc-2111	105	20	role	role	NOUN
dpc-2111	105	21	in	in	ADP
dpc-2111	105	22	the	the	DET
dpc-2111	105	23	pathogenesis	pathogenesis	NOUN
dpc-2111	105	24	of	of	ADP
dpc-2111	105	25	ards	ard	NOUN
dpc-2111	105	26	,	,	PUNCT
dpc-2111	105	27	which	which	PRON
dpc-2111	105	28	is	be	AUX
dpc-2111	105	29	a	a	DET
dpc-2111	105	30	complication	complication	NOUN
dpc-2111	105	31	of	of	ADP
dpc-2111	105	32	severe	severe	ADJ
dpc-2111	105	33	covid-19	covid-19	PROPN
dpc-2111	105	34	cases	case	NOUN
dpc-2111	105	35	,	,	PUNCT
dpc-2111	105	36	table	table	NOUN
dpc-2111	105	37	2	2	NUM
dpc-2111	105	38	.	.	PUNCT
dpc-2111	105	39	symptoms	symptom	NOUN
dpc-2111	105	40	of	of	ADP
dpc-2111	105	41	covid-19	covid-19	PROPN
dpc-2111	105	42	-	-	PUNCT
dpc-2111	105	43	positive	positive	ADJ
dpc-2111	105	44	patients	patient	NOUN
dpc-2111	105	45	(	(	PUNCT
dpc-2111	105	46	comparison	comparison	NOUN
dpc-2111	105	47	between	between	ADP
dpc-2111	105	48	oral	oral	ADJ
dpc-2111	105	49	retinoid	retinoid	NOUN
dpc-2111	105	50	users	user	NOUN
dpc-2111	105	51	and	and	CCONJ
dpc-2111	105	52	topical	topical	ADJ
dpc-2111	105	53	treatment	treatment	NOUN
dpc-2111	105	54	users	user	NOUN
dpc-2111	105	55	)	)	PUNCT
dpc-2111	105	56	symptom	symptom	NOUN
dpc-2111	105	57	oral	oral	ADJ
dpc-2111	105	58	retinoid	retinoid	NOUN
dpc-2111	105	59	users	user	NOUN
dpc-2111	105	60	n	n	PROPN
dpc-2111	105	61	(	(	PUNCT
dpc-2111	105	62	%	%	INTJ
dpc-2111	105	63	)	)	PUNCT
dpc-2111	105	64	topical	topical	ADJ
dpc-2111	105	65	treatment	treatment	NOUN
dpc-2111	105	66	users	user	NOUN
dpc-2111	105	67	n	n	PROPN
dpc-2111	105	68	(	(	PUNCT
dpc-2111	105	69	%	%	INTJ
dpc-2111	105	70	)	)	PUNCT
dpc-2111	106	1	p	p	NOUN
dpc-2111	106	2	taste\smell	taste\smell	NUM
dpc-2111	106	3	loss	loss	NOUN
dpc-2111	106	4	7	7	NUM
dpc-2111	106	5	(	(	PUNCT
dpc-2111	106	6	46.7	46.7	NUM
dpc-2111	106	7	)	)	PUNCT
dpc-2111	106	8	8	8	NUM
dpc-2111	106	9	(	(	PUNCT
dpc-2111	106	10	72.7	72.7	NUM
dpc-2111	106	11	)	)	PUNCT
dpc-2111	106	12	0.246	0.246	NUM
dpc-2111	106	13	headache	headache	NOUN
dpc-2111	106	14	5	5	NUM
dpc-2111	106	15	(	(	PUNCT
dpc-2111	106	16	33.3	33.3	NUM
dpc-2111	106	17	)	)	PUNCT
dpc-2111	106	18	8	8	NUM
dpc-2111	106	19	(	(	PUNCT
dpc-2111	106	20	72.7	72.7	NUM
dpc-2111	106	21	)	)	PUNCT
dpc-2111	106	22	0.047	0.047	NUM
dpc-2111	106	23	fever	fever	NOUN
dpc-2111	106	24	7	7	NUM
dpc-2111	106	25	(	(	PUNCT
dpc-2111	106	26	46.7	46.7	NUM
dpc-2111	106	27	)	)	PUNCT
dpc-2111	106	28	5	5	NUM
dpc-2111	106	29	(	(	PUNCT
dpc-2111	106	30	45.5	45.5	NUM
dpc-2111	106	31	)	)	PUNCT
dpc-2111	106	32	0.951	0.951	NUM
dpc-2111	106	33	malaise	malaise	NOUN
dpc-2111	106	34	7	7	NUM
dpc-2111	106	35	(	(	PUNCT
dpc-2111	106	36	46.7	46.7	NUM
dpc-2111	106	37	)	)	PUNCT
dpc-2111	106	38	5	5	NUM
dpc-2111	106	39	(	(	PUNCT
dpc-2111	106	40	45.5	45.5	NUM
dpc-2111	106	41	)	)	PUNCT
dpc-2111	106	42	0.951	0.951	NUM
dpc-2111	106	43	artralgia	artralgia	PROPN
dpc-2111	106	44	/	/	SYM
dpc-2111	106	45	myalgia	myalgia	NOUN
dpc-2111	106	46	4	4	NUM
dpc-2111	106	47	(	(	PUNCT
dpc-2111	106	48	26.7	26.7	NUM
dpc-2111	106	49	)	)	PUNCT
dpc-2111	106	50	7	7	NUM
dpc-2111	106	51	(	(	PUNCT
dpc-2111	106	52	63.9	63.9	NUM
dpc-2111	106	53	)	)	PUNCT
dpc-2111	106	54	0.109	0.109	NUM
dpc-2111	106	55	cough	cough	NOUN
dpc-2111	106	56	6	6	NUM
dpc-2111	106	57	(	(	PUNCT
dpc-2111	106	58	40.0	40.0	NUM
dpc-2111	106	59	)	)	SYM
dpc-2111	106	60	2	2	NUM
dpc-2111	106	61	(	(	PUNCT
dpc-2111	106	62	18.2	18.2	NUM
dpc-2111	106	63	)	)	PUNCT
dpc-2111	106	64	0.395	0.395	NUM
dpc-2111	106	65	sore	sore	ADJ
dpc-2111	106	66	throat	throat	NOUN
dpc-2111	106	67	4	4	NUM
dpc-2111	106	68	(	(	PUNCT
dpc-2111	106	69	26.7	26.7	NUM
dpc-2111	106	70	)	)	SYM
dpc-2111	106	71	2	2	NUM
dpc-2111	106	72	(	(	PUNCT
dpc-2111	106	73	18.2	18.2	NUM
dpc-2111	106	74	)	)	PUNCT
dpc-2111	106	75	0.999	0.999	NUM
dpc-2111	106	76	shortness	shortness	NOUN
dpc-2111	106	77	of	of	ADP
dpc-2111	106	78	breath	breath	NOUN
dpc-2111	106	79	1	1	NUM
dpc-2111	106	80	(	(	PUNCT
dpc-2111	106	81	6.7	6.7	NUM
dpc-2111	106	82	)	)	PUNCT
dpc-2111	106	83	3	3	NUM
dpc-2111	106	84	(	(	PUNCT
dpc-2111	106	85	27.3	27.3	NUM
dpc-2111	106	86	)	)	PUNCT
dpc-2111	106	87	0.279	0.279	NUM
dpc-2111	106	88	original	original	ADJ
dpc-2111	106	89	article	article	NOUN
dpc-2111	106	90	|	|	ADV
dpc-2111	106	91	dermatol	dermatol	ADJ
dpc-2111	106	92	pract	pract	NOUN
dpc-2111	106	93	concept	concept	NOUN
dpc-2111	106	94	.	.	PUNCT
dpc-2111	107	1	2022;12(3):e2022146	2022;12(3):e2022146	NUM
dpc-2111	107	2	5	5	NUM
dpc-2111	107	3	loss	loss	NOUN
dpc-2111	107	4	of	of	ADP
dpc-2111	107	5	taste	taste	NOUN
dpc-2111	107	6	/	/	SYM
dpc-2111	107	7	smell	smell	NOUN
dpc-2111	107	8	,	,	PUNCT
dpc-2111	107	9	which	which	PRON
dpc-2111	107	10	persisted	persist	VERB
dpc-2111	107	11	1	1	NUM
dpc-2111	107	12	month	month	NOUN
dpc-2111	107	13	after	after	ADP
dpc-2111	107	14	recovery	recovery	NOUN
dpc-2111	107	15	,	,	PUNCT
dpc-2111	107	16	was	be	AUX
dpc-2111	107	17	lower	low	ADJ
dpc-2111	107	18	in	in	ADP
dpc-2111	107	19	patients	patient	NOUN
dpc-2111	107	20	using	use	VERB
dpc-2111	107	21	oral	oral	ADJ
dpc-2111	107	22	isotretinoin	isotretinoin	NOUN
dpc-2111	107	23	compared	compare	VERB
dpc-2111	107	24	to	to	ADP
dpc-2111	107	25	patients	patient	NOUN
dpc-2111	107	26	receiving	receive	VERB
dpc-2111	107	27	topical	topical	ADJ
dpc-2111	107	28	treatment	treatment	NOUN
dpc-2111	107	29	(	(	PUNCT
dpc-2111	107	30	12.5	12.5	NUM
dpc-2111	107	31	%	%	NOUN
dpc-2111	107	32	and	and	CCONJ
dpc-2111	107	33	36	36	NUM
dpc-2111	107	34	%	%	NOUN
dpc-2111	107	35	,	,	PUNCT
dpc-2111	107	36	respectively	respectively	ADV
dpc-2111	107	37	)	)	PUNCT
dpc-2111	107	38	,	,	PUNCT
dpc-2111	107	39	which	which	PRON
dpc-2111	107	40	may	may	AUX
dpc-2111	107	41	be	be	AUX
dpc-2111	107	42	related	relate	VERB
dpc-2111	107	43	to	to	ADP
dpc-2111	107	44	the	the	DET
dpc-2111	107	45	faster	fast	ADJ
dpc-2111	107	46	recovery	recovery	NOUN
dpc-2111	107	47	of	of	ADP
dpc-2111	107	48	olfactory	olfactory	ADJ
dpc-2111	107	49	function	function	NOUN
dpc-2111	107	50	by	by	ADP
dpc-2111	107	51	isotretinoin	isotretinoin	PROPN
dpc-2111	107	52	,	,	PUNCT
dpc-2111	107	53	but	but	CCONJ
dpc-2111	107	54	again	again	ADV
dpc-2111	107	55	,	,	PUNCT
dpc-2111	107	56	no	no	DET
dpc-2111	107	57	statistical	statistical	ADJ
dpc-2111	107	58	difference	difference	NOUN
dpc-2111	107	59	was	be	AUX
dpc-2111	107	60	observed	observe	VERB
dpc-2111	107	61	(	(	PUNCT
dpc-2111	107	62	p	p	X
dpc-2111	107	63	=	=	NOUN
dpc-2111	107	64	0.350	0.350	NUM
dpc-2111	107	65	)	)	PUNCT
dpc-2111	107	66	.	.	PUNCT
dpc-2111	108	1	the	the	DET
dpc-2111	108	2	main	main	ADJ
dpc-2111	108	3	weakness	weakness	NOUN
dpc-2111	108	4	of	of	ADP
dpc-2111	108	5	this	this	DET
dpc-2111	108	6	study	study	NOUN
dpc-2111	108	7	is	be	AUX
dpc-2111	108	8	that	that	SCONJ
dpc-2111	108	9	the	the	DET
dpc-2111	108	10	small	small	ADJ
dpc-2111	108	11	number	number	NOUN
dpc-2111	108	12	of	of	ADP
dpc-2111	108	13	patients	patient	NOUN
dpc-2111	108	14	.	.	PUNCT
dpc-2111	109	1	smell	smell	NOUN
dpc-2111	109	2	/	/	SYM
dpc-2111	109	3	taste	taste	NOUN
dpc-2111	109	4	loss	loss	NOUN
dpc-2111	109	5	levels	level	NOUN
dpc-2111	109	6	could	could	AUX
dpc-2111	109	7	not	not	PART
dpc-2111	109	8	be	be	AUX
dpc-2111	109	9	evaluated	evaluate	VERB
dpc-2111	109	10	objectively	objectively	ADV
dpc-2111	109	11	because	because	SCONJ
dpc-2111	109	12	it	it	PRON
dpc-2111	109	13	is	be	AUX
dpc-2111	109	14	a	a	DET
dpc-2111	109	15	retrospective	retrospective	ADJ
dpc-2111	109	16	study	study	NOUN
dpc-2111	109	17	.	.	PUNCT
dpc-2111	110	1	in	in	ADP
dpc-2111	110	2	conclusion	conclusion	NOUN
dpc-2111	110	3	,	,	PUNCT
dpc-2111	110	4	the	the	DET
dpc-2111	110	5	use	use	NOUN
dpc-2111	110	6	of	of	ADP
dpc-2111	110	7	oral	oral	ADJ
dpc-2111	110	8	isotretinoin	isotretinoin	PROPN
dpc-2111	110	9	did	do	AUX
dpc-2111	110	10	not	not	PART
dpc-2111	110	11	cause	cause	VERB
dpc-2111	110	12	an	an	DET
dpc-2111	110	13	increase	increase	NOUN
dpc-2111	110	14	or	or	CCONJ
dpc-2111	110	15	decrease	decrease	NOUN
dpc-2111	110	16	in	in	ADP
dpc-2111	110	17	the	the	DET
dpc-2111	110	18	risk	risk	NOUN
dpc-2111	110	19	of	of	ADP
dpc-2111	110	20	covid-19	covid-19	PROPN
dpc-2111	110	21	transmission	transmission	NOUN
dpc-2111	110	22	.	.	PUNCT
dpc-2111	111	1	headache	headache	NOUN
dpc-2111	111	2	symptom	symptom	NOUN
dpc-2111	111	3	was	be	AUX
dpc-2111	111	4	seen	see	VERB
dpc-2111	111	5	less	less	ADV
dpc-2111	111	6	frequently	frequently	ADV
dpc-2111	111	7	in	in	ADP
dpc-2111	111	8	oral	oral	ADJ
dpc-2111	111	9	isotretinoin	isotretinoin	PROPN
dpc-2111	111	10	users	user	NOUN
dpc-2111	111	11	.	.	PUNCT
dpc-2111	112	1	in	in	ADP
dpc-2111	112	2	patients	patient	NOUN
dpc-2111	112	3	using	use	VERB
dpc-2111	112	4	oral	oral	ADJ
dpc-2111	112	5	isotretinoin	isotretinoin	NOUN
dpc-2111	112	6	,	,	PUNCT
dpc-2111	112	7	the	the	DET
dpc-2111	112	8	rates	rate	NOUN
dpc-2111	112	9	of	of	ADP
dpc-2111	112	10	taste	taste	NOUN
dpc-2111	112	11	/	/	SYM
dpc-2111	112	12	smell	smell	NOUN
dpc-2111	112	13	loss	loss	NOUN
dpc-2111	112	14	were	be	AUX
dpc-2111	112	15	lower	low	ADJ
dpc-2111	112	16	,	,	PUNCT
dpc-2111	112	17	although	although	SCONJ
dpc-2111	112	18	not	not	PART
dpc-2111	112	19	statistically	statistically	ADV
dpc-2111	112	20	significant	significant	ADJ
dpc-2111	112	21	.	.	PUNCT
dpc-2111	113	1	the	the	DET
dpc-2111	113	2	rates	rate	NOUN
dpc-2111	113	3	of	of	ADP
dpc-2111	113	4	complete	complete	ADJ
dpc-2111	113	5	recovery	recovery	NOUN
dpc-2111	113	6	of	of	ADP
dpc-2111	113	7	taste	taste	NOUN
dpc-2111	113	8	/	/	SYM
dpc-2111	113	9	smell	smell	NOUN
dpc-2111	113	10	loss	loss	NOUN
dpc-2111	113	11	were	be	AUX
dpc-2111	113	12	higher	high	ADJ
dpc-2111	113	13	in	in	ADP
dpc-2111	113	14	oral	oral	ADJ
dpc-2111	113	15	isotretinoin	isotretinoin	PROPN
dpc-2111	113	16	users	user	NOUN
dpc-2111	113	17	,	,	PUNCT
dpc-2111	113	18	although	although	SCONJ
dpc-2111	113	19	it	it	PRON
dpc-2111	113	20	was	be	AUX
dpc-2111	113	21	not	not	PART
dpc-2111	113	22	statistically	statistically	ADV
dpc-2111	113	23	significant	significant	ADJ
dpc-2111	113	24	.	.	PUNCT
dpc-2111	114	1	references	reference	NOUN
dpc-2111	114	2	1	1	NUM
dpc-2111	114	3	.	.	PUNCT
dpc-2111	114	4	who	who	PRON
dpc-2111	114	5	announces	announce	VERB
dpc-2111	114	6	covid‐19	covid‐19	PROPN
dpc-2111	114	7	outbreak	outbreak	NOUN
dpc-2111	114	8	a	a	DET
dpc-2111	114	9	pandemic	pandemic	NOUN
dpc-2111	114	10	.	.	PUNCT
dpc-2111	115	1	available	available	ADJ
dpc-2111	115	2	from	from	ADP
dpc-2111	115	3	:	:	PUNCT
dpc-2111	115	4	https://www.who.int/director-general/speeches/detail/who	https://www.who.int/director-general/speeches/detail/who	PRON
dpc-2111	115	5	-director	-director	NOUN
dpc-2111	115	6	-	-	PUNCT
dpc-2111	115	7	general	general	ADJ
dpc-2111	115	8	-	-	PUNCT
dpc-2111	115	9	s	s	NOUN
dpc-2111	115	10	-	-	PUNCT
dpc-2111	115	11	opening	opening	ADJ
dpc-2111	115	12	-	-	PUNCT
dpc-2111	115	13	remarks	remark	NOUN
dpc-2111	115	14	-	-	PUNCT
dpc-2111	115	15	at	at	ADP
dpc-2111	115	16	-	-	PUNCT
dpc-2111	115	17	the	the	DET
dpc-2111	115	18	-	-	PUNCT
dpc-2111	115	19	media	media	NOUN
dpc-2111	115	20	-	-	PUNCT
dpc-2111	115	21	briefing	briefing	NOUN
dpc-2111	115	22	-	-	PUNCT
dpc-2111	115	23	on	on	ADP
dpc-2111	115	24	-covid-19—11	-covid-19—11	PROPN
dpc-2111	115	25	-	-	PUNCT
dpc-2111	115	26	march-2020	march-2020	NOUN
dpc-2111	115	27	.	.	PUNCT
dpc-2111	116	1	accessed	access	VERB
dpc-2111	116	2	may	may	PROPN
dpc-2111	116	3	23	23	NUM
dpc-2111	116	4	,	,	PUNCT
dpc-2111	116	5	2020	2020	NUM
dpc-2111	116	6	.	.	PUNCT
dpc-2111	117	1	2	2	X
dpc-2111	117	2	.	.	X
dpc-2111	117	3	abdelmaksoud	abdelmaksoud	PROPN
dpc-2111	117	4	a	a	PROPN
dpc-2111	117	5	,	,	PUNCT
dpc-2111	117	6	 	 	SPACE
dpc-2111	117	7	lotti	lotti	PROPN
dpc-2111	117	8	t	t	PROPN
dpc-2111	117	9	,	,	PUNCT
dpc-2111	117	10	 	 	SPACE
dpc-2111	117	11	anadolu	anadolu	PROPN
dpc-2111	117	12	r	r	PROPN
dpc-2111	117	13	,	,	PUNCT
dpc-2111	117	14	et	et	PROPN
dpc-2111	117	15	al	al	PROPN
dpc-2111	117	16	.	.	PROPN
dpc-2111	117	17	 	 	SPACE
dpc-2111	117	18	low	low	PROPN
dpc-2111	117	19	dose	dose	PROPN
dpc-2111	117	20	of	of	ADP
dpc-2111	117	21	isotretinoin	isotretinoin	PROPN
dpc-2111	117	22	:	:	PUNCT
dpc-2111	117	23	a	a	DET
dpc-2111	117	24	comprehensive	comprehensive	ADJ
dpc-2111	117	25	review	review	NOUN
dpc-2111	117	26	.	.	PUNCT
dpc-2111	117	27	 	 	SPACE
dpc-2111	118	1	dermatol	dermatol	NOUN
dpc-2111	118	2	ther	ther	ADV
dpc-2111	118	3	.	.	PUNCT
dpc-2111	118	4	 	 	SPACE
dpc-2111	119	1	2020;33(2):e13251	2020;33(2):e13251	PROPN
dpc-2111	119	2	.	.	PUNCT
dpc-2111	120	1	doi	doi	NOUN
dpc-2111	120	2	:	:	PUNCT
dpc-2111	120	3	10.1111	10.1111	NUM
dpc-2111	120	4	/	/	SYM
dpc-2111	120	5	dth.13251	dth.13251	NUM
dpc-2111	120	6	.	.	PUNCT
dpc-2111	121	1	pmid	pmid	NOUN
dpc-2111	121	2	:	:	PUNCT
dpc-2111	121	3	32022958	32022958	NUM
dpc-2111	121	4	.	.	PUNCT
dpc-2111	122	1	3	3	X
dpc-2111	122	2	.	.	X
dpc-2111	122	3	skroza	skroza	PROPN
dpc-2111	122	4	n	n	CCONJ
dpc-2111	122	5	,	,	PUNCT
dpc-2111	122	6	tolino	tolino	NOUN
dpc-2111	122	7	e	e	NOUN
dpc-2111	122	8	,	,	PUNCT
dpc-2111	122	9	mambrin	mambrin	PROPN
dpc-2111	122	10	a	a	X
dpc-2111	122	11	,	,	PUNCT
dpc-2111	122	12	et	et	PROPN
dpc-2111	122	13	al	al	PROPN
dpc-2111	122	14	.	.	PUNCT
dpc-2111	122	15	adult	adult	PROPN
dpc-2111	122	16	acne	acne	NOUN
dpc-2111	122	17	versus	versus	ADP
dpc-2111	122	18	adolescent	adolescent	ADJ
dpc-2111	122	19	acne	acne	NOUN
dpc-2111	122	20	:	:	PUNCT
dpc-2111	122	21	a	a	DET
dpc-2111	122	22	retrospective	retrospective	ADJ
dpc-2111	122	23	study	study	NOUN
dpc-2111	122	24	of	of	ADP
dpc-2111	122	25	1,167	1,167	NUM
dpc-2111	122	26	patients	patient	NOUN
dpc-2111	122	27	.	.	PUNCT
dpc-2111	122	28	 	 	SPACE
dpc-2111	123	1	j	j	PROPN
dpc-2111	123	2	clin	clin	PROPN
dpc-2111	123	3	aesthet	aesthet	PROPN
dpc-2111	123	4	dermatol	dermatol	PROPN
dpc-2111	123	5	.	.	PUNCT
dpc-2111	124	1	2018;11(1):21	2018;11(1):21	NUM
dpc-2111	124	2	-	-	SYM
dpc-2111	124	3	25	25	NUM
dpc-2111	124	4	.	.	PUNCT
dpc-2111	125	1	pmid	pmid	NOUN
dpc-2111	125	2	:	:	PUNCT
dpc-2111	125	3	29410726	29410726	NUM
dpc-2111	125	4	.	.	PUNCT
dpc-2111	126	1	pmcid	pmcid	ADJ
dpc-2111	126	2	:	:	PUNCT
dpc-2111	126	3	pmc5788264	pmc5788264	ADJ
dpc-2111	126	4	.	.	PUNCT
dpc-2111	127	1	4	4	X
dpc-2111	127	2	.	.	X
dpc-2111	127	3	hamming	ham	VERB
dpc-2111	127	4	i	i	PRON
dpc-2111	127	5	,	,	PUNCT
dpc-2111	127	6	timens	timens	PROPN
dpc-2111	127	7	w	w	PROPN
dpc-2111	127	8	,	,	PUNCT
dpc-2111	127	9	bulthuis	bulthuis	NOUN
dpc-2111	127	10	ml	ml	NOUN
dpc-2111	127	11	,	,	PUNCT
dpc-2111	127	12	lely	lely	ADV
dpc-2111	127	13	at	at	ADP
dpc-2111	127	14	,	,	PUNCT
dpc-2111	127	15	navis	navis	ADP
dpc-2111	127	16	g	g	PROPN
dpc-2111	127	17	,	,	PUNCT
dpc-2111	127	18	van	van	PROPN
dpc-2111	127	19	goor	goor	PROPN
dpc-2111	127	20	h.	h.	PROPN
dpc-2111	127	21	tissue	tissue	NOUN
dpc-2111	127	22	distribution	distribution	NOUN
dpc-2111	127	23	of	of	ADP
dpc-2111	127	24	ace2	ace2	NOUN
dpc-2111	127	25	protein	protein	NOUN
dpc-2111	127	26	,	,	PUNCT
dpc-2111	127	27	the	the	DET
dpc-2111	127	28	functional	functional	ADJ
dpc-2111	127	29	receptor	receptor	NOUN
dpc-2111	127	30	for	for	ADP
dpc-2111	127	31	sars	sars	PROPN
dpc-2111	127	32	coronavirus	coronavirus	PROPN
dpc-2111	127	33	.	.	PUNCT
dpc-2111	128	1	a	a	DET
dpc-2111	128	2	first	first	ADJ
dpc-2111	128	3	step	step	NOUN
dpc-2111	128	4	in	in	ADP
dpc-2111	128	5	understanding	understand	VERB
dpc-2111	128	6	sars	sar	NOUN
dpc-2111	128	7	pathogenesis	pathogenesis	NOUN
dpc-2111	128	8	.	.	PUNCT
dpc-2111	128	9	 	 	SPACE
dpc-2111	129	1	j	j	PROPN
dpc-2111	129	2	pathol	pathol	NOUN
dpc-2111	129	3	.	.	PUNCT
dpc-2111	130	1	2004;203(2):631	2004;203(2):631	NUM
dpc-2111	130	2	-	-	PUNCT
dpc-2111	130	3	637	637	NUM
dpc-2111	130	4	.	.	PUNCT
dpc-2111	130	5	doi:10.1002	doi:10.1002	NOUN
dpc-2111	130	6	/	/	SYM
dpc-2111	130	7	path.1570	path.1570	PROPN
dpc-2111	130	8	.	.	PUNCT
dpc-2111	131	1	pmid	pmid	NOUN
dpc-2111	131	2	:	:	PUNCT
dpc-2111	131	3	15141377;.pmcid	15141377;.pmcid	NUM
dpc-2111	131	4	:	:	PUNCT
dpc-2111	131	5	pmc7167720	pmc7167720	NOUN
dpc-2111	131	6	.	.	PUNCT
dpc-2111	132	1	5	5	X
dpc-2111	132	2	.	.	X
dpc-2111	132	3	abdelmaksoud	abdelmaksoud	PROPN
dpc-2111	132	4	a	a	PRON
dpc-2111	132	5	,	,	PUNCT
dpc-2111	132	6	vestita	vestita	NOUN
dpc-2111	132	7	m	m	PROPN
dpc-2111	132	8	,	,	PUNCT
dpc-2111	132	9	el	el	PROPN
dpc-2111	132	10	-	-	PUNCT
dpc-2111	132	11	amawy	amawy	PROPN
dpc-2111	132	12	hs	hs	PROPN
dpc-2111	132	13	,	,	PUNCT
dpc-2111	132	14	ayhan	ayhan	PROPN
dpc-2111	132	15	e	e	PROPN
dpc-2111	132	16	,	,	PUNCT
dpc-2111	132	17	an	an	DET
dpc-2111	132	18	i̇	i̇	ADJ
dpc-2111	132	19	,	,	PUNCT
dpc-2111	132	20	öztürk	öztürk	NOUN
dpc-2111	132	21	m	m	PROPN
dpc-2111	132	22	,	,	PUNCT
dpc-2111	132	23	goldust	goldust	PROPN
dpc-2111	132	24	m.	m.	NOUN
dpc-2111	132	25	systemic	systemic	ADJ
dpc-2111	132	26	isotretinoin	isotretinoin	PROPN
dpc-2111	132	27	therapy	therapy	NOUN
dpc-2111	132	28	in	in	ADP
dpc-2111	132	29	the	the	DET
dpc-2111	132	30	era	era	NOUN
dpc-2111	132	31	of	of	ADP
dpc-2111	132	32	covid-19	covid-19	PROPN
dpc-2111	132	33	.	.	PUNCT
dpc-2111	132	34	dermatol	dermatol	NOUN
dpc-2111	132	35	ther	ther	ADV
dpc-2111	132	36	.	.	PUNCT
dpc-2111	133	1	2020;33(4):e13482	2020;33(4):e13482	X
dpc-2111	133	2	.	.	X
dpc-2111	133	3	doi	doi	NOUN
dpc-2111	133	4	:	:	PUNCT
dpc-2111	133	5	10.1111	10.1111	NUM
dpc-2111	133	6	/dth.13482	/dth.13482	PROPN
dpc-2111	133	7	.	.	PUNCT
dpc-2111	134	1	pmid	pmid	NOUN
dpc-2111	134	2	:	:	PUNCT
dpc-2111	134	3	32358858	32358858	NUM
dpc-2111	134	4	.	.	PUNCT
dpc-2111	135	1	pmcid	pmcid	NOUN
dpc-2111	135	2	:	:	PUNCT
dpc-2111	135	3	pmc7261989	pmc7261989	ADJ
dpc-2111	135	4	.	.	PUNCT
dpc-2111	136	1	during	during	ADP
dpc-2111	136	2	the	the	DET
dpc-2111	136	3	course	course	NOUN
dpc-2111	136	4	of	of	ADP
dpc-2111	136	5	covid-19	covid-19	PROPN
dpc-2111	136	6	,	,	PUNCT
dpc-2111	136	7	the	the	DET
dpc-2111	136	8	most	most	ADV
dpc-2111	136	9	common	common	ADJ
dpc-2111	136	10	clinical	clinical	ADJ
dpc-2111	136	11	symptoms	symptom	NOUN
dpc-2111	136	12	were	be	AUX
dpc-2111	136	13	reported	report	VERB
dpc-2111	136	14	as	as	ADP
dpc-2111	136	15	fever	fever	NOUN
dpc-2111	136	16	,	,	PUNCT
dpc-2111	136	17	cough	cough	NOUN
dpc-2111	136	18	,	,	PUNCT
dpc-2111	136	19	headache	headache	NOUN
dpc-2111	136	20	,	,	PUNCT
dpc-2111	136	21	and	and	CCONJ
dpc-2111	136	22	sore	sore	ADJ
dpc-2111	136	23	throat	throat	NOUN
dpc-2111	136	24	,	,	PUNCT
dpc-2111	136	25	in	in	ADP
dpc-2111	136	26	decreasing	decrease	VERB
dpc-2111	136	27	order	order	NOUN
dpc-2111	136	28	of	of	ADP
dpc-2111	136	29	frequency	frequency	NOUN
dpc-2111	136	30	[	[	X
dpc-2111	136	31	13	13	NUM
dpc-2111	136	32	]	]	PUNCT
dpc-2111	136	33	.	.	PUNCT
dpc-2111	137	1	in	in	ADP
dpc-2111	137	2	our	our	PRON
dpc-2111	137	3	patients	patient	NOUN
dpc-2111	137	4	,	,	PUNCT
dpc-2111	137	5	this	this	DET
dpc-2111	137	6	order	order	NOUN
dpc-2111	137	7	was	be	AUX
dpc-2111	137	8	taste\smell	taste\smell	NUM
dpc-2111	137	9	loss	loss	NOUN
dpc-2111	137	10	,	,	PUNCT
dpc-2111	137	11	headache	headache	NOUN
dpc-2111	137	12	,	,	PUNCT
dpc-2111	137	13	fever	fever	NOUN
dpc-2111	137	14	,	,	PUNCT
dpc-2111	137	15	malaise	malaise	NOUN
dpc-2111	137	16	,	,	PUNCT
dpc-2111	137	17	arthralgia\myalgia	arthralgia\myalgia	NOUN
dpc-2111	137	18	,	,	PUNCT
dpc-2111	137	19	cough	cough	NOUN
dpc-2111	137	20	,	,	PUNCT
dpc-2111	137	21	sore	sore	ADJ
dpc-2111	137	22	throat	throat	NOUN
dpc-2111	137	23	,	,	PUNCT
dpc-2111	137	24	and	and	CCONJ
dpc-2111	137	25	shortness	shortness	NOUN
dpc-2111	137	26	of	of	ADP
dpc-2111	137	27	breath	breath	NOUN
dpc-2111	137	28	.	.	PUNCT
dpc-2111	138	1	we	we	PRON
dpc-2111	138	2	found	find	VERB
dpc-2111	138	3	that	that	SCONJ
dpc-2111	138	4	the	the	DET
dpc-2111	138	5	headache	headache	NOUN
dpc-2111	138	6	symptom	symptom	NOUN
dpc-2111	138	7	decreased	decrease	VERB
dpc-2111	138	8	with	with	ADP
dpc-2111	138	9	the	the	DET
dpc-2111	138	10	use	use	NOUN
dpc-2111	138	11	of	of	ADP
dpc-2111	138	12	oral	oral	ADJ
dpc-2111	138	13	isotretinoin	isotretinoin	NOUN
dpc-2111	138	14	(	(	PUNCT
dpc-2111	138	15	p	p	X
dpc-2111	138	16	=	=	NOUN
dpc-2111	138	17	0.047	0.047	NUM
dpc-2111	138	18	)	)	PUNCT
dpc-2111	138	19	.	.	PUNCT
dpc-2111	139	1	various	various	ADJ
dpc-2111	139	2	mechanisms	mechanism	NOUN
dpc-2111	139	3	have	have	AUX
dpc-2111	139	4	been	be	AUX
dpc-2111	139	5	described	describe	VERB
dpc-2111	139	6	for	for	ADP
dpc-2111	139	7	headaches	headache	NOUN
dpc-2111	139	8	due	due	ADP
dpc-2111	139	9	to	to	ADP
dpc-2111	139	10	covid-19	covid-19	PROPN
dpc-2111	139	11	.	.	PUNCT
dpc-2111	140	1	the	the	DET
dpc-2111	140	2	first	first	ADJ
dpc-2111	140	3	of	of	ADP
dpc-2111	140	4	these	these	DET
dpc-2111	140	5	mechanisms	mechanism	NOUN
dpc-2111	140	6	has	have	AUX
dpc-2111	140	7	been	be	AUX
dpc-2111	140	8	reported	report	VERB
dpc-2111	140	9	to	to	PART
dpc-2111	140	10	be	be	AUX
dpc-2111	140	11	the	the	DET
dpc-2111	140	12	invasion	invasion	NOUN
dpc-2111	140	13	of	of	ADP
dpc-2111	140	14	the	the	DET
dpc-2111	140	15	trigeminal	trigeminal	ADJ
dpc-2111	140	16	nerve	nerve	NOUN
dpc-2111	140	17	endings	ending	NOUN
dpc-2111	140	18	of	of	ADP
dpc-2111	140	19	the	the	DET
dpc-2111	140	20	virus	virus	NOUN
dpc-2111	140	21	that	that	PRON
dpc-2111	140	22	is	be	AUX
dpc-2111	140	23	bound	bind	VERB
dpc-2111	140	24	to	to	PART
dpc-2111	140	25	ace2	ace2	VERB
dpc-2111	140	26	receptors	receptor	NOUN
dpc-2111	140	27	in	in	ADP
dpc-2111	140	28	the	the	DET
dpc-2111	140	29	nasal	nasal	ADJ
dpc-2111	140	30	cavity	cavity	NOUN
dpc-2111	140	31	.	.	PUNCT
dpc-2111	141	1	we	we	PRON
dpc-2111	141	2	thought	think	VERB
dpc-2111	141	3	that	that	SCONJ
dpc-2111	141	4	the	the	DET
dpc-2111	141	5	use	use	NOUN
dpc-2111	141	6	of	of	ADP
dpc-2111	141	7	oral	oral	ADJ
dpc-2111	141	8	isotretinoin	isotretinoin	PROPN
dpc-2111	141	9	may	may	AUX
dpc-2111	141	10	cause	cause	VERB
dpc-2111	141	11	a	a	DET
dpc-2111	141	12	less	less	ADV
dpc-2111	141	13	frequent	frequent	ADJ
dpc-2111	141	14	occurrence	occurrence	NOUN
dpc-2111	141	15	of	of	ADP
dpc-2111	141	16	headache	headache	NOUN
dpc-2111	141	17	due	due	ADP
dpc-2111	141	18	to	to	ADP
dpc-2111	141	19	covid-19	covid-19	PROPN
dpc-2111	141	20	,	,	PUNCT
dpc-2111	141	21	with	with	ADP
dpc-2111	141	22	the	the	DET
dpc-2111	141	23	down	down	ADV
dpc-2111	141	24	-	-	PUNCT
dpc-2111	141	25	regulating	regulate	VERB
dpc-2111	141	26	effect	effect	NOUN
dpc-2111	141	27	of	of	ADP
dpc-2111	141	28	isotretinoin	isotretinoin	PROPN
dpc-2111	141	29	on	on	ADP
dpc-2111	141	30	ace2	ace2	NOUN
dpc-2111	141	31	receptors	receptor	NOUN
dpc-2111	141	32	[	[	X
dpc-2111	141	33	6,11,14	6,11,14	NUM
dpc-2111	141	34	]	]	PUNCT
dpc-2111	141	35	.	.	PUNCT
dpc-2111	142	1	although	although	SCONJ
dpc-2111	142	2	taste\smell	taste\smell	NUM
dpc-2111	142	3	loss	loss	NOUN
dpc-2111	142	4	is	be	AUX
dpc-2111	142	5	one	one	NUM
dpc-2111	142	6	of	of	ADP
dpc-2111	142	7	the	the	DET
dpc-2111	142	8	most	most	ADV
dpc-2111	142	9	commonly	commonly	ADV
dpc-2111	142	10	known	know	VERB
dpc-2111	142	11	symptoms	symptom	NOUN
dpc-2111	142	12	of	of	ADP
dpc-2111	142	13	covid-19	covid-19	PROPN
dpc-2111	142	14	in	in	ADP
dpc-2111	142	15	the	the	DET
dpc-2111	142	16	non	non	ADJ
dpc-2111	142	17	-	-	ADJ
dpc-2111	142	18	medical	medical	ADJ
dpc-2111	142	19	community	community	NOUN
dpc-2111	142	20	,	,	PUNCT
dpc-2111	142	21	its	its	PRON
dpc-2111	142	22	incidence	incidence	NOUN
dpc-2111	142	23	varies	vary	VERB
dpc-2111	142	24	between	between	ADP
dpc-2111	142	25	0	0	NUM
dpc-2111	142	26	%	%	NOUN
dpc-2111	142	27	and	and	CCONJ
dpc-2111	142	28	98	98	NUM
dpc-2111	142	29	%	%	NOUN
dpc-2111	142	30	[	[	X
dpc-2111	142	31	15	15	NUM
dpc-2111	142	32	]	]	PUNCT
dpc-2111	142	33	.	.	PUNCT
dpc-2111	143	1	we	we	PRON
dpc-2111	143	2	found	find	VERB
dpc-2111	143	3	the	the	DET
dpc-2111	143	4	rate	rate	NOUN
dpc-2111	143	5	of	of	ADP
dpc-2111	143	6	taste\smell	taste\smell	NUM
dpc-2111	143	7	loss	loss	NOUN
dpc-2111	143	8	to	to	PART
dpc-2111	143	9	be	be	AUX
dpc-2111	143	10	55	55	NUM
dpc-2111	143	11	%	%	NOUN
dpc-2111	143	12	,	,	PUNCT
dpc-2111	143	13	this	this	DET
dpc-2111	143	14	rate	rate	NOUN
dpc-2111	143	15	was	be	AUX
dpc-2111	143	16	higher	high	ADJ
dpc-2111	143	17	in	in	ADP
dpc-2111	143	18	patients	patient	NOUN
dpc-2111	143	19	using	use	VERB
dpc-2111	143	20	a	a	DET
dpc-2111	143	21	topical	topical	ADJ
dpc-2111	143	22	treatment	treatment	NOUN
dpc-2111	143	23	(	(	PUNCT
dpc-2111	143	24	72.7	72.7	NUM
dpc-2111	143	25	%	%	NOUN
dpc-2111	143	26	)	)	PUNCT
dpc-2111	143	27	.	.	PUNCT
dpc-2111	144	1	it	it	PRON
dpc-2111	144	2	has	have	AUX
dpc-2111	144	3	been	be	AUX
dpc-2111	144	4	reported	report	VERB
dpc-2111	144	5	that	that	SCONJ
dpc-2111	144	6	the	the	DET
dpc-2111	144	7	loss	loss	NOUN
dpc-2111	144	8	of	of	ADP
dpc-2111	144	9	taste	taste	NOUN
dpc-2111	144	10	/	/	SYM
dpc-2111	144	11	smell	smell	NOUN
dpc-2111	144	12	is	be	AUX
dpc-2111	144	13	resolved	resolve	VERB
dpc-2111	144	14	in	in	ADP
dpc-2111	144	15	most	most	ADJ
dpc-2111	144	16	cases	case	NOUN
dpc-2111	144	17	within	within	ADP
dpc-2111	144	18	an	an	DET
dpc-2111	144	19	average	average	NOUN
dpc-2111	144	20	of	of	ADP
dpc-2111	144	21	14	14	NUM
dpc-2111	144	22	days	day	NOUN
dpc-2111	144	23	from	from	ADP
dpc-2111	144	24	the	the	DET
dpc-2111	144	25	full	full	ADJ
dpc-2111	144	26	recovery	recovery	NOUN
dpc-2111	144	27	of	of	ADP
dpc-2111	144	28	covid-19	covid-19	PROPN
dpc-2111	144	29	.	.	PUNCT
dpc-2111	145	1	however	however	ADV
dpc-2111	145	2	,	,	PUNCT
dpc-2111	145	3	in	in	ADP
dpc-2111	145	4	some	some	PRON
dpc-2111	145	5	of	of	ADP
dpc-2111	145	6	the	the	DET
dpc-2111	145	7	patients	patient	NOUN
dpc-2111	145	8	,	,	PUNCT
dpc-2111	145	9	it	it	PRON
dpc-2111	145	10	was	be	AUX
dpc-2111	145	11	observed	observe	VERB
dpc-2111	145	12	that	that	SCONJ
dpc-2111	145	13	the	the	DET
dpc-2111	145	14	loss	loss	NOUN
dpc-2111	145	15	of	of	ADP
dpc-2111	145	16	taste	taste	NOUN
dpc-2111	145	17	/	/	SYM
dpc-2111	145	18	smell	smell	NOUN
dpc-2111	145	19	partially	partially	ADV
dpc-2111	145	20	improved	improve	VERB
dpc-2111	145	21	after	after	ADP
dpc-2111	145	22	months	month	NOUN
dpc-2111	145	23	or	or	CCONJ
dpc-2111	145	24	did	do	AUX
dpc-2111	145	25	not	not	PART
dpc-2111	145	26	improve	improve	VERB
dpc-2111	145	27	at	at	ADV
dpc-2111	145	28	all	all	ADV
dpc-2111	145	29	[	[	X
dpc-2111	145	30	15	15	NUM
dpc-2111	145	31	]	]	PUNCT
dpc-2111	145	32	.	.	PUNCT
dpc-2111	146	1	it	it	PRON
dpc-2111	146	2	was	be	AUX
dpc-2111	146	3	found	find	VERB
dpc-2111	146	4	that	that	SCONJ
dpc-2111	146	5	retinoic	retinoic	ADJ
dpc-2111	146	6	acid	acid	NOUN
dpc-2111	146	7	treatment	treatment	NOUN
dpc-2111	146	8	in	in	ADP
dpc-2111	146	9	mice	mouse	NOUN
dpc-2111	146	10	increased	increase	VERB
dpc-2111	146	11	the	the	DET
dpc-2111	146	12	number	number	NOUN
dpc-2111	146	13	of	of	ADP
dpc-2111	146	14	macrophages	macrophage	NOUN
dpc-2111	146	15	expressing	express	VERB
dpc-2111	146	16	retinoic	retinoic	ADJ
dpc-2111	146	17	acid	acid	NOUN
dpc-2111	146	18	receptors	receptor	NOUN
dpc-2111	146	19	,	,	PUNCT
dpc-2111	146	20	and	and	CCONJ
dpc-2111	146	21	this	this	DET
dpc-2111	146	22	increase	increase	NOUN
dpc-2111	146	23	was	be	AUX
dpc-2111	146	24	associated	associate	VERB
dpc-2111	146	25	with	with	ADP
dpc-2111	146	26	a	a	DET
dpc-2111	146	27	faster	fast	ADJ
dpc-2111	146	28	recovery	recovery	NOUN
dpc-2111	146	29	of	of	ADP
dpc-2111	146	30	olfactory	olfactory	ADJ
dpc-2111	146	31	function	function	NOUN
dpc-2111	146	32	[	[	X
dpc-2111	146	33	16,17	16,17	NUM
dpc-2111	146	34	]	]	PUNCT
dpc-2111	146	35	.	.	PUNCT
dpc-2111	147	1	oral	oral	ADJ
dpc-2111	147	2	isotretinoin	isotretinoin	PROPN
dpc-2111	147	3	has	have	AUX
dpc-2111	147	4	been	be	AUX
dpc-2111	147	5	shown	show	VERB
dpc-2111	147	6	to	to	PART
dpc-2111	147	7	improve	improve	VERB
dpc-2111	147	8	the	the	DET
dpc-2111	147	9	sense	sense	NOUN
dpc-2111	147	10	of	of	ADP
dpc-2111	147	11	smell	smell	NOUN
dpc-2111	147	12	in	in	ADP
dpc-2111	147	13	humans	human	NOUN
dpc-2111	147	14	according	accord	VERB
dpc-2111	147	15	to	to	ADP
dpc-2111	147	16	the	the	DET
dpc-2111	147	17	olfactory	olfactory	NOUN
dpc-2111	147	18	function	function	NOUN
dpc-2111	147	19	test	test	NOUN
dpc-2111	147	20	evaluated	evaluate	VERB
dpc-2111	147	21	before	before	ADP
dpc-2111	147	22	starting	start	VERB
dpc-2111	147	23	oral	oral	ADJ
dpc-2111	147	24	isotretinoin	isotretinoin	PROPN
dpc-2111	147	25	treatment	treatment	NOUN
dpc-2111	147	26	and	and	CCONJ
dpc-2111	147	27	at	at	ADP
dpc-2111	147	28	the	the	DET
dpc-2111	147	29	third	third	ADJ
dpc-2111	147	30	month	month	NOUN
dpc-2111	147	31	of	of	ADP
dpc-2111	147	32	treatment	treatment	NOUN
dpc-2111	147	33	[	[	X
dpc-2111	147	34	18	18	NUM
dpc-2111	147	35	]	]	PUNCT
dpc-2111	147	36	.	.	PUNCT
dpc-2111	148	1	according	accord	VERB
dpc-2111	148	2	to	to	ADP
dpc-2111	148	3	the	the	DET
dpc-2111	148	4	data	datum	NOUN
dpc-2111	148	5	of	of	ADP
dpc-2111	148	6	our	our	PRON
dpc-2111	148	7	study	study	NOUN
dpc-2111	148	8	,	,	PUNCT
dpc-2111	148	9	loss	loss	NOUN
dpc-2111	148	10	of	of	ADP
dpc-2111	148	11	smell/	smell/	NUM
dpc-2111	148	12	taste	taste	NOUN
dpc-2111	148	13	was	be	AUX
dpc-2111	148	14	lower	low	ADJ
dpc-2111	148	15	in	in	ADP
dpc-2111	148	16	patients	patient	NOUN
dpc-2111	148	17	using	use	VERB
dpc-2111	148	18	oral	oral	ADJ
dpc-2111	148	19	isotretinoin	isotretinoin	NOUN
dpc-2111	148	20	compared	compare	VERB
dpc-2111	148	21	to	to	ADP
dpc-2111	148	22	patients	patient	NOUN
dpc-2111	148	23	receiving	receive	VERB
dpc-2111	148	24	topical	topical	ADJ
dpc-2111	148	25	treatment	treatment	NOUN
dpc-2111	148	26	(	(	PUNCT
dpc-2111	148	27	46.7	46.7	NUM
dpc-2111	148	28	%	%	NOUN
dpc-2111	148	29	and	and	CCONJ
dpc-2111	148	30	72.7	72.7	NUM
dpc-2111	148	31	%	%	NOUN
dpc-2111	148	32	,	,	PUNCT
dpc-2111	148	33	respectively	respectively	ADV
dpc-2111	148	34	.	.	PUNCT
dpc-2111	148	35	)	)	PUNCT
dpc-2111	149	1	,	,	PUNCT
dpc-2111	149	2	this	this	PRON
dpc-2111	149	3	may	may	AUX
dpc-2111	149	4	be	be	AUX
dpc-2111	149	5	related	relate	VERB
dpc-2111	149	6	to	to	ADP
dpc-2111	149	7	the	the	DET
dpc-2111	149	8	improvement	improvement	NOUN
dpc-2111	149	9	of	of	ADP
dpc-2111	149	10	the	the	DET
dpc-2111	149	11	sense	sense	NOUN
dpc-2111	149	12	of	of	ADP
dpc-2111	149	13	smell	smell	NOUN
dpc-2111	149	14	by	by	ADP
dpc-2111	149	15	oral	oral	ADJ
dpc-2111	149	16	isotretinoin	isotretinoin	PROPN
dpc-2111	149	17	use	use	NOUN
dpc-2111	149	18	,	,	PUNCT
dpc-2111	149	19	but	but	CCONJ
dpc-2111	149	20	we	we	PRON
dpc-2111	149	21	found	find	VERB
dpc-2111	149	22	no	no	DET
dpc-2111	149	23	statistically	statistically	ADV
dpc-2111	149	24	significant	significant	ADJ
dpc-2111	149	25	difference	difference	NOUN
dpc-2111	149	26	(	(	PUNCT
dpc-2111	149	27	p	p	NOUN
dpc-2111	149	28	=	=	NOUN
dpc-2111	149	29	0.246	0.246	NUM
dpc-2111	149	30	)	)	PUNCT
dpc-2111	149	31	.	.	PUNCT
dpc-2111	150	1	partial	partial	ADJ
dpc-2111	150	2	table	table	NOUN
dpc-2111	150	3	3	3	NUM
dpc-2111	150	4	.	.	PUNCT
dpc-2111	150	5	possible	possible	ADJ
dpc-2111	150	6	associations	association	NOUN
dpc-2111	150	7	between	between	ADP
dpc-2111	150	8	oral	oral	ADJ
dpc-2111	150	9	isotretinoin	isotretinoin	PROPN
dpc-2111	150	10	and	and	CCONJ
dpc-2111	150	11	covid-19	covid-19	PROPN
dpc-2111	150	12	covid-19	covid-19	PROPN
dpc-2111	150	13	transmission	transmission	NOUN
dpc-2111	150	14	risk	risk	NOUN
dpc-2111	150	15	and	and	CCONJ
dpc-2111	150	16	oral	oral	ADJ
dpc-2111	150	17	isotretinoin	isotretinoin	PROPN
dpc-2111	150	18	use	use	NOUN
dpc-2111	150	19	oral	oral	ADJ
dpc-2111	150	20	isotretinoin	isotretinoin	PROPN
dpc-2111	150	21	may	may	AUX
dpc-2111	150	22	increase	increase	VERB
dpc-2111	150	23	the	the	DET
dpc-2111	150	24	risk	risk	NOUN
dpc-2111	150	25	of	of	ADP
dpc-2111	150	26	transmission	transmission	NOUN
dpc-2111	150	27	by	by	ADP
dpc-2111	150	28	exposing	expose	VERB
dpc-2111	150	29	ace-2	ace-2	NUM
dpc-2111	150	30	receptors	receptor	NOUN
dpc-2111	150	31	in	in	ADP
dpc-2111	150	32	the	the	DET
dpc-2111	150	33	nasal	nasal	PROPN
dpc-2111	150	34	mucosa	mucosa	PROPN
dpc-2111	150	35	.	.	PUNCT
dpc-2111	151	1	oral	oral	ADJ
dpc-2111	151	2	isotretinoin	isotretinoin	PROPN
dpc-2111	151	3	can	can	AUX
dpc-2111	151	4	reduce	reduce	VERB
dpc-2111	151	5	the	the	DET
dpc-2111	151	6	risk	risk	NOUN
dpc-2111	151	7	of	of	ADP
dpc-2111	151	8	transmission	transmission	NOUN
dpc-2111	151	9	by	by	ADP
dpc-2111	151	10	down	down	ADV
dpc-2111	151	11	-	-	PUNCT
dpc-2111	151	12	regulating	regulate	VERB
dpc-2111	151	13	ace-2	ace-2	NUM
dpc-2111	151	14	receptors	receptor	NOUN
dpc-2111	151	15	.	.	PUNCT
dpc-2111	152	1	severe	severe	ADJ
dpc-2111	152	2	covid-19	covid-19	PROPN
dpc-2111	152	3	and	and	CCONJ
dpc-2111	152	4	use	use	NOUN
dpc-2111	152	5	of	of	ADP
dpc-2111	152	6	oral	oral	ADJ
dpc-2111	152	7	isotretinoin	isotretinoin	NOUN
dpc-2111	152	8	because	because	SCONJ
dpc-2111	152	9	covid-19	covid-19	PROPN
dpc-2111	152	10	disease	disease	NOUN
dpc-2111	152	11	resembles	resemble	VERB
dpc-2111	152	12	an	an	DET
dpc-2111	152	13	endogenous	endogenous	ADJ
dpc-2111	152	14	form	form	NOUN
dpc-2111	152	15	of	of	ADP
dpc-2111	152	16	hypervitaminosis	hypervitaminosis	NOUN
dpc-2111	152	17	of	of	ADP
dpc-2111	152	18	vitamin	vitamin	NOUN
dpc-2111	152	19	 	 	SPACE
dpc-2111	152	20	a	a	NOUN
dpc-2111	152	21	,	,	PUNCT
dpc-2111	152	22	the	the	DET
dpc-2111	152	23	use	use	NOUN
dpc-2111	152	24	of	of	ADP
dpc-2111	152	25	oral	oral	ADJ
dpc-2111	152	26	isotretinoin	isotretinoin	PROPN
dpc-2111	152	27	may	may	AUX
dpc-2111	152	28	worsen	worsen	VERB
dpc-2111	152	29	the	the	DET
dpc-2111	152	30	disease	disease	NOUN
dpc-2111	152	31	severity	severity	NOUN
dpc-2111	152	32	.	.	PUNCT
dpc-2111	153	1	thanks	thank	NOUN
dpc-2111	153	2	to	to	ADP
dpc-2111	153	3	its	its	PRON
dpc-2111	153	4	antioxidant	antioxidant	ADJ
dpc-2111	153	5	and	and	CCONJ
dpc-2111	153	6	surfactant	surfactant	NOUN
dpc-2111	153	7	-	-	PUNCT
dpc-2111	153	8	mediated	mediate	VERB
dpc-2111	153	9	properties	property	NOUN
dpc-2111	153	10	,	,	PUNCT
dpc-2111	153	11	oral	oral	ADJ
dpc-2111	153	12	isotretinoin	isotretinoin	PROPN
dpc-2111	153	13	may	may	AUX
dpc-2111	153	14	be	be	AUX
dpc-2111	153	15	protective	protective	ADJ
dpc-2111	153	16	in	in	ADP
dpc-2111	153	17	the	the	DET
dpc-2111	153	18	pathogenesis	pathogenesis	NOUN
dpc-2111	153	19	of	of	ADP
dpc-2111	153	20	ards	ard	NOUN
dpc-2111	153	21	,	,	PUNCT
dpc-2111	153	22	which	which	PRON
dpc-2111	153	23	is	be	AUX
dpc-2111	153	24	a	a	DET
dpc-2111	153	25	complication	complication	NOUN
dpc-2111	153	26	of	of	ADP
dpc-2111	153	27	severe	severe	ADJ
dpc-2111	153	28	covid-19	covid-19	PROPN
dpc-2111	153	29	cases	case	NOUN
dpc-2111	153	30	.	.	PUNCT
dpc-2111	154	1	covid-19	covid-19	PROPN
dpc-2111	154	2	treatment	treatment	NOUN
dpc-2111	154	3	and	and	CCONJ
dpc-2111	154	4	oral	oral	ADJ
dpc-2111	154	5	isotretinoin	isotretinoin	PROPN
dpc-2111	154	6	use	use	NOUN
dpc-2111	154	7	oral	oral	ADJ
dpc-2111	154	8	isotretinoin	isotretinoin	PROPN
dpc-2111	154	9	can	can	AUX
dpc-2111	154	10	be	be	AUX
dpc-2111	154	11	used	use	VERB
dpc-2111	154	12	in	in	ADP
dpc-2111	154	13	the	the	DET
dpc-2111	154	14	treatment	treatment	NOUN
dpc-2111	154	15	of	of	ADP
dpc-2111	154	16	covid-19	covid-19	PROPN
dpc-2111	154	17	as	as	SCONJ
dpc-2111	154	18	it	it	PRON
dpc-2111	154	19	has	have	VERB
dpc-2111	154	20	anti	anti	ADJ
dpc-2111	154	21	-	-	ADJ
dpc-2111	154	22	viral	viral	ADJ
dpc-2111	154	23	,	,	PUNCT
dpc-2111	154	24	anti	anti	ADJ
dpc-2111	154	25	-	-	ADJ
dpc-2111	154	26	inflammatory	inflammatory	ADJ
dpc-2111	154	27	,	,	PUNCT
dpc-2111	154	28	and	and	CCONJ
dpc-2111	154	29	immunomodulatory	immunomodulatory	ADJ
dpc-2111	154	30	effects	effect	NOUN
dpc-2111	154	31	.	.	PUNCT
dpc-2111	155	1	symptoms	symptom	NOUN
dpc-2111	155	2	due	due	ADJ
dpc-2111	155	3	to	to	ADP
dpc-2111	155	4	covid-19	covid-19	PROPN
dpc-2111	155	5	and	and	CCONJ
dpc-2111	155	6	use	use	NOUN
dpc-2111	155	7	of	of	ADP
dpc-2111	155	8	oral	oral	ADJ
dpc-2111	155	9	isotretinoin	isotretinoin	PROPN
dpc-2111	155	10	oral	oral	ADJ
dpc-2111	155	11	isotretinoin	isotretinoin	PROPN
dpc-2111	155	12	can	can	AUX
dpc-2111	155	13	alleviate	alleviate	VERB
dpc-2111	155	14	covid-19	covid-19	PROPN
dpc-2111	155	15	-	-	PUNCT
dpc-2111	155	16	related	relate	VERB
dpc-2111	155	17	headache	headache	NOUN
dpc-2111	155	18	with	with	ADP
dpc-2111	155	19	its	its	PRON
dpc-2111	155	20	down	down	ADV
dpc-2111	155	21	-	-	PUNCT
dpc-2111	155	22	regulating	regulate	VERB
dpc-2111	155	23	effect	effect	NOUN
dpc-2111	155	24	on	on	ADP
dpc-2111	155	25	ace-2	ace-2	ADJ
dpc-2111	155	26	receptors	receptor	NOUN
dpc-2111	155	27	and	and	CCONJ
dpc-2111	155	28	anti	anti	ADJ
dpc-2111	155	29	-	-	ADJ
dpc-2111	155	30	inflammatory	inflammatory	ADJ
dpc-2111	155	31	-	-	PUNCT
dpc-2111	155	32	immunomodulatory	immunomodulatory	ADJ
dpc-2111	155	33	effects	effect	NOUN
dpc-2111	155	34	.	.	PUNCT
dpc-2111	156	1	since	since	SCONJ
dpc-2111	156	2	oral	oral	ADJ
dpc-2111	156	3	isotretinoin	isotretinoin	PROPN
dpc-2111	156	4	increases	increase	VERB
dpc-2111	156	5	the	the	DET
dpc-2111	156	6	sense	sense	NOUN
dpc-2111	156	7	of	of	ADP
dpc-2111	156	8	smell	smell	NOUN
dpc-2111	156	9	and	and	CCONJ
dpc-2111	156	10	improves	improve	VERB
dpc-2111	156	11	the	the	DET
dpc-2111	156	12	lost	lost	ADJ
dpc-2111	156	13	sense	sense	NOUN
dpc-2111	156	14	of	of	ADP
dpc-2111	156	15	smell	smell	NOUN
dpc-2111	156	16	,	,	PUNCT
dpc-2111	156	17	it	it	PRON
dpc-2111	156	18	can	can	AUX
dpc-2111	156	19	reduce	reduce	VERB
dpc-2111	156	20	the	the	DET
dpc-2111	156	21	level	level	NOUN
dpc-2111	156	22	of	of	ADP
dpc-2111	156	23	taste	taste	NOUN
dpc-2111	156	24	-	-	PUNCT
dpc-2111	156	25	smell	smell	NOUN
dpc-2111	156	26	loss	loss	NOUN
dpc-2111	156	27	due	due	ADP
dpc-2111	156	28	to	to	ADP
dpc-2111	156	29	covid-19	covid-19	PROPN
dpc-2111	156	30	and	and	CCONJ
dpc-2111	156	31	accelerate	accelerate	VERB
dpc-2111	156	32	its	its	PRON
dpc-2111	156	33	recovery	recovery	NOUN
dpc-2111	156	34	.	.	PUNCT
dpc-2111	157	1	6	6	NUM
dpc-2111	157	2	original	original	ADJ
dpc-2111	157	3	article	article	NOUN
dpc-2111	157	4	|	|	ADV
dpc-2111	157	5	dermatol	dermatol	ADJ
dpc-2111	157	6	pract	pract	NOUN
dpc-2111	157	7	concept	concept	NOUN
dpc-2111	157	8	.	.	PUNCT
dpc-2111	158	1	2022;12(3):e2022146	2022;12(3):e2022146	NUM
dpc-2111	158	2	12	12	NUM
dpc-2111	158	3	.	.	PUNCT
dpc-2111	159	1	demirel	demirel	PROPN
dpc-2111	159	2	öğüt	öğüt	PROPN
dpc-2111	159	3	n	n	PROPN
dpc-2111	159	4	,	,	PUNCT
dpc-2111	159	5	kutlu	kutlu	PROPN
dpc-2111	159	6	ö	ö	PROPN
dpc-2111	159	7	,	,	PUNCT
dpc-2111	159	8	rbağcı	rbağcı	VERB
dpc-2111	159	9	e.	e.	PROPN
dpc-2111	159	10	oral	oral	PROPN
dpc-2111	159	11	isotretinoin	isotretinoin	PROPN
dpc-2111	159	12	treatment	treatment	NOUN
dpc-2111	159	13	in	in	ADP
dpc-2111	159	14	patients	patient	NOUN
dpc-2111	159	15	with	with	ADP
dpc-2111	159	16	acne	acne	NOUN
dpc-2111	159	17	vulgaris	vulgaris	NOUN
dpc-2111	159	18	during	during	ADP
dpc-2111	159	19	the	the	DET
dpc-2111	159	20	covid-19	covid-19	PROPN
dpc-2111	159	21	pandemic	pandemic	NOUN
dpc-2111	159	22	:	:	PUNCT
dpc-2111	159	23	a	a	DET
dpc-2111	159	24	retrospective	retrospective	ADJ
dpc-2111	159	25	cohort	cohort	NOUN
dpc-2111	159	26	study	study	NOUN
dpc-2111	159	27	in	in	ADP
dpc-2111	159	28	a	a	DET
dpc-2111	159	29	tertiary	tertiary	ADJ
dpc-2111	159	30	care	care	NOUN
dpc-2111	159	31	hospital	hospital	NOUN
dpc-2111	159	32	.	.	PUNCT
dpc-2111	160	1	j	j	PROPN
dpc-2111	160	2	cosmet	cosmet	PROPN
dpc-2111	160	3	dermatol	dermatol	NOUN
dpc-2111	160	4	.	.	PUNCT
dpc-2111	161	1	2021;20(7):1969	2021;20(7):1969	PROPN
dpc-2111	161	2	-	-	SYM
dpc-2111	161	3	1974	1974	NUM
dpc-2111	161	4	.	.	PUNCT
dpc-2111	162	1	doi	doi	NOUN
dpc-2111	162	2	:	:	PUNCT
dpc-2111	162	3	10.1111	10.1111	NUM
dpc-2111	162	4	/	/	SYM
dpc-2111	162	5	jocd.14168	jocd.14168	PROPN
dpc-2111	162	6	.	.	PUNCT
dpc-2111	163	1	pmid	pmid	NOUN
dpc-2111	163	2	:	:	PUNCT
dpc-2111	163	3	33884755	33884755	NUM
dpc-2111	163	4	.	.	PUNCT
dpc-2111	164	1	pmcid	pmcid	NOUN
dpc-2111	164	2	:	:	PUNCT
dpc-2111	164	3	pmc8251193	pmc8251193	ADV
dpc-2111	164	4	.	.	PUNCT
dpc-2111	165	1	13	13	NUM
dpc-2111	165	2	.	.	X
dpc-2111	166	1	lavezzo	lavezzo	PROPN
dpc-2111	166	2	e.	e.	PROPN
dpc-2111	166	3	suppression	suppression	NOUN
dpc-2111	166	4	of	of	ADP
dpc-2111	166	5	a	a	DET
dpc-2111	166	6	sars	sar	NOUN
dpc-2111	166	7	-	-	PUNCT
dpc-2111	166	8	cov-2	cov-2	NOUN
dpc-2111	166	9	outbreak	outbreak	NOUN
dpc-2111	166	10	in	in	ADP
dpc-2111	166	11	the	the	DET
dpc-2111	166	12	italian	italian	ADJ
dpc-2111	166	13	municipality	municipality	NOUN
dpc-2111	166	14	of	of	ADP
dpc-2111	166	15	vo	vo	NOUN
dpc-2111	166	16	’	'	PUNCT
dpc-2111	166	17	.	.	PUNCT
dpc-2111	166	18	 	 	SPACE
dpc-2111	167	1	nature	nature	NOUN
dpc-2111	167	2	.	.	PUNCT
dpc-2111	167	3	 	 	SPACE
dpc-2111	168	1	2020;584(7821):425–429.doi	2020;584(7821):425–429.doi	NUM
dpc-2111	168	2	:	:	PUNCT
dpc-2111	168	3	10.1038	10.1038	NUM
dpc-2111	168	4	/	/	SYM
dpc-2111	168	5	s41586	s41586	PROPN
dpc-2111	168	6	-	-	PUNCT
dpc-2111	168	7	020	020	NUM
dpc-2111	168	8	-	-	PUNCT
dpc-2111	168	9	2488	2488	NUM
dpc-2111	168	10	-	-	PUNCT
dpc-2111	168	11	1	1	NUM
dpc-2111	168	12	.	.	PUNCT
dpc-2111	169	1	pmid	pmid	NOUN
dpc-2111	169	2	:	:	PUNCT
dpc-2111	169	3	32604404	32604404	NUM
dpc-2111	169	4	.	.	PUNCT
dpc-2111	170	1	14	14	NUM
dpc-2111	170	2	.	.	PUNCT
dpc-2111	170	3	bolay	bolay	PROPN
dpc-2111	170	4	h	h	PROPN
dpc-2111	170	5	,	,	PUNCT
dpc-2111	170	6	gül	gül	NOUN
dpc-2111	170	7	a	a	PRON
dpc-2111	170	8	,	,	PUNCT
dpc-2111	170	9	baykan	baykan	PROPN
dpc-2111	170	10	b.	b.	PROPN
dpc-2111	170	11	covid-19	covid-19	PROPN
dpc-2111	170	12	is	be	AUX
dpc-2111	170	13	a	a	DET
dpc-2111	170	14	real	real	ADJ
dpc-2111	170	15	headache	headache	NOUN
dpc-2111	170	16	!	!	PUNCT
dpc-2111	170	17	.	.	PUNCT
dpc-2111	171	1	headache	headache	NOUN
dpc-2111	171	2	.	.	PUNCT
dpc-2111	172	1	2020;60(7):1415	2020;60(7):1415	NUM
dpc-2111	172	2	-	-	SYM
dpc-2111	172	3	1421	1421	NUM
dpc-2111	172	4	.	.	PUNCT
dpc-2111	173	1	doi:10.1111	doi:10.1111	ADJ
dpc-2111	173	2	/	/	SYM
dpc-2111	173	3	head.13856	head.13856	PROPN
dpc-2111	173	4	.	.	PUNCT
dpc-2111	173	5	pmid	pmid	PROPN
dpc-2111	173	6	:	:	PUNCT
dpc-2111	173	7	32412101	32412101	NUM
dpc-2111	173	8	.	.	PUNCT
dpc-2111	174	1	pmcid	pmcid	NOUN
dpc-2111	174	2	:	:	PUNCT
dpc-2111	174	3	pmc7272895	pmc7272895	PROPN
dpc-2111	174	4	.	.	PUNCT
dpc-2111	175	1	15	15	NUM
dpc-2111	175	2	.	.	PUNCT
dpc-2111	176	1	boscutti	boscutti	PROPN
dpc-2111	176	2	a	a	PROPN
dpc-2111	176	3	,	,	PUNCT
dpc-2111	176	4	delvecchio	delvecchio	VERB
dpc-2111	176	5	g	g	NOUN
dpc-2111	176	6	,	,	PUNCT
dpc-2111	176	7	pigoni	pigoni	VERB
dpc-2111	176	8	a	a	X
dpc-2111	176	9	,	,	PUNCT
dpc-2111	177	1	et	et	PROPN
dpc-2111	177	2	al	al	PROPN
dpc-2111	177	3	.	.	PROPN
dpc-2111	177	4	olfactory	olfactory	NOUN
dpc-2111	177	5	and	and	CCONJ
dpc-2111	177	6	gustatory	gustatory	NOUN
dpc-2111	177	7	dysfunctions	dysfunction	NOUN
dpc-2111	177	8	in	in	ADP
dpc-2111	177	9	sars	sar	NOUN
dpc-2111	177	10	-	-	PUNCT
dpc-2111	177	11	cov-2	cov-2	PART
dpc-2111	177	12	infection	infection	NOUN
dpc-2111	177	13	:	:	PUNCT
dpc-2111	177	14	a	a	DET
dpc-2111	177	15	systematic	systematic	ADJ
dpc-2111	177	16	review	review	NOUN
dpc-2111	177	17	.	.	PUNCT
dpc-2111	177	18	 	 	SPACE
dpc-2111	178	1	brain	brain	NOUN
dpc-2111	178	2	behav	behav	PROPN
dpc-2111	178	3	immun	immun	PROPN
dpc-2111	178	4	health	health	PROPN
dpc-2111	178	5	.	.	PUNCT
dpc-2111	179	1	2021;15:100268	2021;15:100268	X
dpc-2111	179	2	.	.	PUNCT
dpc-2111	179	3	doi	doi	NOUN
dpc-2111	179	4	:	:	PUNCT
dpc-2111	179	5	10.1016	10.1016	NUM
dpc-2111	179	6	/	/	SYM
dpc-2111	179	7	j.	j.	PROPN
dpc-2111	179	8	bbih.2021.100268	bbih.2021.100268	PROPN
dpc-2111	179	9	.	.	PUNCT
dpc-2111	180	1	pmid	pmid	NOUN
dpc-2111	180	2	:	:	PUNCT
dpc-2111	180	3	34027497	34027497	NUM
dpc-2111	180	4	.	.	PUNCT
dpc-2111	181	1	pmcid	pmcid	NOUN
dpc-2111	181	2	:	:	PUNCT
dpc-2111	181	3	pmc8129998	pmc8129998	PROPN
dpc-2111	181	4	.	.	PUNCT
dpc-2111	182	1	16	16	NUM
dpc-2111	182	2	.	.	PUNCT
dpc-2111	183	1	yee	yee	PROPN
dpc-2111	183	2	kk	kk	PROPN
dpc-2111	183	3	,	,	PUNCT
dpc-2111	183	4	rawson	rawson	PROPN
dpc-2111	183	5	ne	ne	PROPN
dpc-2111	183	6	.	.	PROPN
dpc-2111	183	7	immunolocalization	immunolocalization	PROPN
dpc-2111	183	8	of	of	ADP
dpc-2111	183	9	retinoic	retinoic	ADJ
dpc-2111	183	10	acid	acid	NOUN
dpc-2111	183	11	receptors	receptor	NOUN
dpc-2111	183	12	in	in	ADP
dpc-2111	183	13	the	the	DET
dpc-2111	183	14	mammalian	mammalian	ADJ
dpc-2111	183	15	olfactory	olfactory	NOUN
dpc-2111	183	16	system	system	NOUN
dpc-2111	183	17	and	and	CCONJ
dpc-2111	183	18	the	the	DET
dpc-2111	183	19	effects	effect	NOUN
dpc-2111	183	20	of	of	ADP
dpc-2111	183	21	olfactory	olfactory	ADJ
dpc-2111	183	22	denervation	denervation	NOUN
dpc-2111	183	23	on	on	ADP
dpc-2111	183	24	receptor	receptor	NOUN
dpc-2111	183	25	distribution	distribution	NOUN
dpc-2111	183	26	.	.	PUNCT
dpc-2111	183	27	 	 	SPACE
dpc-2111	183	28	neuroscience	neuroscience	NOUN
dpc-2111	183	29	.	.	PUNCT
dpc-2111	183	30	 	 	SPACE
dpc-2111	184	1	2005;131(3):733	2005;131(3):733	NUM
dpc-2111	184	2	–	–	PUNCT
dpc-2111	184	3	743	743	NUM
dpc-2111	184	4	.	.	PUNCT
dpc-2111	184	5	 	 	SPACE
dpc-2111	184	6	doi	doi	NOUN
dpc-2111	184	7	:	:	PUNCT
dpc-2111	184	8	10.1016	10.1016	NUM
dpc-2111	184	9	/	/	SYM
dpc-2111	184	10	j.neuroscience.2004.11.011	j.neuroscience.2004.11.011	PROPN
dpc-2111	184	11	.	.	PUNCT
dpc-2111	185	1	pmid	pmid	NOUN
dpc-2111	185	2	:	:	PUNCT
dpc-2111	185	3	15730877	15730877	NUM
dpc-2111	185	4	.	.	PUNCT
dpc-2111	186	1	17	17	NUM
dpc-2111	186	2	.	.	PUNCT
dpc-2111	187	1	kobal	kobal	PROPN
dpc-2111	187	2	g	g	PROPN
dpc-2111	187	3	,	,	PUNCT
dpc-2111	187	4	hummel	hummel	PROPN
dpc-2111	187	5	t	t	PROPN
dpc-2111	187	6	,	,	PUNCT
dpc-2111	187	7	sekinger	sekinger	NOUN
dpc-2111	187	8	b	b	PROPN
dpc-2111	187	9	,	,	PUNCT
dpc-2111	187	10	barz	barz	PROPN
dpc-2111	187	11	s	s	PROPN
dpc-2111	187	12	,	,	PUNCT
dpc-2111	187	13	roscher	roscher	PROPN
dpc-2111	187	14	s	s	PROPN
dpc-2111	187	15	,	,	PUNCT
dpc-2111	187	16	wolf	wolf	PROPN
dpc-2111	187	17	s.	s.	PROPN
dpc-2111	187	18	“	"	PUNCT
dpc-2111	187	19	sniffin’sticks	sniffin’stick	NOUN
dpc-2111	187	20	”	"	PUNCT
dpc-2111	187	21	:	:	PUNCT
dpc-2111	187	22	screening	screen	VERB
dpc-2111	187	23	of	of	ADP
dpc-2111	187	24	olfactory	olfactory	ADJ
dpc-2111	187	25	performance	performance	NOUN
dpc-2111	187	26	.	.	PUNCT
dpc-2111	187	27	  	  	SPACE
dpc-2111	187	28	rhinology	rhinology	NOUN
dpc-2111	187	29	.	.	PUNCT
dpc-2111	187	30	 	 	SPACE
dpc-2111	188	1	1996;34(4):222–226	1996;34(4):222–226	NUM
dpc-2111	188	2	.	.	PUNCT
dpc-2111	189	1	pmid	pmid	NOUN
dpc-2111	189	2	:	:	PUNCT
dpc-2111	189	3	9050101	9050101	NUM
dpc-2111	189	4	.	.	PUNCT
dpc-2111	190	1	18	18	NUM
dpc-2111	190	2	.	.	X
dpc-2111	190	3	kartal	kartal	PROPN
dpc-2111	190	4	d	d	PROPN
dpc-2111	190	5	,	,	PUNCT
dpc-2111	190	6	yaşar	yaşar	NOUN
dpc-2111	190	7	m	m	PROPN
dpc-2111	190	8	,	,	PUNCT
dpc-2111	190	9	kartal	kartal	PROPN
dpc-2111	190	10	l	l	NOUN
dpc-2111	190	11	,	,	PUNCT
dpc-2111	190	12	özcan	özcan	PROPN
dpc-2111	190	13	i	i	PROPN
dpc-2111	190	14	,	,	PUNCT
dpc-2111	190	15	borlu	borlu	VERB
dpc-2111	190	16	m.	m.	NOUN
dpc-2111	190	17	effects	effect	NOUN
dpc-2111	190	18	of	of	ADP
dpc-2111	190	19	isotretinoin	isotretinoin	PROPN
dpc-2111	190	20	on	on	ADP
dpc-2111	190	21	the	the	DET
dpc-2111	190	22	olfactory	olfactory	NOUN
dpc-2111	190	23	function	function	NOUN
dpc-2111	190	24	in	in	ADP
dpc-2111	190	25	patients	patient	NOUN
dpc-2111	190	26	with	with	ADP
dpc-2111	190	27	acne	acne	NOUN
dpc-2111	190	28	.	.	PUNCT
dpc-2111	190	29	 	 	SPACE
dpc-2111	191	1	an	an	DET
dpc-2111	191	2	bras	bras	NOUN
dpc-2111	191	3	dermatol	dermatol	NOUN
dpc-2111	191	4	.	.	PUNCT
dpc-2111	192	1	2017;92(2):191	2017;92(2):191	NUM
dpc-2111	192	2	-	-	PUNCT
dpc-2111	192	3	195	195	NUM
dpc-2111	192	4	.	.	PUNCT
dpc-2111	192	5	doi	doi	NOUN
dpc-2111	192	6	:	:	PUNCT
dpc-2111	192	7	10.1590	10.1590	NUM
dpc-2111	192	8	/	/	SYM
dpc-2111	192	9	abd18064841.20175483	abd18064841.20175483	NOUN
dpc-2111	192	10	.	.	PUNCT
dpc-2111	193	1	pmid	pmid	NOUN
dpc-2111	193	2	:	:	PUNCT
dpc-2111	193	3	28538877	28538877	NUM
dpc-2111	193	4	.	.	PUNCT
dpc-2111	194	1	pmcid	pmcid	NOUN
dpc-2111	194	2	:	:	PUNCT
dpc-2111	194	3	pmc5429103	pmc5429103	PROPN
dpc-2111	194	4	.	.	PUNCT
dpc-2111	195	1	6	6	NUM
dpc-2111	195	2	.	.	X
dpc-2111	196	1	sinha	sinha	PROPN
dpc-2111	196	2	s	s	PROPN
dpc-2111	196	3	,	,	PUNCT
dpc-2111	196	4	cheng	cheng	PROPN
dpc-2111	196	5	k	k	PROPN
dpc-2111	196	6	,	,	PUNCT
dpc-2111	196	7	aldape	aldape	PROPN
dpc-2111	196	8	k	k	PROPN
dpc-2111	196	9	,	,	PUNCT
dpc-2111	196	10	schiff	schiff	PROPN
dpc-2111	196	11	e	e	PROPN
dpc-2111	196	12	,	,	PUNCT
dpc-2111	196	13	ruppin	ruppin	PROPN
dpc-2111	196	14	e.	e.	PROPN
dpc-2111	196	15	systematic	systematic	PROPN
dpc-2111	196	16	cell	cell	NOUN
dpc-2111	196	17	line	line	NOUN
dpc-2111	196	18	-	-	PUNCT
dpc-2111	196	19	based	base	VERB
dpc-2111	196	20	identification	identification	NOUN
dpc-2111	196	21	of	of	ADP
dpc-2111	196	22	drugs	drug	NOUN
dpc-2111	196	23	modifying	modify	VERB
dpc-2111	196	24	ace2	ace2	NOUN
dpc-2111	196	25	expression	expression	NOUN
dpc-2111	196	26	.	.	PUNCT
dpc-2111	197	1	preprints	preprint	NOUN
dpc-2111	197	2	.	.	PUNCT
dpc-2111	198	1	2020	2020	NUM
dpc-2111	198	2	,	,	PUNCT
dpc-2111	198	3	2020030446	2020030446	NUM
dpc-2111	198	4	.	.	PUNCT
dpc-2111	199	1	doi	doi	NOUN
dpc-2111	199	2	:	:	PUNCT
dpc-2111	199	3	10.20944/	10.20944/	NUM
dpc-2111	199	4	preprints	preprint	NOUN
dpc-2111	199	5	202003.0446.v1	202003.0446.v1	ADV
dpc-2111	199	6	.	.	PUNCT
dpc-2111	200	1	7	7	X
dpc-2111	200	2	.	.	X
dpc-2111	200	3	li	li	PROPN
dpc-2111	200	4	r	r	PROPN
dpc-2111	200	5	,	,	PUNCT
dpc-2111	200	6	wu	wu	PROPN
dpc-2111	200	7	k	k	PROPN
dpc-2111	200	8	,	,	PUNCT
dpc-2111	200	9	li	li	PROPN
dpc-2111	200	10	y	y	PROPN
dpc-2111	200	11	,	,	PUNCT
dpc-2111	200	12	et	et	PROPN
dpc-2111	200	13	al	al	PROPN
dpc-2111	200	14	.	.	PUNCT
dpc-2111	200	15	revealing	reveal	VERB
dpc-2111	200	16	the	the	DET
dpc-2111	200	17	targets	target	NOUN
dpc-2111	200	18	and	and	CCONJ
dpc-2111	200	19	mechanisms	mechanism	NOUN
dpc-2111	200	20	of	of	ADP
dpc-2111	200	21	vitamin	vitamin	NOUN
dpc-2111	200	22	a	a	PRON
dpc-2111	200	23	in	in	ADP
dpc-2111	200	24	the	the	DET
dpc-2111	200	25	treatment	treatment	NOUN
dpc-2111	200	26	of	of	ADP
dpc-2111	200	27	covid-19	covid-19	PROPN
dpc-2111	200	28	.	.	PUNCT
dpc-2111	200	29	  	  	SPACE
dpc-2111	200	30	aging	aging	NOUN
dpc-2111	200	31	(	(	PUNCT
dpc-2111	200	32	albany	albany	PROPN
dpc-2111	200	33	ny	ny	PROPN
dpc-2111	200	34	)	)	PUNCT
dpc-2111	200	35	.	.	PUNCT
dpc-2111	201	1	2020;12(15):15784	2020;12(15):15784	NUM
dpc-2111	201	2	-	-	SYM
dpc-2111	201	3	15796	15796	NUM
dpc-2111	201	4	.	.	PUNCT
dpc-2111	202	1	doi:10.18632	doi:10.18632	PROPN
dpc-2111	202	2	/	/	SYM
dpc-2111	202	3	aging.103888	aging.103888	PROPN
dpc-2111	202	4	.	.	PROPN
dpc-2111	202	5	pmid	pmid	PROPN
dpc-2111	202	6	:	:	PUNCT
dpc-2111	202	7	32805728	32805728	NUM
dpc-2111	202	8	.	.	PUNCT
dpc-2111	203	1	pmcid	pmcid	NOUN
dpc-2111	203	2	:	:	PUNCT
dpc-2111	203	3	pmc7467385	pmc7467385	VERB
dpc-2111	203	4	.	.	PUNCT
dpc-2111	204	1	8	8	X
dpc-2111	204	2	.	.	X
dpc-2111	204	3	mawson	mawson	PROPN
dpc-2111	204	4	ar	ar	PROPN
dpc-2111	204	5	,	,	PUNCT
dpc-2111	204	6	croft	croft	PROPN
dpc-2111	204	7	am	am	PROPN
dpc-2111	204	8	,	,	PUNCT
dpc-2111	204	9	gonzalez	gonzalez	PROPN
dpc-2111	204	10	-	-	PUNCT
dpc-2111	204	11	fernandez	fernandez	PROPN
dpc-2111	204	12	f.	f.	PROPN
dpc-2111	204	13	liver	liver	PROPN
dpc-2111	204	14	damage	damage	NOUN
dpc-2111	204	15	and	and	CCONJ
dpc-2111	204	16	exposure	exposure	NOUN
dpc-2111	204	17	to	to	ADP
dpc-2111	204	18	toxic	toxic	ADJ
dpc-2111	204	19	concentrations	concentration	NOUN
dpc-2111	204	20	of	of	ADP
dpc-2111	204	21	endogenous	endogenous	ADJ
dpc-2111	204	22	retinoids	retinoid	NOUN
dpc-2111	204	23	in	in	ADP
dpc-2111	204	24	the	the	DET
dpc-2111	204	25	pathogenesis	pathogenesis	NOUN
dpc-2111	204	26	of	of	ADP
dpc-2111	204	27	covid-19	covid-19	PROPN
dpc-2111	204	28	disease	disease	NOUN
dpc-2111	204	29	:	:	PUNCT
dpc-2111	204	30	hypothesis	hypothesis	NOUN
dpc-2111	204	31	.	.	PUNCT
dpc-2111	204	32	  	  	SPACE
dpc-2111	204	33	viral	viral	ADJ
dpc-2111	204	34	immunol	immunol	NOUN
dpc-2111	204	35	.	.	PUNCT
dpc-2111	205	1	2021;34(6):376	2021;34(6):376	NUM
dpc-2111	205	2	-	-	SYM
dpc-2111	205	3	379	379	NUM
dpc-2111	205	4	.	.	PUNCT
dpc-2111	206	1	doi	doi	NOUN
dpc-2111	206	2	:	:	PUNCT
dpc-2111	206	3	10.1089	10.1089	NUM
dpc-2111	206	4	/	/	SYM
dpc-2111	206	5	vim.2020.0330	vim.2020.0330	NUM
dpc-2111	206	6	.	.	PUNCT
dpc-2111	207	1	pmid	pmid	NOUN
dpc-2111	207	2	:	:	PUNCT
dpc-2111	207	3	33983857	33983857	NUM
dpc-2111	207	4	.	.	PUNCT
dpc-2111	208	1	pmcid	pmcid	NOUN
dpc-2111	208	2	:	:	PUNCT
dpc-2111	208	3	pmc8392079	pmc8392079	NOUN
dpc-2111	208	4	.	.	PUNCT
dpc-2111	209	1	9	9	X
dpc-2111	209	2	.	.	X
dpc-2111	209	3	jovic	jovic	PROPN
dpc-2111	209	4	th	th	PROPN
dpc-2111	209	5	,	,	PUNCT
dpc-2111	209	6	ali	ali	PROPN
dpc-2111	209	7	sr	sr	PROPN
dpc-2111	209	8	,	,	PUNCT
dpc-2111	209	9	ibrahim	ibrahim	PROPN
dpc-2111	209	10	n	n	CCONJ
dpc-2111	209	11	,	,	PUNCT
dpc-2111	209	12	et	et	PROPN
dpc-2111	209	13	al	al	PROPN
dpc-2111	209	14	.	.	PROPN
dpc-2111	210	1	could	could	AUX
dpc-2111	210	2	vitamins	vitamin	NOUN
dpc-2111	210	3	help	help	VERB
dpc-2111	210	4	in	in	ADP
dpc-2111	210	5	the	the	DET
dpc-2111	210	6	fight	fight	NOUN
dpc-2111	210	7	against	against	ADP
dpc-2111	210	8	covid-19	covid-19	PROPN
dpc-2111	210	9	?	?	PUNCT
dpc-2111	210	10	  	  	SPACE
dpc-2111	210	11	nutrients	nutrient	NOUN
dpc-2111	210	12	.	.	PUNCT
dpc-2111	211	1	2020;12(9):2550	2020;12(9):2550	NUM
dpc-2111	211	2	.	.	PUNCT
dpc-2111	211	3	published	publish	VERB
dpc-2111	211	4	2020;12(9):2550	2020;12(9):2550	NUM
dpc-2111	211	5	.	.	PUNCT
dpc-2111	212	1	doi:10.3390	doi:10.3390	NOUN
dpc-2111	212	2	/	/	SYM
dpc-2111	212	3	nu12092550	nu12092550	PROPN
dpc-2111	212	4	.	.	PUNCT
dpc-2111	213	1	pmid	pmid	NOUN
dpc-2111	213	2	:	:	PUNCT
dpc-2111	213	3	32842513	32842513	NUM
dpc-2111	213	4	.	.	PUNCT
dpc-2111	214	1	pmcid	pmcid	ADJ
dpc-2111	214	2	:	:	PUNCT
dpc-2111	214	3	pmc7551685	pmc7551685	NOUN
dpc-2111	214	4	.	.	PUNCT
dpc-2111	215	1	10	10	NUM
dpc-2111	215	2	.	.	PUNCT
dpc-2111	215	3	li	li	PROPN
dpc-2111	215	4	j	j	PROPN
dpc-2111	215	5	,	,	PUNCT
dpc-2111	215	6	huang	huang	PROPN
dpc-2111	215	7	dq	dq	PROPN
dpc-2111	215	8	,	,	PUNCT
dpc-2111	215	9	zou	zou	PROPN
dpc-2111	215	10	b	b	PROPN
dpc-2111	215	11	,	,	PUNCT
dpc-2111	215	12	et	et	PROPN
dpc-2111	215	13	al	al	PROPN
dpc-2111	215	14	.	.	PUNCT
dpc-2111	215	15	epidemiology	epidemiology	NOUN
dpc-2111	215	16	of	of	ADP
dpc-2111	215	17	covid-19	covid-19	PROPN
dpc-2111	215	18	:	:	PUNCT
dpc-2111	215	19	a	a	DET
dpc-2111	215	20	systematic	systematic	ADJ
dpc-2111	215	21	review	review	NOUN
dpc-2111	215	22	and	and	CCONJ
dpc-2111	215	23	meta	meta	NOUN
dpc-2111	215	24	-	-	PUNCT
dpc-2111	215	25	analysis	analysis	NOUN
dpc-2111	215	26	of	of	ADP
dpc-2111	215	27	clinical	clinical	ADJ
dpc-2111	215	28	characteristics	characteristic	NOUN
dpc-2111	215	29	,	,	PUNCT
dpc-2111	215	30	risk	risk	NOUN
dpc-2111	215	31	factors	factor	NOUN
dpc-2111	215	32	,	,	PUNCT
dpc-2111	215	33	and	and	CCONJ
dpc-2111	215	34	outcomes	outcome	NOUN
dpc-2111	215	35	.	.	PUNCT
dpc-2111	215	36	  	  	SPACE
dpc-2111	216	1	j	j	PROPN
dpc-2111	216	2	med	med	ADJ
dpc-2111	216	3	virol	virol	NOUN
dpc-2111	216	4	.	.	PUNCT
dpc-2111	217	1	2021;93(3):14491458	2021;93(3):14491458	NUM
dpc-2111	217	2	.	.	PUNCT
dpc-2111	218	1	doi:10.1002	doi:10.1002	NOUN
dpc-2111	218	2	/	/	SYM
dpc-2111	218	3	jmv.26424	jmv.26424	PROPN
dpc-2111	218	4	.	.	PUNCT
dpc-2111	219	1	pmid	pmid	NOUN
dpc-2111	219	2	:	:	PUNCT
dpc-2111	219	3	32790106	32790106	NUM
dpc-2111	219	4	.	.	PUNCT
dpc-2111	220	1	pmcid	pmcid	NOUN
dpc-2111	220	2	:	:	PUNCT
dpc-2111	220	3	pmc7436673	pmc7436673	PROPN
dpc-2111	220	4	.	.	PUNCT
dpc-2111	221	1	11	11	NUM
dpc-2111	221	2	.	.	PUNCT
dpc-2111	222	1	li	li	PROPN
dpc-2111	222	2	w	w	PROPN
dpc-2111	222	3	,	,	PUNCT
dpc-2111	222	4	moore	moore	PROPN
dpc-2111	222	5	mj	mj	PROPN
dpc-2111	222	6	,	,	PUNCT
dpc-2111	222	7	vasilieva	vasilieva	PROPN
dpc-2111	222	8	n	n	CCONJ
dpc-2111	222	9	,	,	PUNCT
dpc-2111	222	10	et	et	PROPN
dpc-2111	222	11	al	al	PROPN
dpc-2111	222	12	.	.	PUNCT
dpc-2111	222	13	angiotensin	angiotensin	NOUN
dpc-2111	222	14	-	-	PUNCT
dpc-2111	222	15	converting	convert	VERB
dpc-2111	222	16	enzyme	enzyme	NOUN
dpc-2111	222	17	2	2	NUM
dpc-2111	222	18	is	be	AUX
dpc-2111	222	19	a	a	DET
dpc-2111	222	20	functional	functional	ADJ
dpc-2111	222	21	receptor	receptor	NOUN
dpc-2111	222	22	for	for	ADP
dpc-2111	222	23	the	the	DET
dpc-2111	222	24	sars	sars	PROPN
dpc-2111	222	25	coronavirus	coronavirus	PROPN
dpc-2111	222	26	.	.	PUNCT
dpc-2111	222	27	 	 	SPACE
dpc-2111	222	28	nature	nature	NOUN
dpc-2111	222	29	.	.	PUNCT
dpc-2111	223	1	2003;426(6965):450	2003;426(6965):450	NUM
dpc-2111	223	2	-	-	SYM
dpc-2111	223	3	454	454	NUM
dpc-2111	223	4	.	.	PUNCT
dpc-2111	223	5	doi:10.1038	doi:10.1038	NOUN
dpc-2111	223	6	/	/	SYM
dpc-2111	223	7	nature02145	nature02145	PROPN
dpc-2111	223	8	.	.	PUNCT
dpc-2111	224	1	pmid	pmid	NOUN
dpc-2111	224	2	:	:	PUNCT
dpc-2111	224	3	14647384	14647384	NUM
dpc-2111	224	4	.	.	PUNCT
dpc-2111	225	1	pmcid	pmcid	NOUN
dpc-2111	225	2	:	:	PUNCT
dpc-2111	225	3	pmc7095016	pmc7095016	ADJ
dpc-2111	225	4	.	.	PUNCT